[go: up one dir, main page]

WO2021261975A1 - Vegetable extract comprising vegetable collagen and vegetable mucin, and method for preparing same - Google Patents

Vegetable extract comprising vegetable collagen and vegetable mucin, and method for preparing same Download PDF

Info

Publication number
WO2021261975A1
WO2021261975A1 PCT/KR2021/008104 KR2021008104W WO2021261975A1 WO 2021261975 A1 WO2021261975 A1 WO 2021261975A1 KR 2021008104 W KR2021008104 W KR 2021008104W WO 2021261975 A1 WO2021261975 A1 WO 2021261975A1
Authority
WO
WIPO (PCT)
Prior art keywords
extract
mushroom
collagen
skin
plant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2021/008104
Other languages
French (fr)
Korean (ko)
Inventor
조기환
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Koreahongsamwon CoLtd
Original Assignee
Koreahongsamwon CoLtd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020200078772A external-priority patent/KR102535894B1/en
Priority claimed from KR1020200182639A external-priority patent/KR102351730B1/en
Priority claimed from KR1020210043663A external-priority patent/KR102432924B1/en
Application filed by Koreahongsamwon CoLtd filed Critical Koreahongsamwon CoLtd
Priority to JP2022580932A priority Critical patent/JP2023532093A/en
Publication of WO2021261975A1 publication Critical patent/WO2021261975A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/185Vegetable proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations

Definitions

  • the present invention relates to a plant extract comprising plant collagen and plant mucin and a method for preparing the same.
  • Collagen is a fibrous structural protein constituting animal connective tissue, skin, bone, tendon, skin, cartilage, nails, toenails, teeth, blood vessels, and the like. Collagen accounts for about 30% of human protein, is the main component of connective tissue, and accounts for 70-90% of the dermal layer of the skin.
  • the basic structural unit of collagen is tropocollagen, which is a very large macromolecular protein of 300,000 Daltons (Da) in which a peptide having a molecular weight of 100,000 Daltons (Da) has a triple helix structure.
  • the amino acids constituting collagen are glycine, proline, hydroxyproline, and other amino acids combined with G-X-Y.
  • Collagen contains relatively low hydroxyproline in other proteins, so the hydroxyproline content is also a measure of the collagen content in the organ.
  • collagen When collagen is treated with heat or chemicals, it denatures into gelatin. It has been expected that collagen can be ingested by ingesting pork skin or chicken feet, but collagen is a high molecular weight protein of 300,000 Daltons, so the absorption rate in the body is less than 10%. have. According to the 500 Dalton Rule, in order for collagen to be absorbed into the skin, it must be less than 500 Daltons. It is known that the absorption rate of 2,000 to 6,000 daltons of pharmaceutical grade collagen is 50%, and more than 90% of collagen hydrolyzed to 500 daltons is absorbed.
  • the collagen is a fibrous protein constituting skin, cartilage, hair, nails, toenails, teeth, and blood vessels, and serves to maintain the structure of the extracellular matrix (ECM) and maintain elasticity.
  • ECM extracellular matrix
  • ROS reactive oxygen species
  • Plant collagen present in plants promotes collagen production in the body and inhibits collagen degradation by inhibiting MMP-1, a collagen-degrading enzyme.
  • vegetable collagen is rich in antioxidants that animal collagen does not have.
  • Most of the collagen products currently on the market are animal collagen extracted from fish or cattle, and there are concerns about consumers being uncomfortable to eat due to their unique smell or using mad cow disease or antibiotics.
  • Most of the vegetable collagen of the present invention has a molecular weight of 100 to 400 Daltons and is hydrolyzed to an average of 500 Daltons or less, so the absorption rate is more than 90%. can be useful for
  • the present inventors made intensive research efforts to develop a method for producing a plant extract containing a large amount of vegetable collagen that can replace the existing animal collagen.
  • viscous vegetable collagen and vegetable mucin are contained in large amounts in the extract extracted through enzyme and microbial fermentation after plant powder is immersed in a solvent.
  • the present invention was completed.
  • an object of the present invention is to provide an extract comprising vegetable collagen and vegetable mucin and a method for preparing the same.
  • Another object of the present invention is to provide a food composition or cosmetic composition for skin anti-aging, wrinkle improvement, skin barrier strengthening, or skin moisturizing comprising an extract containing vegetable collagen and vegetable mucin as an active ingredient.
  • the present invention provides a food composition for skin anti-aging, wrinkle improvement, skin barrier strengthening, or skin moisturizing comprising a plant extract as an active ingredient.
  • the plant extract includes plant collagen and plant mucin.
  • vegetable collagen refers to collagen derived from plants.
  • the extract extracts at least one herbal material selected from the group consisting of spinach, Swiss chard, carrot, tomato, astragalus, chrysanthemum, mushrooms, round hemp, lotus root, rape flower, and rapeseed it was obtained by
  • the one or more herbal ingredients may be one single herbal ingredient, or a mixture of two or more kinds of herbal ingredients.
  • the mushrooms are not strictly classified as plants, but the plant extract of the present invention is a concept including the extract of mushrooms.
  • the food composition is pomegranate, tart cherry, blueberry, garlic, mango, orange, avocado, white lily, cashew nut, hibiscus, strawberry, goldfish, kiwi, guava, pineapple, soybean,
  • An extract obtained by extracting a mixture of one or more herbal ingredients selected from the group consisting of bell pepper, raspberry, blackberry, goji berry, bokryeong, and sukjihwang is additionally included.
  • the mushrooms are white wood ear mushroom, wood ear mushroom, reishi mushroom, chima mushroom, matsutake mushroom, shiitake mushroom, truffle, situation mushroom, horseshoe mushroom, pine mushroom, chaga mushroom, neungi mushroom, roe deer At least one mushroom selected from the group consisting of oyster mushroom, oyster mushroom, and blackcurrant mushroom, but is not limited thereto.
  • the white woody mushroom belongs to the white woody mushroom and its scientific name is Tremella fuciformis. It is widely distributed in Korea, China, Japan, and tropical regions.
  • the fruiting body (mushroom) of the white-necked ear is agaric, wrinkled and split, or has the shape of an earlobe or a crest, and the size is about 10 cm. When dried, it forms a thin film, but swells when water is absorbed. It is known to have various effects such as immunity enhancement, bone health enhancement, constipation improvement, anticancer action, skin beauty, prevention of vascular disease, and prevention of anemia.
  • the present inventors have attempted to develop an extraction method according to the enzymatic treatment of the white wood ear mushroom in order to further improve the efficacy of the white wood ear mushroom and to improve the properties as a food composition.
  • the mushrooms refer to the fruiting bodies of each type of mushroom, but are not limited thereto.
  • the extract may be included in the range of 0.001 to 20% (w/w) based on the total weight of the food composition, but this is only exemplary and not limited thereto.
  • the extract contains hyaluronic acid. Accordingly, the extract of the present invention contains vegetable hyaluronic acid.
  • the plant extract which is an active ingredient of the composition, contains vegetable collagen and plant mucin, and increases the expression of collagen in the skin.
  • the plant extract of the present invention contains collagen peptides and is prepared by fermentation. Therefore, the plant extract of the present invention can be called a fermented collagen peptide composition.
  • the raw material of the plant extract of the present invention is white wood ear mushroom, it may be called a white wood ear mushroom fermented collagen peptide composition.
  • Collagen a major component of the extracellular matrix, is a protein expressed in fibroblasts of the skin and forms most of the organic materials of skin, bones, and teeth. It has various functions such as cell support (Brenneisen et al., 2002; Kim et al., 2015).
  • Collagen is known to be closely related to the formation of wrinkles in the skin, and a lack of collagen can cause wrinkles.
  • Collagen is synthesized in the form of procollagen, a precursor, and is known to be cleaved and separated from collagen molecules during collagen polymerization (Lee et al., 2015). That is, by measuring the amount of propeptide, it is possible to determine the degree of collagen biosynthesis in the cell.
  • the food composition of the present invention may include ingredients commonly added during food production, as well as the extract.
  • the additional ingredients include, for example, proteins, carbohydrates, fats, nutrients, seasonings and flavoring agents.
  • examples of the above-mentioned carbohydrates include monosaccharides such as glucose, fructose and the like; disaccharides such as maltose, sucrose, oligosaccharides and the like; and polysaccharides, for example, conventional sugars such as dextrin, cyclodextrin, and the like, and sugar alcohols such as xylitol, sorbitol, and erythritol.
  • natural flavoring agents [taumatin, stevia extract (eg, rebaudioside A, glycyrrhizin, etc.)) and synthetic flavoring agents (saccharin, aspartame, etc.) can be used.
  • the present invention provides a plant fermented food comprising the food composition.
  • the plant may be, for example, white wood ear mushroom, but is not limited thereto.
  • the present invention provides a fermented food of white wood ear mushroom.
  • the fermented white wood ear mushroom food of the present invention may include not only the fermented collagen peptide composition prepared by the above manufacturing method, but also the ingredients commonly added during the preparation of the above-described food.
  • the food composition may be prepared in the form of a beverage.
  • citric acid, high fructose, sugar, glucose, acetic acid, malic acid, fruit juice, tofu extract, jujube extract, licorice extract, etc. may be additionally included in addition to the extract of the present invention.
  • the fermented food may be a fermented white wood ear mushroom drink.
  • the food composition of the present invention includes processed forms of all natural materials such as food, functional food, nutritional supplement, health food, and food additives.
  • Food compositions of this type can be prepared in various forms according to conventional methods known in the art.
  • the extract may be prepared in the form of tea, juice, and drink to be consumed, or granulated, encapsulated and powdered.
  • beverages including alcoholic beverages
  • fruits and their processed foods eg, canned fruit, bottled, jam, marmalade, etc.
  • fish, meat and their processed foods eg, ham, sausage corn beef, etc.
  • breads and noodles eg udon noodles, soba noodles, ramen, spaghetti, macaroni, etc.
  • fruit juice various drinks, cookies, syrup, dairy products (eg yogurt, fermented milk, butter, cheese, etc.), edible vegetable oils and fats, margarine, Vegetable protein, retort food, frozen food, various seasonings (eg, soybean paste, soy sauce, sauce, etc.) may be prepared by adding the extract of the present invention.
  • vegetable paste, soy sauce, sauce, etc. may be prepared by adding the extract of the present invention.
  • vegetable paste e.g., soybean paste, soy sauce, sauce, etc.
  • the present invention provides a cosmetic composition for skin anti-aging, wrinkle improvement, skin barrier strengthening or skin moisturizing comprising a plant extract as an active ingredient.
  • the extract is also characterized in that it contains vegetable collagen and vegetable mucin.
  • the cosmetic composition of the present invention contains the same extract as the above-described food composition as an active ingredient, and descriptions of common contents between the two inventions are omitted in order to avoid the complexity of the present specification.
  • the extract containing the vegetable collagen and vegetable mucin may be included in an amount of 0.001 to 20% by weight.
  • the formulation of the cosmetic is not particularly limited, but preferably skin lotion, skin softener, skin toner, astringent, lotion, milk lotion, moisture lotion, nourishing lotion, massage cream, nourishing cream, moisture cream, hand cream, foundation, essence , nutritional essence, pack, soap, cleansing foam, cleansing lotion, cleansing cream, body lotion and body cleanser.
  • the cosmetic of the present invention may also contain other ingredients that are formulated in conventional cosmetics.
  • Other ingredients that may be added include oils and fats, moisturizers, emollients, surfactants, organic and inorganic pigments, organic powders, UV absorbers, preservatives, bactericides, antioxidants, plant extracts, pH adjusters, alcohols, colorants, fragrances, A blood circulation promoter, a cooling agent, a restrictive agent, purified water, etc. are mentioned.
  • Blending components that may be added other than the above are not limited thereto, and any of the above components can be blended within a range that does not impair the object and effect of the present invention, but preferably 0.01 to 5 wt%, more preferably, based on the total weight 0.01 - 3 wt%, 0.01 - 2 wt%, 0.01 - 1 wt%, 0.1 - 3 wt%, 0.5 - 3 wt%, 1 - 3 wt%, or 2 - 3 wt%, etc. may be blended.
  • the cosmetic of the present invention may take the form of a solution, an emulsion, a viscous mixture, or the like.
  • the ingredients included in the cosmetic of the present invention may include ingredients commonly used in cosmetics in addition to the peptide composition as an active ingredient, for example, conventional adjuvants such as stabilizers, solubilizers, vitamins, pigments and fragrances carrier.
  • conventional adjuvants such as stabilizers, solubilizers, vitamins, pigments and fragrances carrier.
  • the cosmetic formulation of the present invention is a paste, cream or gel, animal fiber, vegetable fiber, wax, paraffin, starch, tracanth, cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc or zinc oxide, etc.
  • the cosmetic formulation of the present invention is a powder or a spray
  • lactose, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder may be used as a carrier component, and in particular, in the case of a spray, additional chlorofluorohydrocarbon, propellants such as propane/butane or dimethyl ether.
  • a solvent, solvating agent or emulsifying agent is used as a carrier component, for example, water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol, 1,3-butylglycol oil, glycerol fatty esters, fatty acid esters of polyethylene glycol or sorbitan.
  • the cosmetic formulation of the present invention is a suspension
  • a liquid diluent such as water, ethanol or propylene glycol
  • a suspending agent such as ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester, and microcrystals
  • a suspending agent such as ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester, and microcrystals
  • cellulose, aluminum metahydroxide, bentonite, agar or tracanth may be used.
  • the cosmetic formulation of the present invention is a surfactant-containing cleansing agent
  • aliphatic alcohol sulfate, aliphatic alcohol ether sulfate, sulfosuccinic acid monoester, isethionate, imidazolinium derivative, methyl taurate, sarcosinate, Fatty acid amide ether sulfate, alkylamidobetaine, fatty alcohol, fatty acid glyceride, fatty acid diethanolamide, vegetable oil, linoline derivative or ethoxylated glycerol fatty acid ester and the like can be used.
  • alkali metal salts of fatty acids When the formulation of the present invention is soap, alkali metal salts of fatty acids, fatty acid hemiester salts, fatty acid protein hydrolysates, isethionate, lanolin derivatives, aliphatic alcohols, vegetable oils, glycerol, sugar, etc. are used as carrier components may be, but is not limited thereto. These may be used alone or in combination of two or more.
  • the present invention provides a method for preparing a vegetable extract comprising the steps of:
  • the plant extract according to the present invention abundantly contains vegetable collagen, plant mucin, and the like.
  • the method for preparing the extract further comprises the step of (e) obtaining a powdery extract by drying the liquid extract or the same.
  • the herbal material powder of step (a) is pulverized to a particle size in the range of 10 to 100 mesh (mesh).
  • a method of pulverizing and pulverizing food commonly used in the art may be used without limitation.
  • the herbal material is at least one selected from the group consisting of spinach, Swiss chard, carrot, tomato, astragalus, chrysanthemum, mushrooms, round hemp, lotus root, rape flower and rapeseed.
  • the herbal material is pomegranate, tart cherry, blueberry, garlic, mango, orange, avocado, white lily, cashew nut, hibiscus, strawberry, goldfish, kiwi, guava, pineapple, soybean, Bell pepper, raspberry, blackberry, goji berry, bokryeong, and additionally includes at least one selected from the group consisting of sukjihwang.
  • the mushrooms are white wood ear mushroom, wood ear mushroom, reishi mushroom, chima mushroom, matsutake mushroom, shiitake mushroom, truffle, situation mushroom, horseshoe mushroom, pine mushroom, chaga mushroom, neungi mushroom, roe deer At least one mushroom selected from the group consisting of oyster mushroom, oyster mushroom, and blackcurrant mushroom, but is not limited thereto.
  • the solvent is purified water or a C1 to C4 aqueous solution of lower alcohol, and more specifically, purified water or an aqueous ethanol solution.
  • the solvent in step (a), is added in an amount of 1 to 100 parts by weight based on 1 part by weight of the herbal herbal material powder.
  • the purified water may be added in an amount of 2 to 80 parts by weight, 2 to 50 parts by weight, 3 to 30 parts by weight, 5 to 20 parts by weight, 5 to 15 parts by weight, or 5 to 10 parts by weight, but is not limited thereto. .
  • the plant herbal material powder of step (a) is treated with an acid selected from citric acid, acetic acid, or dilute hydrochloric acid at a concentration of 1 to 80% (w/w) for 1 to 5 hours.
  • the acid is 1 to 60% (w/w), 1 to 50% (w/w), 1 to 40% (w/w), 1 to 30% (w/w), 1 to 20% (w/w) ), or 1 to 10% (w/w), but is not limited thereto.
  • the preparation method of the present invention may include neutralizing after treatment with an acid selected from citric acid, acetic acid, or dilute hydrochloric acid.
  • step (a) may include a step of adding an aqueous ethanol solution as a solvent to the plant herbal material powder.
  • the process of adding the aqueous ethanol solution as a solvent may be performed after acid treatment or acid treatment and neutralization of the above-described vegetable herbal material powder.
  • the extract of the present invention may be extracted by a known natural product extraction method.
  • extraction may be performed by cold extraction, hot water extraction, ultrasonic extraction, reflux cooling extraction, or heating extraction method, and specifically, extraction may be performed by hot water extraction or reflux cooling extraction method, 1 to 10 times, more specifically 2 Extraction can be repeated 7 to 7 times.
  • the extraction solvent may be water (purified water).
  • the extract may be used in the form of a crude extract extracted with a solvent, and may be purified and used with high purity.
  • the term 'extract' has the meaning commonly used as a crude extract in the art as described above, but in a broad sense also includes a fraction obtained by additionally fractionating the extract. That is, the extract of the herbal herbal material includes not only those obtained by using the above-described extraction solvent, but also those obtained by additionally applying a purification process thereto. For example, a fraction obtained by passing the extract through an ultrafiltration membrane having a constant molecular weight cut-off value, dialysis, separation by various chromatography (prepared for separation according to size, charge, hydrophobicity or affinity), etc., additionally carried out The fractions obtained through various purification methods are also included in the extract of the herbal herbal material of the present invention.
  • step (a) an aqueous ethanol solution is added to the vegetable herbal material powder as a solvent and extracted, followed by solid-liquid separation to obtain a liquid component, and the solid content is 60-95° C. after adding water After hot water extraction in the ethanol solution, it is mixed with the liquid component extracted with the aqueous ethanol solution.
  • step (a) a solvent is added to the herbal herbal material powder, and the pressure treatment may be performed under 0.2 to 5 atmospheres.
  • the pressurization treatment may be performed in parallel with the hot water extraction step.
  • the pressurization treatment is performed under conditions of 0.2 atm or more and less than 1 atm; pressure treatment under conditions of more than 1 atmosphere and less than 5 atmospheres; Alternatively, after being pressurized under conditions of 0.2 atm or more and less than 1 atm, it may be pressurized again under conditions of greater than 1 atm and below 5 atm.
  • the pressure treatment under the conditions of 0.2 to 5 atmospheres may be performed for 30 minutes to 2 days, and may be performed one or more times under different pressure and time conditions.
  • the pressure treatment may be, for example, pressurized under conditions of 0.2 atm or more and less than 1 atm for 30 minutes to 1 day, and then pressurized under conditions of greater than 1 atm and below 5 atm, for 30 minutes to 1 day.
  • the pressurization process under the conditions of more than 0.2 atm and 1 atm or less expands and removes (de-foaming) fine air bubbles contained in the mixture of powder and solvent so that the herbal material powder can be mixed with the solvent better, and through this Increases extraction efficiency by allowing collagen, vegetable mucin, and vegetable polysaccharide to be better extracted into the solvent.
  • the pressurization process under the conditions of more than 1 atmosphere and less than 5 atmospheres increases the extraction efficiency by increasing the solubility of vegetable collagen and vegetable mucin contained in the herbal material powder by applying high pressure to the herbal powder and the solvent.
  • the heat treatment may be performed at a temperature condition of 50-130 °C during the pressure treatment under the 0.2 to 5 atmospheres pressure condition.
  • the heat treatment process increases the solubility of useful components dissolved in the solvent, thereby increasing the extraction efficiency of vegetable collagen and vegetable mucin contained in the herbal material.
  • step (a) a solvent is added to the herbal herbal material powder, and the pressure and heat treatment are performed for 30 minutes to 2 days under conditions of 0.2 to 5 atmospheres and a temperature of 50-130 °C.
  • the present invention is not limited thereto.
  • This step is a step of adding an enzyme, lactic acid bacteria, or a combination thereof to the mixed solution prepared in step (a) and culturing.
  • the enzyme or lactic acid bacteria may be added alone and cultured, or the enzyme and the lactic acid bacteria may be added together (sequentially or simultaneously) and cultured.
  • the enzyme of step (b) is selected from the group consisting of cellulase, hemicellulase, beta-glucosidase, betaglucanase, xylanase, arabinase, protease, and amylase
  • cellulase hemicellulase
  • beta-glucosidase betaglucanase
  • xylanase arabinase
  • protease and amylase
  • the protease is at least one protease selected from the group consisting of pepsin, papain, trypsin, and elastase.
  • the enzyme may be used as a complex enzyme, such as Sumizyme, Ultimase, Viscozyme, Lyvarome A5, but is not limited thereto.
  • the enzyme may be added at a concentration of 0.01 to 3 wt%, but is not limited thereto.
  • the amount of the enzyme added is more specifically 0.1-4%, 0.1-3%, 0.1-2%, 0.1-1%, 1-4%, 1-3%, 1- 2%, 1%, 2%, or 3%, but not limited thereto. If the addition amount of the enzyme is less than 0.01%, the hydrolysis effect of the enzyme does not appear, and if it exceeds 5%, the manufacturing cost is excessive and not economical.
  • the temperature during the treatment of the enzyme is 40-70 °C, more specifically 40-65 °C, 45-65 °C, or 50-65 °C, but is not limited thereto.
  • the enzyme treatment it is preferable to perform the treatment while stirring in order to increase the contact frequency and reaction efficiency between the enzyme and the plant herbal material.
  • the stirring speed is 50-250 rpm, but is not limited thereto.
  • the polysaccharide when enzyme treatment is performed on the vegetable herbal material, the polysaccharide is reduced in molecular weight according to the hydrolysis of the polysaccharide and the taste is also improved.
  • the whole powder of vegetable herbal material is added here, the texture of the vegetable herbal material containing a large amount of vegetable collagen and the preference of the whole composition are greatly improved.
  • the extract prepared by enzymatic treatment may be called a white wood ear mushroom enzyme-treated polysaccharide extract.
  • the enzyme-treated polysaccharide extract of the white oyster mushroom can be prepared as a food composition by adding the whole powder of the white rhododendron mushroom. In this case, the texture and taste of the food composition are improved.
  • the lactic acid bacteria of step (b) is Leuconostok genus, Lactobacillus genus, Bifidobacterium genus, Enterococcus sp. strain, Lactococcus genus, or a combination thereof.
  • the Leuconostok genus bacteria is a Leukonostok mecenteroides strain
  • the Lactobacillus genus bacteria is Lactobacillus delbrooki spp. Bulgaricus, Lactobacillus helveticus, Lactobacillus permentum, Lactobacillus thermophilus, Lactobacillus casei, Lactobacillus rhamnosus, Lactobacillus plantarum, Lactobacillus acidophilus, Lactobacillus reuteri, or these is a combination of
  • the Lactobacillus genus fungus is Lactobacillus alementarius ( Lactobacillus alementarius ), and more specifically Lactobacillus alementarius Reuter strain ( Lactobacillus alementarius Reuter, ATCC 29643).
  • the Enterococcus sp. strain is Enterococcus faecium, Enterococcus faecalis, or a combination thereof.
  • the Lactobacillus genus bacteria are Lactobacillus plantarum, Lactobacillus acidophilus, Lactobacillus rhamnosus, Lactobacillus casei, Lactobacillus reuteri, Lactobacillus permentum, Lactobacillus Helveticus, Lactobacillus brevis, Lactobacillus elementurius, Lactobacillus delbrooki bulgaricus, or a combination thereof.
  • the Bifidobacterium genus bacteria is Bifidobacterium bifidum, Bifidobacterium longum, Bifidobacterium breve, Bifidobacterium animalis lactis, or a combination thereof. to be.
  • the Lactococcus genus bacteria is Lactococcus lactis.
  • the culturing in step (b) is made for 1 to 50 days.
  • the culturing in step (b) is made for 1 day to 14 days, more specifically 1 day to 10 days, 1 day to 7 days, 1 day to 5 days, or 1 day to 3 days, but is not limited thereto.
  • the culture in step (b) is controlled within the range of pH 6 to 8, more specifically pH 6.5 to 7.5, and even more specifically 6.5 to 7, but limited thereto It can be adjusted appropriately depending on the enzyme used and the optimal culture conditions of the lactic acid bacteria.
  • the step is to remove the sludge and starch by centrifuging or filtering the culture solution of the enzyme, lactic acid bacteria, or a combination thereof prepared in step (b), and to separate the viscous supernatant, or to prepare the filtrate remaining after filtering. is a step
  • the centrifugation may be performed under suitable conditions that can be generally used for solid-liquid separation in the art, and it is sufficient as long as it can achieve the purpose of separating the supernatant from the precipitate.
  • the step is a step of inactivating and sterilizing the enzyme, lactic acid bacteria, or a combination thereof contained therein by heating the viscous supernatant or the filtrate prepared in step (c).
  • the heating in step (d) is performed at 60-150° C. for 0.5 seconds to 3 hours.
  • the heating in step (d) is performed at 61-65° C. for 30 minutes to 1 hour, or at 95-150° C. for 0.5 seconds to 30 seconds.
  • the step is a step of obtaining a liquid extract from step (d), or drying the liquid extract to obtain a powdery extract.
  • drying method natural drying, drying under reduced pressure, and drying methods of the extract that can be used in the art, such as freeze-drying, may be used without limitation, but drying under reduced pressure or freeze-drying is preferable.
  • the present invention provides a method for producing a plant composition comprising a plant extract and whole powder of a plant herbal material, comprising:
  • step (c) Mixing the above-mentioned plant extract with a powder prepared by drying and pulverizing the precipitate remaining after centrifugation or filtration in step (c), or the filtrate.
  • the extract is prepared by a manufacturing method comprising steps (a) to (d), or (a) to (e) of the above-described method for preparing the extract.
  • the plant extract may be prepared as a food composition by adding whole powder of plant raw materials. In this case, the texture and taste of the food composition are improved.
  • the present invention provides an extract comprising vegetable collagen and plant mucin, a food composition and a cosmetic composition comprising the extract, and a method for preparing the extract.
  • the extract containing vegetable collagen and vegetable mucin of the present invention contains low molecular weight collagen of 500 Da or less, and has excellent skin moisturizing effect, skin aging prevention effect, and skin wrinkle improvement effect when orally administered and applied to the skin. It can be usefully used as a raw material of functional food and cosmetics for improvement.
  • 1 is a diagram showing the results of a cytotoxicity test of the enzyme-treated extract of white wood ear mushroom of the present invention.
  • Figure 2 is a view showing the results of confirming the procollagen synthesis promoting effect of the enzyme-treated extract of white wood ear mushroom of the present invention.
  • FIG. 3 is a schematic diagram of a method for producing a fermented composition for white wood ear mushroom according to the present invention.
  • FIG. 4 is a diagram showing that the thickness of the epidermis of the UVB irradiation group (CON) was significantly increased as compared to the normal control group (NOR) as a result of H&E staining, and the epidermis thickness was decreased when the preparation of the present invention was administered to be.
  • % used to indicate the concentration of a specific substance is (weight/weight) % for solid/solid, (weight/volume) % for solid/liquid, and Liquid/liquid is (volume/volume) %.
  • Example 1-1 Preparation of Enzyme-treated Polysaccharide Extract from White Wood Ear Mushroom
  • the SUMIZYME AC (Shin Nihon Chemical, Japan) is an enzyme complex produced by Aspergillus niger (A. niger), and is a complex enzyme including cellulase, hemicellulase and beta-glucosidase.
  • the Ultimase is a complex enzyme including beta-glucanase and xylanase.
  • the Viscozyme is a complex enzyme comprising arabanase, cellulase, beta-glucanase, hemicellulase, and xylanase.
  • the Lyvarome A5 is a pectinase extracted from Aspergillus niger.
  • Example 1-2 Cytotoxicity evaluation of polysaccharide extracts treated with Enzyme-treated White wood ear mushroom
  • Each of the HDFn cells was dispensed in a 96 well plate at 5 ⁇ 10 4 cells/mL, and the concentration of each sample extract (Preparation Examples 1-1 to 1-4) prepared in Example 1-1 under Media-FBS 10% conditions. Each was treated for 72 hours. After that, after adding 1/10 times the volume of each cell culture solution, MTS lysate was added, followed by incubation at 37°C for 2 hours, and then absorbance was measured at 490 nm using an ELISA reader (Spectrostar-nano, BMG Labtech, Offenburg, Germany). did. Through this, it was tested whether each sample affects the cell viability.
  • the HDFn cells were purchased from Korea Cell Line Bank (KCLB, Seoul, Korea), and penicillin/streptomycin 100 unit/mL (10378, Invitrogen, Grand Island, NY, USA) and 10% FBS (16000, Invitrogen, Grand Island, NY) , USA) containing DMEM medium (11995, Invitrogen, Grand Island, NY, USA) at 37° C., 5% CO 2 Incubated in an incubator (MCO-17A1, Sanyo, Osaka, Japan).
  • the concentration of each polysaccharide extract treated with the enzymatic process of the white wood ear mushroom was treated in the range of 31.2 - 1,000 ⁇ g/mL.
  • all samples had an effect on cell viability from a concentration of 500 ⁇ g/mL, so the following experiments were performed at a concentration of 500 ⁇ g/mL or less showing a high viability.
  • Example 1-3 Measurement of Collagen Synthesis Promotion Effect of Enzyme-treated Polysaccharide Extract from White Wood Ear Mushroom
  • HDFn cells were cultured in a 96 well plate at 1 ⁇ 10 5 cells/well for 24 hours, and then a sample diluted stepwise with a new serum-free medium was dispensed and added again. Incubated in a CO2 incubator for hours. After obtaining the culture medium, the procedure was performed according to the manual using the procollagen type I Cpepited EIA kit (MK101, Takara Bio inc, Shiga, Japan). After mixing 20 ⁇ l of cell culture solution and 100 ⁇ L of secondary antibody in a 96 well plate with primary collagen antibody, incubate at 37° C. for 3 hours, wash 4 times with PBS, and then 450 using an ELISA reader (BMG Labtech). Absorbance was measured in nm.
  • procollagen synthesis experiment was performed using polysaccharides treated with enzyme-treated white wood ear mushroom, and in the samples treated with Viscozyme, SUMIZYME, and Ultimase, procollagen synthesis was increased from 62.5 ⁇ g/mL concentration, and Lyvarome was treated. In one extract and in the sample not treated with the enzyme, procollagen synthesis was significantly increased from the concentration of 125 ⁇ g/mL. From the above results, it can be seen that the enzyme-treated extract of white wood ear mushroom of the present invention exhibits wrinkle improvement effect by promoting procollagen synthesis to make elastic skin.
  • Example 1-4 Preparation of a food composition comprising a white wood ear mushroom enzyme-treated polysaccharide extract and white wood ear mushroom whole powder
  • Example 1-1 the Viscozyme-treated extract (Preparation Example 1-3), which had the best effect, and the white wood ear mushroom were hot water extracted and filtered, and the remaining white wood ear mushroom was dried and finely pulverized.
  • the prepared powder was mixed in a weight ratio of 1:10 to prepare a food composition (Preparation Example 1-5) containing the white wood ear mushroom extract and the white wood ear mushroom whole powder.
  • the extract that did not contain the white oyster mushroom powder was named Comparative Example 1-1 for the extract not treated with the enzyme, and Comparative Example 1-2 for the extract treated with the enzyme.
  • Example 1-5 Sensory test of a food composition comprising an enzyme-treated polysaccharide extract of a white wood ear mushroom and whole powder of a white wood ear mushroom
  • a beverage was prepared by taking a predetermined amount of each of the samples of Preparation Example 1-5, Comparative Example 1-1, and Comparative Example 1-2, and the odor, taste, and overall preference of the prepared beverage were evaluated.
  • the sensory inspector finally selected 10 people through a preliminary experiment from among those who received identification training in advance, and the sensory evaluation items were sweetness, flavor, texture and overall preference.
  • the degree of weakness was graded 1, and the degree of strength was graded 5.
  • the enzyme hydrolyzes the components such as cellulose and hemicellulose contained in the mushroom, and the effect of improving the taste and flavor can be obtained.
  • the effect of improving the overall taste can be obtained.
  • Example 2 Lactic acid bacteria and complex enzyme treatment
  • Example 2-1 Preparation of Fermented Collagen Peptide Composition for White Wood Ear Mushroom
  • the pH was adjusted so that the pH of the culture solution was 6 to 8.
  • the culture solution was filtered to remove sludge.
  • the filtered filtrate was collected and heated at 95° C. for 1 hour to sterilize the filtrate.
  • the filtrate was concentrated under reduced pressure at 50-65° C. and then freeze-dried to obtain 8 g of a powdery white wood ear mushroom fermented collagen peptide composition.
  • Example 2-2 Peptide Amino Acid Content and Component Analysis of Fermented Collagen Peptide Composition of White Wood Ear Mushroom
  • the white wood ear mushroom fermented collagen peptide composition of the present invention prepared in Example 2-1 was diluted to a concentration of 1 wt%, and the content and components of peptide amino acids constituting it were analyzed. The results are shown in Table 4 below.
  • the amino acid content of the fermented white wood ear mushroom collagen peptide composition of the present invention was 3,787.5 mg/kg based on 1wt% concentration, and it was confirmed that it contained a very high content of amino acids.
  • it contains 1372 mg/kg of Arginine, which is known to help improve blood flow by expanding blood vessels, and can be usefully used as a functional food for improving blood circulation.
  • Arginine which is known to help improve blood flow by expanding blood vessels, and can be usefully used as a functional food for improving blood circulation.
  • Example 2-4 sensory evaluation
  • the fermented white wood ear mushroom fermented beverage in which the enzyme and lactic acid strain of the present invention were cultured had the best overall preferences, such as sweetness and flavor.
  • the fermented beverage of the present invention had more sweetness and superior color and flavor compared to the comparative example in which lactic acid bacteria and enzymes were not treated, despite the same sugar content.
  • Example 2-5 Preparation of fermented collagen cosmetic composition for white oyster mushroom
  • a nutrient lotion containing 0.5% of the white wood ear mushroom fermented collagen peptide composition prepared in Example 2-1 based on the total weight was prepared at the component ratios shown in Table 6 below.
  • Example 2-6 Comparison of transdermal moisture loss, skin moisture content, skin elasticity, fine wrinkles improvement effect
  • the amount of transdermal moisture loss, the amount of skin moisture, the elasticity of the skin, and the effect of improving fine wrinkles were measured for the cosmetic composition containing the fermented collagen of the white wood ear mushroom of the present invention prepared in Examples 2-5.
  • Examples 2-5 were typically applied to the skin of the test subject's face and forearm for 4 weeks, 8 weeks, and 12 weeks respectively.
  • the applied skin condition was measured using anterior ocular imaging, Antera 3D imaging, Corneometer, Spectrophotometer CM2500d, and Skin-Visiometer. The results were averaged and shown in Table 7 below.
  • the feeling of use was evaluated by using 30 women in their 30s and 40s as a panel.
  • the cosmetic composition prepared in Example 2-5 was used as a test group, and a powder obtained by pulverizing the dried white wood ear mushroom fruiting body into 10-100 mesh particles was put in water, boiled for 4 hours, concentrated to dryness, and then powdered.
  • a cosmetic composition prepared at the same concentration as in Example 5 was used as a comparative example.
  • Each sample was applied to the face 3 times a week for 2 weeks, and the skin cosmetic effect was measured on a 5-point scale for each item according to the items shown in Table 8 below, and the results are representatively shown.
  • Example 5 comparative example overall sign 4.3 3.7 Skin feel after use 4.3 3.6 Spreadability when applied to the skin 4.2 3.6 Degree of skin irritation after use 0.5 1.1
  • Example 3-1 Preparation of extracts (Preparation Examples 3-1 to 3-16) containing vegetable collagen and vegetable mucin using plant herbal materials
  • a complex enzyme SUMIZYME, Ultimase, Viscozyme, or Lyvarome A5; denoted as S, U, V, and L, respectively
  • lactic acid bacteria Lactobacillus alimentarius Reuter ATCC 29643, 1x10 3 cfu/ml
  • the mixture was stirred once every 12 hours of incubation.
  • the pH was adjusted so that the pH of the culture solution was 6 to 8.
  • the culture solution was centrifuged to remove the precipitated sludge and starch, and the viscous supernatant was separated. The separated viscous supernatant was heated at 130° C.
  • Herbal medicine powder (g) Solvent (50 g) Enzyme (0.1 g) Lactobacillus strain (10 3 cfu/ml) 3-1 5g Purified water SUMIZYME - 3-2 5g Purified water Ultimases - 3-3 5g Purified water Viscozyme - 3-4 5g Purified water Lyvarome A5 - 3-5 5g Purified water - O 3-6 5g Purified water - O 3-7 5g Purified water - O 3-8 5g Purified water - O 3-9 5g Purified water SUMIZYME O 3-10 5g Purified water Ultimases O 3-11 5g Purified water Viscozyme O 3-12 5g Purified water Lyvarome A5 O 3-13 5g 20% ethanol aqueous solution SUMIZYME - 3-14 5g 20% ethanol aqueous solution Ultimases - 3-15 5g 20% ethanol aqueous solution Viscozyme - 3-16 5g 20% ethanol aqueous solution Lyvarome A5 -
  • Examples 3-2 to 3-5 evaluated the efficacy as a food composition
  • Experimental Examples 3-6 and 3-7 evaluated the efficacy as a cosmetic composition.
  • Example 3-2 Skin water retention, transepidermal water loss (TEWL) and erythema evaluation
  • the experimental group was a total of 6 groups (6 mice per group), a normal control group (normal, not UVB-induced), a negative control group (control, UVB-irradiated), Preparation Examples 3-1, 3-5, 3-9, and 3-13 of the treatment group.
  • SKH-1 hairless mice (SkH: HR-1) were purchased from Orient Bio and were bred.
  • the environment temperature of the animal breeding room was 22 ⁇ 2°C, the relative humidity was 50 ⁇ 10%, and the light and dark were adjusted in a 12-hour cycle. Drinking water and feed were ad libitum.
  • UVB-ultraviolet lamp T-8M; Vilber Lourmat, France
  • T-8M normal control group
  • NOR normal control group
  • UVB-ultraviolet lamp UV-ultraviolet lamp
  • the present inventors measured the intake of water and feed once a week during the period of irradiating the mouse with UV light and administering the sample in order to confirm the effect of the composition of the present invention on the intake of water and feed of the mouse. There was no significant difference in dietary intake between groups (Tables 11 and 12).
  • the present inventors used Multi Probe Adapter® MPA 6 (Courage und Khazaka, Germany) on the dorsal skin of rats irradiated with ultraviolet rays to confirm the effect of the composition of the present invention on the skin condition, the amount of moisture retention in the skin and the amount of transepidermal water loss (TEWL) and erythema were measured. Skin measurements were carried out in all groups before the start of UV irradiation, and skin measurements were performed every week from 4 weeks after UV irradiation to confirm that there was a significant difference in skin measurement results between the NOR and CON groups. The skin measurement results are shown in Tables 13 to 15, showing the results of the last measurement on the day before sacrifice.
  • Table 13 shows the amount of skin moisture retention for each experimental group of the present invention.
  • Table 14 shows the amount of transdermal water loss for each experimental group of the present invention.
  • the amount of transepidermal water loss was significantly increased by about 4.47 times in the negative control group (CON) compared to the normal control group (NOR) (p ⁇ 0.05). All sample administration groups significantly decreased transepithelial water loss compared to the negative control group (CON), and in particular, the greatest decrease in transepithelial water loss was achieved in Preparation Example 3-9 treated group, which was cultured by simultaneously treating enzymes and lactic acid bacteria. (p ⁇ 0.05).
  • the erythema level in the negative control group showed a significant increase of about 1.58 times compared to the normal control group (NOR) (p ⁇ 0.05), and the erythema level in the sample administration group was significant compared to the negative control group. decreased to
  • the extract containing vegetable collagen and vegetable mucin of the present invention exhibited positive activity in both water retention, transepidermal water loss, and erythema level. Therefore, it was found that the plant mixed extract of the present invention helps prevent skin moisture loss and damage to the skin barrier caused by UV rays, and helps the skin barrier function to function normally.
  • the present inventors photographed the dorsal skin of a rat and used a replica obtained using Visioline (VL650; CK electronic GmbH, Germany) to analyze the wrinkle pattern Thus, the area, number, length, and depth of wrinkles were analyzed. The results are shown in Table 16.
  • Example 3-4 Epidermal thickness and collagen measurement
  • the present inventors collected the dorsal skin of all mice after UV irradiation and the composition administration experiment was completed, put it in 10% formalin, and confirmed histopathological changes Hematoxylin and eosin (H&E) staining was performed, and immunohistochemistry (IHC) staining was performed to confirm collagen present in the dermis. After the stained tissue was imaged by taking a picture using an optical microscope, it was analyzed.
  • H&E Hematoxylin and eosin
  • IHC immunohistochemistry
  • the thickness of the epidermis of the UVB irradiation group was significantly increased (p ⁇ 0.05) compared to the normal control group (NOR).
  • the epidermal thickness was significantly reduced compared to the negative control group (CON), and in particular, in the group cultured by treating enzymes and lactic acid bacteria at the same time (Preparation Example 3-9), the epidermal thickness was significantly higher than that of the negative control group was confirmed to show a decreasing trend (p ⁇ 0.05).
  • Elastin a component of the skin dermis, is an elastic substance that affects the elasticity of the skin tissue.
  • the present inventors extracted about 10 mg of skin tissue from each experimental group, and then used the method provided by Fastin Elastin assay (F2000; Biocolor, UK) to elastin in the skin tissue. The amount was measured.
  • composition administration group of the present invention showed a tendency to increase the elastin content in all compared to the negative control group (CON), in particular, the group cultured by treating the enzyme and lactic acid bacteria of the present invention at the same time (Preparation Example) 3-9) showed the most significant increase compared to the negative control group (CON) (p ⁇ 0.05).
  • the extracts of Preparation Examples 3-1, 3-5, 3-9, and 3-13 of the present invention were added to the culture solution of human-derived fibroblasts to measure the total amount of collagen at the cellular level.
  • the total amount of collagen was quantified using the PICP EIA kit (Procollagen Type I C-Peptide Enzyme ImmunoAssay KIT).
  • human-derived fibroblasts were evaluated for cytotoxicity at concentrations of 10 ppm, 1 ppm, 0.1 ppm, 0.01 ppm, and 0.001 ppm of the test substance, and the total amount of collagen was measured by selecting a concentration without cytotoxicity.
  • the concentrations of the preparation examples of the present invention were 1 ppm and 10 ppm, respectively, and each sample was added to the culture medium of human fibroblasts and cultured for 2 days, then the culture solution was taken and the total amount of collagen at each concentration with the PICP EIA kit. was measured at 450 nm using a spectrophotometer.
  • the total amount of collagen was measured in the same manner for the fibroblast culture medium (control group) to which nothing was added and the sample to which vitamin C was added to a final concentration of 52.8 ppm.
  • the total amount of collagen was measured as UV absorbance, and the increase rate of the total amount of collagen was calculated as the ratio of the total amount of collagen relative to the control group, and the results are summarized in Table 19 below.
  • the extract of Preparation Example of the present invention generally exhibited an excellent collagen increase rate at a lower concentration than when vitamin C, which is known to have a collagen synthesis ability, was applied. Therefore, it was found that the extract of Preparation Example of the present invention can be used for skin regeneration and wrinkle improvement.
  • fibroblasts were evaluated for cytotoxicity at concentrations of 10 ppm, 1 ppm, 0.1 ppm, 0.01 ppm, and 0.001 ppm of the test substance, and a collagenase evaluation method was performed by selecting a concentration without cytotoxicity.
  • Fibroblasts which are normal human skin cells, were inoculated in a 24-well microplate so as to become 2.5x10 4 cells per well, and cultured for 24 hours in 10% serum DMEM medium and 37° C., and then 10% serum DMEM medium was removed.
  • TNF- ⁇ tumor necrosis factor- ⁇
  • MMP-1 collagen degrading enzyme
  • MMP-1 production inhibition rate (%) [1 - (Experimental group MMP-1 production amount - Negative control group MMP-1 production amount) / (Normal control group MMP-1 production amount - Negative control group MMP-1 production amount)]x100
  • a nutrient lotion (lotion) containing the extract obtained in Preparation Examples 3-1 to 3-16 was prepared according to a conventional method.
  • a softening lotion (skin) containing the extract obtained in Preparation Examples 3-1 to 3-16 was prepared according to a conventional method.
  • a nutritional cream containing the extract obtained in Preparation Examples 3-1 to 3-16 was prepared according to a conventional method.
  • hair conditioners containing the extracts obtained in Preparation Examples 3-1 to 3-16 were prepared according to a conventional method.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cosmetics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • General Preparation And Processing Of Foods (AREA)

Abstract

The present invention provides an extract comprising vegetable collagen and vegetable mucin, a food composition and a cosmetic composition comprising the extract, and a method for preparing the extract. The extract comprising vegetable collagen and vegetable mucin of the present invention contains low molecular weight collagen of 500 Da or less, and has an excellent skin moisturizing effect, a skin aging prevention effect, and a skin wrinkle improvement effect when administered orally and applied to the skin, and thus, can be helpfully used as a raw material of functional foods and cosmetics for improving skin condition.

Description

식물성 콜라겐 및 식물성 뮤신을 포함하는 식물 추출물 및 이의 제조방법Plant extract containing plant collagen and plant mucin and method for preparing the same

본 특허출원은 i) 2020년 6월 26일에 대한민국 특허청에 제출된 대한민국 특허출원 제10-2020-0078772호, ii) 2020년 12월 23일에 대한민국 특허청에 제출된 대한민국 특허출원 제10-2020-0182639호, 및 iii) 2021년 4월 2일에 대한민국 특허청에 제출된 대한민국 특허출원 제10-2021-0043663호에 대하여 우선권을 주장하며, 상기 특허출원의 개시사항은 본 명세서에 참조로서 삽입된다.This patent application is i) Korean Patent Application No. 10-2020-0078772, filed with the Korean Intellectual Property Office on June 26, 2020, ii) Korean Patent Application No. 10-2020, filed with the Korean Intellectual Property Office on December 23, 2020 -0182639, and iii) claim priority to Korean Patent Application No. 10-2021-0043663 filed with the Korean Intellectual Property Office on April 2, 2021, the disclosure of which is incorporated herein by reference. .

본 발명은 식물성 콜라겐 및 식물성 뮤신을 포함하는 식물 추출물 및 이의 제조방법에 관한 것이다.The present invention relates to a plant extract comprising plant collagen and plant mucin and a method for preparing the same.

콜라겐(collagen)은 동물의 결합조직, 피부, 뼈, 힘줄, 피부, 연골, 손톱, 발톱, 치아, 혈관 등을 구성하는 섬유상 구조단백질이다. 콜라겐은 인체 단백질의 약 30%를 차지하고, 결합조직의 주성분이며 피부 진피층의 70~90%를 차지한다. 콜라겐의 기본 구조단위는 트로포콜라겐(tropocollagen)으로 분자량 10만달톤(Da)의 펩타이드가 3중 나선구조로 이루어지는 30만 달톤(Da)의 매우 큰 고분자 단백질이다. 콜라겐을 구성하는 아미노산은 글라이신(glycine), 프롤린(proline), 하이드록시프롤린(hydroxyproline), 그 외 아미노산이 G-X-Y로 결합되어 있다. 콜라겐은 다른 단백질에는 비교적 적은 하이드록시프롤린을 함유하고 있어 하이드록시프롤린의 함량이 그 기관 내의 콜라겐 함량의 척도가 되기도 한다. 콜라겐을 열 또는 화학약품으로 처리하면 변성되어 젤라틴이 된다. 돼지껍질이나 닭발 등을 섭취하면 콜라겐을 섭취할 수 있을 것으로 기대해 왔으나, 콜라겐은 30만 달톤의 고분자 단백질이어서 체내 흡수율이 10% 미만으로 식품으로 섭취한 콜라겐의 실질적인 흡수와 효과는 기대하기 어려운 것으로 알려져 있다. 500달톤의 법칙(500 Dalton Rule)에 의하면, 콜라겐이 피부에 흡수되기 위해서는 500달톤 이하여야 한다. 2,000~6,000달톤의 의약품급 콜라겐의 흡수율은 50%이고, 500달톤 크기로 가수분해한 콜라겐은 90%이상 흡수되는 것으로 알려져 있다.Collagen is a fibrous structural protein constituting animal connective tissue, skin, bone, tendon, skin, cartilage, nails, toenails, teeth, blood vessels, and the like. Collagen accounts for about 30% of human protein, is the main component of connective tissue, and accounts for 70-90% of the dermal layer of the skin. The basic structural unit of collagen is tropocollagen, which is a very large macromolecular protein of 300,000 Daltons (Da) in which a peptide having a molecular weight of 100,000 Daltons (Da) has a triple helix structure. The amino acids constituting collagen are glycine, proline, hydroxyproline, and other amino acids combined with G-X-Y. Collagen contains relatively low hydroxyproline in other proteins, so the hydroxyproline content is also a measure of the collagen content in the organ. When collagen is treated with heat or chemicals, it denatures into gelatin. It has been expected that collagen can be ingested by ingesting pork skin or chicken feet, but collagen is a high molecular weight protein of 300,000 Daltons, so the absorption rate in the body is less than 10%. have. According to the 500 Dalton Rule, in order for collagen to be absorbed into the skin, it must be less than 500 Daltons. It is known that the absorption rate of 2,000 to 6,000 daltons of pharmaceutical grade collagen is 50%, and more than 90% of collagen hydrolyzed to 500 daltons is absorbed.

이러한 콜라겐은 피부, 연골, 모발, 손톱, 발톱, 치아, 혈관을 구성하는 섬유상 단백질로, 세포외기질(extracellular matrix, ECM)의 구조를 유지하고, 탄력을 유지시키는 역할을 한다. 자외선이 피부 진피에 침투하면 콜라겐과 엘라스틴이 분해되고, 산화적 스트레스 및 활성산소(ROS)가 증가되어 자외선에 의한 피부노화가 일어난다. 또한 흡연, 알코올, 환경오염 등에 지속적으로 노출되면 체내 항산화시스템이 무너져 진피 속 콜라겐 섬유의 변성이 일어나고, 피부 수분이 감소하여 피부가 건조해지고 피부탄력이 떨어져 피부가 접히게 되면서 주름이 생긴다.The collagen is a fibrous protein constituting skin, cartilage, hair, nails, toenails, teeth, and blood vessels, and serves to maintain the structure of the extracellular matrix (ECM) and maintain elasticity. When UV rays penetrate the dermis of the skin, collagen and elastin are decomposed, and oxidative stress and reactive oxygen species (ROS) increase, causing skin aging by UV rays. In addition, continuous exposure to smoking, alcohol, environmental pollution, etc. causes the body's antioxidant system to collapse, degeneration of collagen fibers in the dermis, and decrease in skin moisture, resulting in dry skin and loss of skin elasticity, resulting in wrinkles.

성장기 청소년나 임신을 한 여성의 경우, 부신피질 호르몬 과다, 급격한 체중증가 등 피부가 빠르게 늘어나게 되어 콜라겐 섬유들 사이의 결합이 일부 파괴되면서 튼살이 생기기도 한다. 나이가 들면 관절의 연골이 닳게 되어 보행이 어렵게 되는데, 연구결과에 의하면 효소 가수분해된 콜라겐은 체내로 잘 흡수되어 관절부위의 진통억제, 항염증 작용을 하며, 골밀도를 증가시킨다. 콜라겐은 피부 뿐만 아니라 뼈, 관절, 치아, 모발, 눈, 손톱, 발톱을 건강하게 유지시켜 준다. In the case of adolescents or pregnant women, the skin stretches rapidly due to excessive adrenal cortex hormones and rapid weight gain, and some of the bonds between collagen fibers are destroyed, leading to stretch marks. As we age, the cartilage in the joints wears away, making it difficult to walk. According to research results, enzymatically hydrolyzed collagen is well absorbed into the body, suppressing pain in the joints, anti-inflammatory, and increasing bone density. Collagen not only keeps skin, but also bones, joints, teeth, hair, eyes, nails and toenails healthy.

식물에 존재하는 식물성 콜라겐은 체내 콜라겐 생성을 촉진하고, 콜라겐 분해 효소인 MMP-1을 억제하여 콜라겐 분해를 억제한다. 또한 식물성 콜라겐에는 동물성 콜라겐에는 없는 항산화성분이 풍부하다. 현재 시판되고 있는 대부분의 콜라겐 제품들은 어류 또는 소에서 추출한 동물성 콜라겐으로, 특유의 냄새로 인해 먹기 불편하거나, 광우병이나 항생제 사용 등의 소비자 우려가 있다. 본 발명의 식물성 콜라겐은 분자량이 대부분 100~400달톤이고, 평균 500달톤이하로 가수분해 시킨 콜라겐이어서 흡수율이 90% 이상되는 바, 우리 몸에서 필요한 부위에서 잘 작용할 수 있어 노화를 방지하고 피부상태 개선에 유용하게 사용할 수 있다.Plant collagen present in plants promotes collagen production in the body and inhibits collagen degradation by inhibiting MMP-1, a collagen-degrading enzyme. In addition, vegetable collagen is rich in antioxidants that animal collagen does not have. Most of the collagen products currently on the market are animal collagen extracted from fish or cattle, and there are concerns about consumers being uncomfortable to eat due to their unique smell or using mad cow disease or antibiotics. Most of the vegetable collagen of the present invention has a molecular weight of 100 to 400 Daltons and is hydrolyzed to an average of 500 Daltons or less, so the absorption rate is more than 90%. can be useful for

본 명세서 전체에 걸쳐 다수의 논문 및 특허문헌이 참조되고 그 인용이 표시되어 있다. 인용된 논문 및 특허문헌의 개시 내용은 그 전체로서 본 명세서에 참조로 삽입되어 본 발명이 속하는 기술 분야의 수준 및 본 발명의 내용이 보다 명확하게 설명된다.Numerous papers and patent documents are referenced throughout this specification and their citations are indicated. The disclosures of the cited papers and patent documents are incorporated herein by reference in their entirety to more clearly describe the level of the technical field to which the present invention pertains and the content of the present invention.

[특허문헌][Patent Literature]

PCT 국제공개공보 WO 2012-096760 A1(2012.07.19. 공개)PCT International Publication No. WO 2012-096760 A1 (published on July 19, 2012)

본 발명자들은 기존의 동물성 콜라겐을 대체할 수 있는 식물성 콜라겐을 다량 함유하는 식물 추출물의 제조방법을 개발하고자 예의 연구 노력하였다. 그 결과 식물 분말을 용매에 침지시킨 후 효소 및 미생물 발효를 통하여 추출한 추출물에 점성을 띄는 식물성 콜라겐과 식물성 뮤신이 다량 함유되어 있고, 이러한 추출물을 섭취하거나 피부에 적용할 경우 피부주름개선, 노화방지, 피부장벽개선, 피부보습 효과 등이 우수하다는 점을 규명함으로써, 본 발명을 완성하게 되었다. The present inventors made intensive research efforts to develop a method for producing a plant extract containing a large amount of vegetable collagen that can replace the existing animal collagen. As a result, viscous vegetable collagen and vegetable mucin are contained in large amounts in the extract extracted through enzyme and microbial fermentation after plant powder is immersed in a solvent. By identifying the excellent skin barrier improvement and skin moisturizing effect, the present invention was completed.

따라서, 본 발명의 목적은 식물성 콜라겐 및 식물성 뮤신을 포함하는 추출물 및 이의 제조방법을 제공하는 것이다. Accordingly, an object of the present invention is to provide an extract comprising vegetable collagen and vegetable mucin and a method for preparing the same.

본 발명의 다른 목적은 식물성 콜라겐 및 식물성 뮤신을 포함하는 추출물을 유효성분으로 포함하는 피부노화방지, 주름개선, 피부장벽 강화 또는 피부보습용 식품조성물 또는 화장료 조성물을 제공하는 것이다. Another object of the present invention is to provide a food composition or cosmetic composition for skin anti-aging, wrinkle improvement, skin barrier strengthening, or skin moisturizing comprising an extract containing vegetable collagen and vegetable mucin as an active ingredient.

본 발명의 일 양태에 따르면, 본 발명은 식물 추출물을 유효성분으로 포함하는 피부노화방지, 주름개선, 피부장벽 강화 또는 피부보습용 식품조성물을 제공한다. 상기 식물 추출물은 식물성 콜라겐 및 식물성 뮤신을 포함한다. According to one aspect of the present invention, the present invention provides a food composition for skin anti-aging, wrinkle improvement, skin barrier strengthening, or skin moisturizing comprising a plant extract as an active ingredient. The plant extract includes plant collagen and plant mucin.

본 발명의 용어 "식물성"은 "식물에서 유래한"이라는 의미를 가진다. 예를 들어, 식물성 콜라겐은 식물로부터 유래한 콜라겐을 의미한다.The term "vegetable" in the present invention has the meaning of "derived from a plant". For example, vegetable collagen refers to collagen derived from plants.

본 발명의 일 구현예에 있어서, 상기 추출물은 시금치, 스위스차드, 당근, 토마토, 황기, 천궁, 버섯류, 둥근마, 연근, 유채꽃, 및 유채씨로 이루어진 군으로부터 선택된 1종 이상의 생약 재료를 추출하여 얻은 것이다. 상기 1종 이상의 생약재료는 1종의 단일한 생약 재료, 또는 2종 이상의 생약 재료의 혼합물일 수 있다. 상기 버섯류는 엄밀하게는 식물로 분류되지 않으나, 본 발명의 식물 추출물은 버섯류의 추출물을 포함하는 개념이다. In one embodiment of the present invention, the extract extracts at least one herbal material selected from the group consisting of spinach, Swiss chard, carrot, tomato, astragalus, chrysanthemum, mushrooms, round hemp, lotus root, rape flower, and rapeseed it was obtained by The one or more herbal ingredients may be one single herbal ingredient, or a mixture of two or more kinds of herbal ingredients. The mushrooms are not strictly classified as plants, but the plant extract of the present invention is a concept including the extract of mushrooms.

본 발명의 일 구현예에 있어서, 상기 식품조성물은 석류, 타트체리, 블루베리, 마늘, 망고, 오렌지, 아보카도, 화이트리, 케슈넛, 히비스커스, 딸기, 금화규, 키위, 구아바, 파인애플, 콩, 피망, 라즈베리, 블랙베리, 구기자, 복령, 및 숙지황으로 이루어진 군으로부터 선택된 1종 이상의 생약 재료를 혼합한 혼합물을 추출하여 얻은 추출물을 추가적으로 포함한다.In one embodiment of the present invention, the food composition is pomegranate, tart cherry, blueberry, garlic, mango, orange, avocado, white lily, cashew nut, hibiscus, strawberry, goldfish, kiwi, guava, pineapple, soybean, An extract obtained by extracting a mixture of one or more herbal ingredients selected from the group consisting of bell pepper, raspberry, blackberry, goji berry, bokryeong, and sukjihwang is additionally included.

본 발명의 구체적인 구현예에 있어서, 상기 버섯류는 흰목이버섯, 목이버섯, 영지버섯, 치마버섯, 송이버섯, 표고버섯, 송로버섯, 상황버섯, 말굽버섯, 송화버섯, 차가버섯, 능이버섯, 노루궁뎅이버섯, 느타리버섯, 및 까치버섯으로 이루어진 군으로부터 선택된 1종 이상의 버섯이나, 이에 한정되는 것은 아니다.In a specific embodiment of the present invention, the mushrooms are white wood ear mushroom, wood ear mushroom, reishi mushroom, chima mushroom, matsutake mushroom, shiitake mushroom, truffle, situation mushroom, horseshoe mushroom, pine mushroom, chaga mushroom, neungi mushroom, roe deer At least one mushroom selected from the group consisting of oyster mushroom, oyster mushroom, and blackcurrant mushroom, but is not limited thereto.

본 발명에서, 흰목이(-木耳) 버섯은 흰목이목에 속하며 학명은 Tremella fuciformis이다. 흰목이는 우리나라를 비롯하여 중국과 일본, 열대지방에 널리 분포한다. 흰목이의 자실체(버섯)은 한천질로서, 주름이 되어 갈라져 있거나 또는 귓불 모양 또는 볏 모양을 이루고 있으며, 크기는 10 cm 정도이다. 건조되면 얇은 막 모양이 되지만 물을 흡수하면 부풀어오른다. 흰목이는 면역증진, 뼈건강증진, 변비개선, 항암작용, 피부미용, 혈관질환예방, 빈혈예방 등 다양한 효능이 있는 것으로 알려져 있다. 본 발명자들은 흰목이 버섯의 상기 효능을 보다 더 개선하고 식품조성물로서의 특성을 개선하고자 흰목이버섯의 효소처리에 따른 추출방법을 개발하고자 하였다. In the present invention, the white woody mushroom belongs to the white woody mushroom and its scientific name is Tremella fuciformis. It is widely distributed in Korea, China, Japan, and tropical regions. The fruiting body (mushroom) of the white-necked ear is agaric, wrinkled and split, or has the shape of an earlobe or a crest, and the size is about 10 cm. When dried, it forms a thin film, but swells when water is absorbed. It is known to have various effects such as immunity enhancement, bone health enhancement, constipation improvement, anticancer action, skin beauty, prevention of vascular disease, and prevention of anemia. The present inventors have attempted to develop an extraction method according to the enzymatic treatment of the white wood ear mushroom in order to further improve the efficacy of the white wood ear mushroom and to improve the properties as a food composition.

본 발명의 일 구현예에 있어서, 상기 버섯류는 각 종류의 버섯의 자실체를 의미하나, 이에 한정되는 것은 아니다. In one embodiment of the present invention, the mushrooms refer to the fruiting bodies of each type of mushroom, but are not limited thereto.

본 발명의 일 구현예에 있어서, 상기 추출물은 식품 조성물의 총 중량 대비 0.001~20%(w/w)의 범위 내에서 포함될 수 있으나, 이는 예시적인 것일 뿐 이에 한정되는 것은 아니다. In one embodiment of the present invention, the extract may be included in the range of 0.001 to 20% (w/w) based on the total weight of the food composition, but this is only exemplary and not limited thereto.

본 발명의 일 구현예에 있어서, 상기 추출물은 히알루론산을 포함한다. 따라서, 본 발명의 추출물은 식물성 히알루론산을 포함한다. In one embodiment of the present invention, the extract contains hyaluronic acid. Accordingly, the extract of the present invention contains vegetable hyaluronic acid.

본 발명의 일 구현예에 있어서, 상기 조성물의 유효성분인 식물 추출물은 식물성 콜라겐 및 식물성 뮤신을 함유하고, 피부 내 콜라겐의 발현을 증가시킨다.In one embodiment of the present invention, the plant extract, which is an active ingredient of the composition, contains vegetable collagen and plant mucin, and increases the expression of collagen in the skin.

또한, 본 발명의 식물 추출물은 콜라겐 펩타이드를 포함하며, 발효에 의해 제조된다. 따라서, 본 발명의 식물 추출물은 발효 콜라겐 펩타이드 조성물이라고 불릴 수 있다. 본 발명의 식물 추출물의 원재료가 흰목이버섯일 경우, 흰목이버섯 발효 콜라겐 펩타이드 조성물이라고 불릴 수 있다. In addition, the plant extract of the present invention contains collagen peptides and is prepared by fermentation. Therefore, the plant extract of the present invention can be called a fermented collagen peptide composition. When the raw material of the plant extract of the present invention is white wood ear mushroom, it may be called a white wood ear mushroom fermented collagen peptide composition.

세포외기질 주요 구성 성분인 collagen은 피부의 섬유아세포에서 발현되는 단백질로 피부, 뼈 및 치아의 유기 물질의 대부분을 형성하고 피부의 견고성, 결합조직의 저항력, 조직의 결합력, 세포 증식과 분화 유도, 세포의 지탱 등 다양한 기능을 가진다 (Brenneisen et al., 2002; Kim et al., 2015).Collagen, a major component of the extracellular matrix, is a protein expressed in fibroblasts of the skin and forms most of the organic materials of skin, bones, and teeth. It has various functions such as cell support (Brenneisen et al., 2002; Kim et al., 2015).

Collagen은 피부에서 주름 형성과 밀접한 연관이 있다고 알려져 있고 collagen이 부족할 경우 주름을 유발할 수 있다. Collagen은 전구물질인 procollagen의 형태로 합성되며, collagen 중합반응 시 collagen 분자로부터 절단 및 분리되어진다고 알려져 있다 (Lee et al., 2015). 즉 프로펩타이드의 양을 측정하여 세포내에서의 collagen 생합성정도를 파악할 수 있다. Collagen is known to be closely related to the formation of wrinkles in the skin, and a lack of collagen can cause wrinkles. Collagen is synthesized in the form of procollagen, a precursor, and is known to be cleaved and separated from collagen molecules during collagen polymerization (Lee et al., 2015). That is, by measuring the amount of propeptide, it is possible to determine the degree of collagen biosynthesis in the cell.

본 발명의 상기 식품조성물은 상기 추출물 뿐만 아니라, 식품 제조 시에 통상적으로 첨가되는 성분을 포함할 수 있다. 상기 첨가 성분은 예를 들어, 단백질, 탄수화물, 지방, 영양소, 조미제 및 향미제를 포함한다. 상술한 탄수화물의 예는 모노사카라이드, 예를 들어, 포도당, 과당 등; 디사카라이드, 예를 들어 말토스, 슈크로스, 올리고당 등; 및 폴리사카라이드, 예를 들어 덱스트린, 사이클로덱스트린 등과 같은 통상적인 당 및 자일리톨, 소르비톨, 에리트리톨 등의 당알콜이다. 향미제로서 천연향미제 [타우마틴, 스테비아 추출물 (예를 들어 레바우디오시드 A, 글리시르히진등]) 및 합성 향미제(사카린, 아스파르탐 등)를 사용할 수 있다. The food composition of the present invention may include ingredients commonly added during food production, as well as the extract. The additional ingredients include, for example, proteins, carbohydrates, fats, nutrients, seasonings and flavoring agents. Examples of the above-mentioned carbohydrates include monosaccharides such as glucose, fructose and the like; disaccharides such as maltose, sucrose, oligosaccharides and the like; and polysaccharides, for example, conventional sugars such as dextrin, cyclodextrin, and the like, and sugar alcohols such as xylitol, sorbitol, and erythritol. As the flavoring agent, natural flavoring agents [taumatin, stevia extract (eg, rebaudioside A, glycyrrhizin, etc.)) and synthetic flavoring agents (saccharin, aspartame, etc.) can be used.

본 발명의 또 다른 일 양태에 따르면, 본 발명은 상기 식품 조성물을 포함하는 식물 발효식품을 제공한다. According to another aspect of the present invention, the present invention provides a plant fermented food comprising the food composition.

본 발명의 일 구현예에 있어서, 상기 식물은 예컨대 흰목이버섯일 수 있으나, 이에 한정되는 것은 아니다. In one embodiment of the present invention, the plant may be, for example, white wood ear mushroom, but is not limited thereto.

따라서, 본 발명은 흰목이버섯의 발효식품을 제공한다. 본 발명의 상기 흰목이버섯 발효식품은 상기 제조방법에 의해 제조된 발효 콜라겐 펩타이드 조성물 뿐만 아니라, 상술한 식품 제조 시에 통상적으로 첨가되는 성분을 포함할 수 있다.Accordingly, the present invention provides a fermented food of white wood ear mushroom. The fermented white wood ear mushroom food of the present invention may include not only the fermented collagen peptide composition prepared by the above manufacturing method, but also the ingredients commonly added during the preparation of the above-described food.

본 발명의 또 다른 일 구현예에 있어서, 상기 식품조성물은 음료의 형태로 제조될 수 있다. 본 발명의 발효식품이 음료로 제조되는 경우에는 본 발명의 상기 추출물 이외에 구연산, 액상과당, 설탕, 포도당, 초산, 사과산, 과즙, 두충 추출액, 대추 추출액, 감초 추출액 등을 추가로 포함시킬 수 있다.In another embodiment of the present invention, the food composition may be prepared in the form of a beverage. When the fermented food of the present invention is manufactured as a beverage, citric acid, high fructose, sugar, glucose, acetic acid, malic acid, fruit juice, tofu extract, jujube extract, licorice extract, etc. may be additionally included in addition to the extract of the present invention.

따라서, 본 발명의 구체적인 구현예에 있어서, 상기 발효식품은 흰목이버섯 발효음료일 수 있다.Therefore, in a specific embodiment of the present invention, the fermented food may be a fermented white wood ear mushroom drink.

본 발명의 식품조성물은 식품, 기능성 식품 (functional food), 영양보조제 (nutritional supplement), 건강식품 (health food) 및 식품 첨가제 (food additives) 등의 모든 천연소재의 가공 형태를 포함한다. 상기 유형의 식품 조성물은 당업계에 공지된 통상적인 방법에 따라 다양한 형태로 제조될 수 있다.The food composition of the present invention includes processed forms of all natural materials such as food, functional food, nutritional supplement, health food, and food additives. Food compositions of this type can be prepared in various forms according to conventional methods known in the art.

예를 들면, 건강식품으로는 상기 추출물(농축액 또는 분말)을 차, 주스 및 드링크의 형태로 제조하여 음용하도록 하거나, 과립화, 캡슐화 및 분말화하여 섭취할 수 있다. 또한, 식품으로는 음료 (알콜성 음료 포함), 과실 및 그의 가공식품 (예: 과일통조림, 병조림, 잼, 마아말레이드 등), 어류, 육류 및 그 가공식품 (예: 햄, 소시지 콘비이프 등), 빵류 및 면류 (예: 우동, 메밀국수, 라면, 스파게티, 마카로니 등), 과즙, 각종 드링크, 쿠키, 엿, 유제품 (예: 요거트, 발효유, 버터, 치즈 등), 식용식물유지, 마아가린, 식물성 단백질, 레토르트 식품, 냉동식품, 각종 조미료 (예: 된장, 간장, 소스 등) 등 본 발명의 추출물을 첨가하여 제조될 수 있다. 또한, 본 발명의 추출물을 식품 첨가제의 형태로 사용하기 위해서는 분말 또는 농축액 형태로 제조하여 사용할 수 있다. For example, as a health food, the extract (concentrate or powder) may be prepared in the form of tea, juice, and drink to be consumed, or granulated, encapsulated and powdered. In addition, as food, beverages (including alcoholic beverages), fruits and their processed foods (eg, canned fruit, bottled, jam, marmalade, etc.), fish, meat and their processed foods (eg, ham, sausage corn beef, etc.) ), breads and noodles (eg udon noodles, soba noodles, ramen, spaghetti, macaroni, etc.), fruit juice, various drinks, cookies, syrup, dairy products (eg yogurt, fermented milk, butter, cheese, etc.), edible vegetable oils and fats, margarine, Vegetable protein, retort food, frozen food, various seasonings (eg, soybean paste, soy sauce, sauce, etc.) may be prepared by adding the extract of the present invention. In addition, in order to use the extract of the present invention in the form of a food additive, it may be prepared and used in the form of a powder or a concentrate.

본 발명의 다른 일 양태에 따르면, 본 발명은 식물 추출물을 유효성분으로 포함하는 피부노화방지, 주름개선, 피부장벽 강화 또는 피부보습용 화장료 조성물을 제공한다. 상기 추출물은 또한 식물성 콜라겐 및 식물성 뮤신을 포함하는 것을 특징으로 한다. According to another aspect of the present invention, the present invention provides a cosmetic composition for skin anti-aging, wrinkle improvement, skin barrier strengthening or skin moisturizing comprising a plant extract as an active ingredient. The extract is also characterized in that it contains vegetable collagen and vegetable mucin.

상기 본 발명의 화장료 조성물은 상술한 식품조성물과 동일한 추출물을 유효성분으로 포함하는 바, 양 발명 간에 공통되는 내용은 본 명세서의 복잡성을 방지하기 위하여 그 기재를 생략한다. The cosmetic composition of the present invention contains the same extract as the above-described food composition as an active ingredient, and descriptions of common contents between the two inventions are omitted in order to avoid the complexity of the present specification.

상기 화장료에는, 화장료의 중량을 전체 100 중량% 기준으로 할 때, 상기 식물성 콜라겐 및 식물성 뮤신을 포함하는 추출물이 0.001~20 중량% 포함될 수 있다. In the cosmetic, when the total weight of the cosmetic is based on 100% by weight, the extract containing the vegetable collagen and vegetable mucin may be included in an amount of 0.001 to 20% by weight.

상기 화장료의 제형은 특별히 제한되지 않으나, 바람직하게는 스킨로션, 스킨소프너, 스킨토너, 아스트린젠트, 로션, 밀크로션, 모이스쳐로션, 영양로션, 맛사지크림, 영양크림, 모이스쳐크림, 핸드크림, 파운데이션, 에센스, 영양에센스, 팩, 비누, 클렌징폼, 클렌징로션, 클렌징크림, 바디로션 및 바디클렌저로 이루어진 그룹에서 선택될 수 있다.The formulation of the cosmetic is not particularly limited, but preferably skin lotion, skin softener, skin toner, astringent, lotion, milk lotion, moisture lotion, nourishing lotion, massage cream, nourishing cream, moisture cream, hand cream, foundation, essence , nutritional essence, pack, soap, cleansing foam, cleansing lotion, cleansing cream, body lotion and body cleanser.

본 발명의 화장료에는 또한 통상의 화장료에 배합되는 다른 성분을 배합할 수도 있다. 이외에 첨가해도 되는 배합 성분으로서는 유지 성분, 보습제, 에몰리엔트제, 계면 활성제, 유기 및 무기 안료, 유기 분체, 자외선 흡수제, 방부제, 살균제, 산화 방지제, 식물 추출물, pH 조정제, 알콜, 색소, 향료, 혈행 촉진제, 냉감제, 제한(制汗)제, 정제수 등을 들 수 있다.The cosmetic of the present invention may also contain other ingredients that are formulated in conventional cosmetics. Other ingredients that may be added include oils and fats, moisturizers, emollients, surfactants, organic and inorganic pigments, organic powders, UV absorbers, preservatives, bactericides, antioxidants, plant extracts, pH adjusters, alcohols, colorants, fragrances, A blood circulation promoter, a cooling agent, a restrictive agent, purified water, etc. are mentioned.

상기 이외에 첨가해도 되는 배합 성분은 이에 한정되는 것은 아니며, 상기 어느 성분도 본 발명의 목적 및 효과를 손상시키지 않는 범위 내에서 배합 가능하지만, 총중량에 대하여 바람직하게는 0.01 내지 5 중량%, 보다 바람직하게는 0.01 - 3 중량%, 0.01 - 2 중량%, 0.01 - 1 중량%, 0.1 - 3 중량%, 0.5 - 3 중량%, 1 - 3 중량%, 또는 2 - 3 중량% 등으로 배합될 수 있다. Blending components that may be added other than the above are not limited thereto, and any of the above components can be blended within a range that does not impair the object and effect of the present invention, but preferably 0.01 to 5 wt%, more preferably, based on the total weight 0.01 - 3 wt%, 0.01 - 2 wt%, 0.01 - 1 wt%, 0.1 - 3 wt%, 0.5 - 3 wt%, 1 - 3 wt%, or 2 - 3 wt%, etc. may be blended.

본 발명의 화장료는 용액, 유화물, 점성형 혼합물 등의 형상을 취할 수 있다. 본 발명의 화장료에 포함되는 성분은 유효성분으로서 상기 펩타이드 조성물 이외에 화장료에 통상적으로 이용되는 성분들을 포함할 수 있으며, 예를 들면, 안정화제, 용해화제, 비타민, 안료 및 향료와 같은 통상적인 보조제 및 담체를 포함한다. 본 발명의 화장료 제형이 페이스트, 크림 또는 겔인 경우에는 담체 성분으로서 동물섬유, 식물섬유, 왁스, 파라 핀, 전분, 트라칸트, 셀룰로오스 유도체, 폴리에틸렌 글리콜, 실리콘, 벤토나이트, 실리카, 탈크 또는 산화아연 등이 이용될 수 있다. 본 발명의 화장료 제형이 파우더 또는 스프레이인 경우에는 담체 성분으로서 락토스, 탈크, 실리카, 알루미늄 히드록시드, 칼슘 실리케이트 또는 폴리아미드 파우더가 이용될 수 있고, 특히 스프레이인 경우에는 추가적으로 클로로플루오로하이드로카본, 프로판/부탄 또는 디메틸 에테르와 같은 추진체를 포함할 수 있다. The cosmetic of the present invention may take the form of a solution, an emulsion, a viscous mixture, or the like. The ingredients included in the cosmetic of the present invention may include ingredients commonly used in cosmetics in addition to the peptide composition as an active ingredient, for example, conventional adjuvants such as stabilizers, solubilizers, vitamins, pigments and fragrances carrier. When the cosmetic formulation of the present invention is a paste, cream or gel, animal fiber, vegetable fiber, wax, paraffin, starch, tracanth, cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc or zinc oxide, etc. can be used When the cosmetic formulation of the present invention is a powder or a spray, lactose, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder may be used as a carrier component, and in particular, in the case of a spray, additional chlorofluorohydrocarbon, propellants such as propane/butane or dimethyl ether.

본 발명의 화장료 제형이 용액 또는 유탁액의 경우에는 담체 성분으로서 용매, 용매화제 또는 유탁화제가 이용되고, 예컨대 물, 에탄올, 이소프로판올, 에틸 카보네이트, 에틸 아세테이트, 벤질 알코올, 벤질 벤조에이트, 프로필렌 글리콜, 1,3-부틸글리콜 오일, 글리세롤 지방족 에스테르, 폴리에틸렌 글리콜 또는 소르비탄의 지방산 에스테르가 있다. When the cosmetic formulation of the present invention is a solution or emulsion, a solvent, solvating agent or emulsifying agent is used as a carrier component, for example, water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol, 1,3-butylglycol oil, glycerol fatty esters, fatty acid esters of polyethylene glycol or sorbitan.

본 발명의 화장료 제형이 현탁액인 경우에는 담체 성분으로서 물, 에탄올 또는 프로필렌 글리콜과 같은 액상 희석제, 에톡실화 이소스테아릴 알코올, 폴리옥시에틸렌 소르비톨 에스테르 및 폴리옥시에틸렌 소르비탄 에스테르 와 같은 현탁제, 미소결정성 셀룰로오스, 알루미늄 메타히드록시드, 벤토나이트, 아가 또는 트라칸트 등이 이용될 수 있다. When the cosmetic formulation of the present invention is a suspension, as a carrier component, a liquid diluent such as water, ethanol or propylene glycol, a suspending agent such as ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester, and microcrystals Adult cellulose, aluminum metahydroxide, bentonite, agar or tracanth may be used.

본 발명의 화장료 제형이 계면-활성제 함유 클린징인 경우에는 담체 성분으로서 지방족 알코올 설페이트, 지방 족 알코올 에테르 설페이트, 설포숙신산 모노에스테르, 이세티오네이트, 이미다졸리늄 유도체, 메틸타우레이트, 사르코시네이트, 지방산 아미드 에테르 설페이트, 알킬아미도베타인, 지방족 알코올, 지방산 글리세리드, 지방 산 디에탄올아미드, 식물성유, 리놀린 유도체 또는 에톡실화 글리세롤 지방산 에스테르 등이 이용될 수 있다.When the cosmetic formulation of the present invention is a surfactant-containing cleansing agent, aliphatic alcohol sulfate, aliphatic alcohol ether sulfate, sulfosuccinic acid monoester, isethionate, imidazolinium derivative, methyl taurate, sarcosinate, Fatty acid amide ether sulfate, alkylamidobetaine, fatty alcohol, fatty acid glyceride, fatty acid diethanolamide, vegetable oil, linoline derivative or ethoxylated glycerol fatty acid ester and the like can be used.

본 발명의 제형이 비누인 경우에는, 담체 성분으로서 지방산의 알칼리 금속 염, 지방산 헤미에스테르 염, 지방산 단백질 히드롤리제이트, 이세티오네이트, 라놀린 유도체, 지방족 알코올, 식물성 유, 글리세롤, 당 등이 이용될 수 있으나, 이에 제한되는 것은 아니다. 이들은 단독으로 사용되거나 2 종 이상 혼합되어 사용될 수 있다.When the formulation of the present invention is soap, alkali metal salts of fatty acids, fatty acid hemiester salts, fatty acid protein hydrolysates, isethionate, lanolin derivatives, aliphatic alcohols, vegetable oils, glycerol, sugar, etc. are used as carrier components may be, but is not limited thereto. These may be used alone or in combination of two or more.

본 발명의 또 다른 일 양태에 따르면, 본 발명은 다음 단계를 포함하는 식물성 추출물의 제조방법을 제공한다:According to another aspect of the present invention, the present invention provides a method for preparing a vegetable extract comprising the steps of:

(a) 식물성 생약재료 분말에 용매를 혼합하는 단계;(a) mixing a solvent in the herbal herbal material powder;

(b) 상기 혼합액에 효소, 유산균, 또는 이들의 조합을 첨가하고 배양하는 단계;(b) adding an enzyme, lactic acid bacteria, or a combination thereof to the mixed solution and culturing;

(c) 상기 배양액을 원심분리 또는 여과하여 슬러지 및 전분을 제거하고 점성 상층액을 분리하거나, 여과액을 제조하는 단계; 및(c) centrifuging or filtering the culture solution to remove sludge and starch and separating the viscous supernatant, or preparing a filtrate; and

(d) 상기 점성 상층액 또는 여과액을 가열하여 효소, 유산균 또는 이들의 조합을 실활 및 살균시키는 단계.(d) heating the viscous supernatant or the filtrate to inactivate and sterilize the enzyme, lactic acid bacteria, or a combination thereof.

본 발명에 따른 상기 식물 추출물은 식물성 콜라겐, 식물성 뮤신 등을 풍부하게 포함하는 점은 상술한 바와 같다.As described above, the plant extract according to the present invention abundantly contains vegetable collagen, plant mucin, and the like.

본 발명의 일 구현예에 있어서, 상기 추출물의 제조방법은 (e) 액상의 추출물 또는 이를 건조하여 분말상의 추출물을 수득하는 단계를 추가적으로 포함한다. In one embodiment of the present invention, the method for preparing the extract further comprises the step of (e) obtaining a powdery extract by drying the liquid extract or the same.

(a) 단계: 식물성 생약재료 분말에 용매를 혼합하는 단계;(a) step: mixing a solvent in the herbal herbal material powder;

본 발명의 일 구현예에 있어서, 상기 (a) 단계의 생약재료 분말은 입자의크기가 10 내지 100 메쉬(mesh)의 범위로 분쇄된 것이다. 상기 분쇄는 당 업계에서 통상적으로 사용되는 식품의 분쇄, 분말화 방법을 제한없이 사용할 수 있다. In one embodiment of the present invention, the herbal material powder of step (a) is pulverized to a particle size in the range of 10 to 100 mesh (mesh). For the pulverization, a method of pulverizing and pulverizing food commonly used in the art may be used without limitation.

본 발명의 일 구현예에 있어서, 상기 생약 재료는 시금치, 스위스차드, 당근, 토마토, 황기, 천궁, 버섯류, 둥근마, 연근, 유채꽃 및 유채씨로 이루어진 군으로부터 선택된 1종 이상이다.In one embodiment of the present invention, the herbal material is at least one selected from the group consisting of spinach, Swiss chard, carrot, tomato, astragalus, chrysanthemum, mushrooms, round hemp, lotus root, rape flower and rapeseed.

본 발명의 일 구현예에 있어서, 상기 생약 재료는 석류, 타트체리, 블루베리, 마늘, 망고, 오렌지, 아보카도, 화이트리, 케슈넛, 히비스커스, 딸기, 금화규, 키위, 구아바, 파인애플, 콩, 피망, 라즈베리, 블랙베리, 구기자, 복령, 및 숙지황으로 이루어진 군으로부터 선택된 1종 이상을 추가적으로 포함한다.In one embodiment of the present invention, the herbal material is pomegranate, tart cherry, blueberry, garlic, mango, orange, avocado, white lily, cashew nut, hibiscus, strawberry, goldfish, kiwi, guava, pineapple, soybean, Bell pepper, raspberry, blackberry, goji berry, bokryeong, and additionally includes at least one selected from the group consisting of sukjihwang.

본 발명의 구체적인 구현예에 있어서, 상기 버섯류는 흰목이버섯, 목이버섯, 영지버섯, 치마버섯, 송이버섯, 표고버섯, 송로버섯, 상황버섯, 말굽버섯, 송화버섯, 차가버섯, 능이버섯, 노루궁뎅이버섯, 느타리버섯, 및 까치버섯으로 이루어진 군으로부터 선택된 1종 이상의 버섯이나, 이에 한정되는 것은 아니다.In a specific embodiment of the present invention, the mushrooms are white wood ear mushroom, wood ear mushroom, reishi mushroom, chima mushroom, matsutake mushroom, shiitake mushroom, truffle, situation mushroom, horseshoe mushroom, pine mushroom, chaga mushroom, neungi mushroom, roe deer At least one mushroom selected from the group consisting of oyster mushroom, oyster mushroom, and blackcurrant mushroom, but is not limited thereto.

본 발명의 일 구현예에 있어서, 상기 용매는 정제수, 또는 C1 내지 C4의 저급알코올 수용액이고, 보다 구체적으로는 정제수 또는 에탄올 수용액이다. In one embodiment of the present invention, the solvent is purified water or a C1 to C4 aqueous solution of lower alcohol, and more specifically, purified water or an aqueous ethanol solution.

본 발명의 일 구현예에 있어서, 상기 (a) 단계에서 상기 용매는 식물성 생약재료 분말 1 중량부에 대하여, 1 내지 100 중량부로 첨가된다. 구체적으로 상기 정제수는 2 내지 80 중량부, 2 내지 50 중량부, 3 내지 30 중량부, 5 내지 20중량부, 5 내지 15중량부 또는 5 내지 10 중량부로 첨가될 수 있으나, 이에 한정되는 것은 아니다.In one embodiment of the present invention, in step (a), the solvent is added in an amount of 1 to 100 parts by weight based on 1 part by weight of the herbal herbal material powder. Specifically, the purified water may be added in an amount of 2 to 80 parts by weight, 2 to 50 parts by weight, 3 to 30 parts by weight, 5 to 20 parts by weight, 5 to 15 parts by weight, or 5 to 10 parts by weight, but is not limited thereto. .

본 발명의 일 구현예에 있어서, 상기 (a) 단계의 식물성 생약재료 분말은 1 내지 80%(w/w) 농도의 구연산, 아세트산, 또는 묽은 염산으로부터 선택된 산으로 1 내지 5시간 동안 처리한 것일 수 있다. 상기 산은 1 내지 60%(w/w), 1 내지 50%(w/w), 1 내지 40%(w/w), 1 내지 30%(w/w), 1 내지 20%(w/w), 또는 1 내지 10%(w/w)일 수 있으나, 이에 한정되는 것은 아니다.In one embodiment of the present invention, the plant herbal material powder of step (a) is treated with an acid selected from citric acid, acetic acid, or dilute hydrochloric acid at a concentration of 1 to 80% (w/w) for 1 to 5 hours. can The acid is 1 to 60% (w/w), 1 to 50% (w/w), 1 to 40% (w/w), 1 to 30% (w/w), 1 to 20% (w/w) ), or 1 to 10% (w/w), but is not limited thereto.

본 발명의 일 구현예에 있어서, 본 발명의 제조방법은 상기 구연산, 아세트산, 또는 묽은 염산으로부터 선택된 산처리 후 중화시키는 단계를 포함할 수 있다.In one embodiment of the present invention, the preparation method of the present invention may include neutralizing after treatment with an acid selected from citric acid, acetic acid, or dilute hydrochloric acid.

본 발명의 일 구현예에 있어서, 상기 (a) 단계는 식물성 생약재료 분말에 에탄올 수용액을 용매로 첨가하는 공정을 포함할 수 있다. In one embodiment of the present invention, step (a) may include a step of adding an aqueous ethanol solution as a solvent to the plant herbal material powder.

상기 에탄올 수용액을 용매로 첨가하는 공정은 상술한 식물성 생약재료 분말을 산처리 또는 산처리 및 중화시킨 후에 이루어질 수 있다.The process of adding the aqueous ethanol solution as a solvent may be performed after acid treatment or acid treatment and neutralization of the above-described vegetable herbal material powder.

본 발명의 추출물은 상기 에탄올을 이용한 추출법 외에도, 공지의 천연물 추출법으로 추출될 수 있다. 예를 들어 냉침추출, 열수추출, 초음파 추출, 환류냉각 추출, 가열 추출법으로 추출할 수 있으며, 구체적으로는 열수추출 또는 환류 냉각 추출법으로 추출할 수 있으며, 1회 내지 10회, 보다 구체적으로는 2회 내지 7회 반복 추출할 수 있다. 이때 상기 추출용매는 물(정제수)일 수 있다. In addition to the extraction method using ethanol, the extract of the present invention may be extracted by a known natural product extraction method. For example, extraction may be performed by cold extraction, hot water extraction, ultrasonic extraction, reflux cooling extraction, or heating extraction method, and specifically, extraction may be performed by hot water extraction or reflux cooling extraction method, 1 to 10 times, more specifically 2 Extraction can be repeated 7 to 7 times. In this case, the extraction solvent may be water (purified water).

본 발명에서 추출물은 용매에 의해 추출된 조추출물(crude extract)의 형태를 이용할 수 있으며, 고순도로 정제하여 사용할 수도 있다.In the present invention, the extract may be used in the form of a crude extract extracted with a solvent, and may be purified and used with high purity.

본 명세서에서 사용되는 용어 '추출물'은 상술한 바와 같이 당업계에서 조추출물(crude extract)로 통용되는 의미를 갖지만, 광의적으로는 추출물을 추가적으로 분획(fractionation)한 분획물도 포함한다. 즉, 식물성 생약재료의 추출물은 상술한 추출용매를 이용하여 얻은 것뿐만 아니라, 여기에 정제과정을 추가적으로 적용하여 얻은 것도 포함한다. 예컨대, 상기 추출물을 일정한 분자량 컷-오프 값을 갖는 한외 여과막을 통과시켜 얻은 분획, 투석, 다양한 크로마토그래피 (크기, 전하, 소수성 또는 친화성에 따른 분리를 위해 제작된 것)에 의한 분리 등, 추가적으로 실시된 다양한 정제 방법을 통해 얻어진 분획도 본 발명의 식물성 생약재료의 추출물에 포함되는 것이다. As used herein, the term 'extract' has the meaning commonly used as a crude extract in the art as described above, but in a broad sense also includes a fraction obtained by additionally fractionating the extract. That is, the extract of the herbal herbal material includes not only those obtained by using the above-described extraction solvent, but also those obtained by additionally applying a purification process thereto. For example, a fraction obtained by passing the extract through an ultrafiltration membrane having a constant molecular weight cut-off value, dialysis, separation by various chromatography (prepared for separation according to size, charge, hydrophobicity or affinity), etc., additionally carried out The fractions obtained through various purification methods are also included in the extract of the herbal herbal material of the present invention.

본 발명의 다른 일 구현예에 있어서, 상기 (a) 단계는 식물성 생약재료 분말에 에탄올 수용액을 용매로 첨가하여 추출한 후 고액 분리하여 액체성분은 수득하고, 고형분은 물을 첨가한 후에 60-95℃에서 열수 추출한 후에 상기 에탄올 수용액으로 추출한 액체성분과 혼합하는 것이다.In another embodiment of the present invention, in step (a), an aqueous ethanol solution is added to the vegetable herbal material powder as a solvent and extracted, followed by solid-liquid separation to obtain a liquid component, and the solid content is 60-95° C. after adding water After hot water extraction in the ethanol solution, it is mixed with the liquid component extracted with the aqueous ethanol solution.

본 발명의 일 구현예에 있어서, 상기 (a) 단계에서는 식물성 생약재료 분말에 용매를 첨가하고, 0.2 내지 5기압 조건에서 가압처리될 수 있다. 상기 가압처리는 상기 열수 추출단계와 병행될 수 있다.In one embodiment of the present invention, in step (a), a solvent is added to the herbal herbal material powder, and the pressure treatment may be performed under 0.2 to 5 atmospheres. The pressurization treatment may be performed in parallel with the hot water extraction step.

상기 가압처리는 0.2 기압 이상 1기압 미만의 조건에서 가압처리; 1기압 초과 5기압 이하의 조건에서 가압처리; 또는 0.2 기압 이상 1기압 미만의 조건에서 가압처리된 후, 다시 1기압 초과 5기압 이하의 조건에서 가압처리될 수 있다.The pressurization treatment is performed under conditions of 0.2 atm or more and less than 1 atm; pressure treatment under conditions of more than 1 atmosphere and less than 5 atmospheres; Alternatively, after being pressurized under conditions of 0.2 atm or more and less than 1 atm, it may be pressurized again under conditions of greater than 1 atm and below 5 atm.

상기 0.2 내지 5기압 조건의 가압처리는 30분 내지 2일간 이루어질 수 있고, 서로 다른 압력 및 시간 조건으로 1회 이상 이루어질 수 있다. 상기 가압처리는 예컨대 0.2 기압 이상 1 기압 미만의 조건에서 30분 내지 1일간 가압처리한 후, 1기압 초과 5기압 이하의 조건에서 30분 내지 1일간 가압처리될 수 있다. The pressure treatment under the conditions of 0.2 to 5 atmospheres may be performed for 30 minutes to 2 days, and may be performed one or more times under different pressure and time conditions. The pressure treatment may be, for example, pressurized under conditions of 0.2 atm or more and less than 1 atm for 30 minutes to 1 day, and then pressurized under conditions of greater than 1 atm and below 5 atm, for 30 minutes to 1 day.

상기 0.2 기압 초과 1 기압 이하의 조건에서의 가압공정은 분말 및 용매의 혼합물 내에 포함된 미세한 기포를 확대 발생시켜 제거(탈포)함으로써 생약재료 분말이 용매와 보다 더 잘 섞일 수 있도록 하고, 이를 통하여 식물성 콜라겐, 식물성 뮤신, 식물성 다당체가 용매 내로 보다 더 잘 추출되도록 하여 추출 효율을 증가시킨다. The pressurization process under the conditions of more than 0.2 atm and 1 atm or less expands and removes (de-foaming) fine air bubbles contained in the mixture of powder and solvent so that the herbal material powder can be mixed with the solvent better, and through this Increases extraction efficiency by allowing collagen, vegetable mucin, and vegetable polysaccharide to be better extracted into the solvent.

또한, 상기 1 기압 초과 및 5기압 이하의 조건에서의 가압공정은 생약분말과 용매에 고압을 가함으로써 생약재료 분말 내에 포함되어 있는 식물성 콜라겐 및 식물성 뮤신의 용해도를 증가시켜 추출 효율을 증가시킨다.In addition, the pressurization process under the conditions of more than 1 atmosphere and less than 5 atmospheres increases the extraction efficiency by increasing the solubility of vegetable collagen and vegetable mucin contained in the herbal material powder by applying high pressure to the herbal powder and the solvent.

본 발명의 일 구현예에 있어서, 상기 0.2 내지 5기압 조건의 압력 처리시에는 50-130 ℃의 온도 조건으로 가열처리 될 수 있다. 상기 가열처리 공정은 용매 내에 용해되는 유용성분의 용해도를 증가시킴으로써, 생약재료 내 포함된 식물성 콜라겐 및 식물성 뮤신의 추출 효율을 증가시킨다.In one embodiment of the present invention, the heat treatment may be performed at a temperature condition of 50-130 °C during the pressure treatment under the 0.2 to 5 atmospheres pressure condition. The heat treatment process increases the solubility of useful components dissolved in the solvent, thereby increasing the extraction efficiency of vegetable collagen and vegetable mucin contained in the herbal material.

따라서, 본 발명의 일 구현예에 있어서, 상기 (a) 단계에서는 식물성 생약재료 분말에 용매를 첨가하고, 0.2 내지 5기압 조건, 50-130 ℃의 온도 하에 30분 내지 2일간 가압 및 가열처리할 수 있으나, 이에 한정되는 것은 아니다.Therefore, in one embodiment of the present invention, in step (a), a solvent is added to the herbal herbal material powder, and the pressure and heat treatment are performed for 30 minutes to 2 days under conditions of 0.2 to 5 atmospheres and a temperature of 50-130 ℃. However, the present invention is not limited thereto.

단계 (b): 상기 혼합액에 효소, 유산균, 또는 이들의 조합을 첨가하고 배양하는 단계Step (b): adding an enzyme, lactic acid bacteria, or a combination thereof to the mixture and culturing

본 단계는 상기 (a) 단계에서 제조한 혼합액에 효소, 유산균, 또는 이들의 조합을 첨가하고 배양하는 단계이다. 상기 혼합액에는 효소 또는 유산균을 단독으로 첨가하고 배양하거나, 또는 효소 및 유산균을 함께 (순차적으로 또는 동시에) 첨가하고 배양할 수 있다. This step is a step of adding an enzyme, lactic acid bacteria, or a combination thereof to the mixed solution prepared in step (a) and culturing. To the mixture, the enzyme or lactic acid bacteria may be added alone and cultured, or the enzyme and the lactic acid bacteria may be added together (sequentially or simultaneously) and cultured.

본 발명의 일 구현예에 있어서, 상기 (b) 단계의 효소는 셀룰라아제, 헤미셀룰라아제, 베타-글루코시다제, 베타글루카나제, 자일라나제, 아라비나제, 프로테아제, 및 아밀라아제로 이루어진 군으로부터 선택되는 1종 이상의 효소이다. In one embodiment of the present invention, the enzyme of step (b) is selected from the group consisting of cellulase, hemicellulase, beta-glucosidase, betaglucanase, xylanase, arabinase, protease, and amylase One or more enzymes that become

본 발명의 일 구현예에 있어서, 상기 프로테아제는 펩신, 파파인, 트립신, 및 엘라스타제로 이루어진 군으로부터 선택되는 1종 이상의 단백질 분해효소이다. In one embodiment of the present invention, the protease is at least one protease selected from the group consisting of pepsin, papain, trypsin, and elastase.

본 발명의 일 실험예에 있어서, 상기 효소는 복합효소로서 Sumizyme, Ultimase, Viscozyme, Lyvarome A5 등이 사용될 수 있으나, 이에 한정되는 것은 아니다.In one experimental example of the present invention, the enzyme may be used as a complex enzyme, such as Sumizyme, Ultimase, Viscozyme, Lyvarome A5, but is not limited thereto.

본 발명의 일 구현예에 있어서, 상기 효소는 0.01 내지 3 wt%의 농도로 첨가될 수 있으나, 이에 한정되는 것은 아니다.In one embodiment of the present invention, the enzyme may be added at a concentration of 0.01 to 3 wt%, but is not limited thereto.

본 발명의 일 구현예에 있어서, 상기 효소의 첨가량은 보다 구체적으로는 0.1~4%, 0.1~3%, 0.1~2%, 0.1~1%, 1~4%, 1~3%, 1~2%, 1%, 2%, 또는 3%이나, 이에 한정되는 것은 아니다. 상기 효소의 첨가량이 0.01% 미만일 경우 효소의 가수분해 효과가 나타나지 않고, 5%를 초과하는 경우 제조비용이 과다하여 경제적이지 않다.In one embodiment of the present invention, the amount of the enzyme added is more specifically 0.1-4%, 0.1-3%, 0.1-2%, 0.1-1%, 1-4%, 1-3%, 1- 2%, 1%, 2%, or 3%, but not limited thereto. If the addition amount of the enzyme is less than 0.01%, the hydrolysis effect of the enzyme does not appear, and if it exceeds 5%, the manufacturing cost is excessive and not economical.

본 발명의 일 구현예에 있어서, 상기 효소의 처리시 온도는 40-70℃이고, 보다 구체적으로는 40-65℃, 45-65℃, 또는 50-65℃이나, 이에 한정되는 것은 아니다. 상기 효소의 처리시에는 효소와 식물성 생약재료의 접촉 빈도 및 반응 효율을 높이기 위하여 교반하면서 처리하는 것이 바람직하다. 상기 교반 속도는 50-250 rpm이나, 이에 한정되는 것은 아니다. In one embodiment of the present invention, the temperature during the treatment of the enzyme is 40-70 ℃, more specifically 40-65 ℃, 45-65 ℃, or 50-65 ℃, but is not limited thereto. In the case of the enzyme treatment, it is preferable to perform the treatment while stirring in order to increase the contact frequency and reaction efficiency between the enzyme and the plant herbal material. The stirring speed is 50-250 rpm, but is not limited thereto.

본 발명의 일 구현예에 있어서, 상기 식물성 생약재료에 효소처리를 하는 경우, 다당체의 가수분해에 따라 다당체의 저분자화가 이루어지고 맛 또한 개선된다. 여기에 식물성 생약재료의 통분말을 추가하면, 식물성 콜라겐이 다량함유되어 있는 식물성 생약재료의 식감과 전체 조성물의 기호도가 크게 개선된다. In one embodiment of the present invention, when enzyme treatment is performed on the vegetable herbal material, the polysaccharide is reduced in molecular weight according to the hydrolysis of the polysaccharide and the taste is also improved. When the whole powder of vegetable herbal material is added here, the texture of the vegetable herbal material containing a large amount of vegetable collagen and the preference of the whole composition are greatly improved.

본 발명의 일 구현예에 있어서, 상기 생약재료가 흰목이버섯인 경우, 효소처리를 수반하여 제조된 추출물은 흰목이버섯 효소처리 다당체 추출물이라고 불리울 수 있다. In one embodiment of the present invention, when the herbal material is white wood ear mushroom, the extract prepared by enzymatic treatment may be called a white wood ear mushroom enzyme-treated polysaccharide extract.

상기 흰목이버섯 효소처리 다당체 추출물은 흰목이 버섯의 통분말을 추가하여 식품조성물로 제조될 수 있다. 이 경우 식품 조성물의 식감과 기호도가 개선되는 특징이 있다. The enzyme-treated polysaccharide extract of the white oyster mushroom can be prepared as a food composition by adding the whole powder of the white rhododendron mushroom. In this case, the texture and taste of the food composition are improved.

본 발명의 일 구현예에 있어서, 상기 (b) 단계의 유산균은 류코노스톡 속, 락토바실러스 속, 비피도박테리움 속, 엔테로코커스 속 균주, 락토코커스 속 균, 또는 이들의 조합이다. In one embodiment of the present invention, the lactic acid bacteria of step (b) is Leuconostok genus, Lactobacillus genus, Bifidobacterium genus, Enterococcus sp. strain, Lactococcus genus, or a combination thereof.

본 발명의 구체적인 구현예에 있어서, 상기 류코노스톡 속 균은 류코노스톡 메센테로이데스 균주이고, 상기 락토바실러스 속 균은 락토바실러스 델브루키 spp. 불가리쿠스, 락토바실러스 헬베티커스, 락토바실러스 퍼멘텀, 락토바실러스 써모필루스, 락토바실러스 카제이, 락토바실러스 람노서스, 락토바실러스 플란타룸, 락토바실러스 애시도필루스, 락토바실러스 류테리, 또는 이들의 조합이다.In a specific embodiment of the present invention, the Leuconostok genus bacteria is a Leukonostok mecenteroides strain, and the Lactobacillus genus bacteria is Lactobacillus delbrooki spp. Bulgaricus, Lactobacillus helveticus, Lactobacillus permentum, Lactobacillus thermophilus, Lactobacillus casei, Lactobacillus rhamnosus, Lactobacillus plantarum, Lactobacillus acidophilus, Lactobacillus reuteri, or these is a combination of

본 발명의 구체적인 일 구현예에 있어서, 상기 락토바실러스 속 균은 락토바실러스 앨리멘터리우스(Lactobacillus alementarius)이고, 보다 구체적으로는 락토바실러스 앨리멘터리우스 로이터 균주(Lactobacillus alementarius Reuter, ATCC 29643)이다. In a specific embodiment of the present invention, the Lactobacillus genus fungus is Lactobacillus alementarius ( Lactobacillus alementarius ), and more specifically Lactobacillus alementarius Reuter strain ( Lactobacillus alementarius Reuter, ATCC 29643).

본 발명의 구체적인 구현예에 있어서, 상기 엔테로코커스 속 균주는 엔테로코커스 패시움, 엔테로코커스 패칼리스, 또는 이들의 조합이다.In a specific embodiment of the present invention, the Enterococcus sp. strain is Enterococcus faecium, Enterococcus faecalis, or a combination thereof.

본 발명의 구체적인 구현예에 있어서, 상기 락토바실러스 속 균은 락토바실러스 플란타룸, 락토바실러스 아시도필러스, 락토바실러스 람노서스, 락토바실러스 카제이, 락토바실러스 류테리, 락토바실러스 퍼멘텀, 락토바실러스 헬베티쿠스, 락토바실러스 브레비스, 락토바실러스 앨리멘터리우스, 락토바실러스 델브루키 불가리쿠스, 또는 이들의 조합이다.In a specific embodiment of the present invention, the Lactobacillus genus bacteria are Lactobacillus plantarum, Lactobacillus acidophilus, Lactobacillus rhamnosus, Lactobacillus casei, Lactobacillus reuteri, Lactobacillus permentum, Lactobacillus Helveticus, Lactobacillus brevis, Lactobacillus elementurius, Lactobacillus delbrooki bulgaricus, or a combination thereof.

본 발명의 구체적인 구현예에 있어서, 상기 비피도박테리움 속 균은 비피도박테리움 비피덤, 비피도박테리움 롱검, 비피도박테리움 브레베, 비피도박테리움 애니멀리스 락티스, 또는 이들의 조합이다. In a specific embodiment of the present invention, the Bifidobacterium genus bacteria is Bifidobacterium bifidum, Bifidobacterium longum, Bifidobacterium breve, Bifidobacterium animalis lactis, or a combination thereof. to be.

본 발명의 구체적인 일 구현예에 있어서, 상기 락토코커스 속 균은 락토코커스 락티스이다.In a specific embodiment of the present invention, the Lactococcus genus bacteria is Lactococcus lactis.

본 발명의 일 구현예에 있어서, 상기 (b) 단계의 배양은 1일 내지 50일간 이루어진다.In one embodiment of the present invention, the culturing in step (b) is made for 1 to 50 days.

본 발명의 구체적인 구현예에 있어서, 상기 (b) 단계의 배양은 1일 내지 14일간 이루어지고, 보다 구체적으로는 1일 내지 10일, 1일 내지 7일, 1일 내지 5일, 또는 1일 내지 3일간 이루어질 수 있으나, 이에 한정되는 것은 아니다.In a specific embodiment of the present invention, the culturing in step (b) is made for 1 day to 14 days, more specifically 1 day to 10 days, 1 day to 7 days, 1 day to 5 days, or 1 day to 3 days, but is not limited thereto.

본 발명의 일 구현예에 있어서, 상기 (b) 단계의 배양은 pH 6 내지 8, 보다 구체적으로는 pH 6.5 내지 7.5, 보다 더 구체적으로는 6.5 내지 7의 범위 내에서 조절되는 것이나, 이에 한정되는 것은 아니며 사용된 효소, 유산균의 최적 배양 조건에 따라 적절히 조절될 수 있다. In one embodiment of the present invention, the culture in step (b) is controlled within the range of pH 6 to 8, more specifically pH 6.5 to 7.5, and even more specifically 6.5 to 7, but limited thereto It can be adjusted appropriately depending on the enzyme used and the optimal culture conditions of the lactic acid bacteria.

단계 (c): 상기 배양액을 원심분리 또는 여과하여 슬러지 및 전분을 제거하고 점성 상층액을 분리하거나, 여과액을 제조하는 단계Step (c): centrifuging or filtering the culture solution to remove sludge and starch and separating the viscous supernatant, or preparing a filtrate

상기 단계는 상기 (b) 단계에서 제조한 효소, 유산균, 또는 이들의 조합의 배양액을 원심분리하거나, 여과함으로써 슬러지 및 전분을 제거하고 점성의 상층액을 분리하거나, 여과되고 남은 여과액을 제조하는 단계이다. The step is to remove the sludge and starch by centrifuging or filtering the culture solution of the enzyme, lactic acid bacteria, or a combination thereof prepared in step (b), and to separate the viscous supernatant, or to prepare the filtrate remaining after filtering. is a step

상기 원심분리는 당업계에서 일반적으로 고액분리에 사용될 수 있는 적절한 조건으로 수행될 수 있고 상층액과 침전물을 분리하는 목적을 달성할 수 있으면 족하다. The centrifugation may be performed under suitable conditions that can be generally used for solid-liquid separation in the art, and it is sufficient as long as it can achieve the purpose of separating the supernatant from the precipitate.

단계 (d): 상기 점성 상층액 또는 여과액을 가열하여 효소, 유산균 또는 이들의 조합을 실활 및 살균시키는 단계Step (d): heating the viscous supernatant or the filtrate to inactivate and sterilize the enzyme, lactic acid bacteria, or a combination thereof

상기 단계는 상기 (c) 단계에서 제조된 점성 상층액 또는 여과액을 가열함으로써 이들 중 포함되어 있는 효소, 유산균, 또는 이들의 조합을 실활시키고 살균시키는 단계이다. The step is a step of inactivating and sterilizing the enzyme, lactic acid bacteria, or a combination thereof contained therein by heating the viscous supernatant or the filtrate prepared in step (c).

본 발명의 일 구현예에 있어서, 상기 (d) 단계의 가열은 60-150℃에서 0.5초 내지 3시간 동안 이루어지는 것이다.In one embodiment of the present invention, the heating in step (d) is performed at 60-150° C. for 0.5 seconds to 3 hours.

본 발명의 보다 구체적인 구현예에 있어서, 상기 (d) 단계의 가열은 61-65℃에서 30분 내지 1시간, 또는 95~150℃에서 0.5초 내지 30초 동안 이루어지는 것이다. In a more specific embodiment of the present invention, the heating in step (d) is performed at 61-65° C. for 30 minutes to 1 hour, or at 95-150° C. for 0.5 seconds to 30 seconds.

단계 (e): 액상의 추출물 또는 이를 건조하여 분말상의 추출물을 수득하는 단계Step (e): obtaining a liquid extract or drying it to obtain a powdery extract

상기 단계는 상기 단계 (d)로부터 액상의 추출물을 수득하거나, 또는 상기 액상의 추출물을 건조하여 분말상의 추출물을 수득하는 단계이다. The step is a step of obtaining a liquid extract from step (d), or drying the liquid extract to obtain a powdery extract.

상기 건조의 방법은 자연건조, 감압건조, 동결건조 등 당 업계에서 사용될 수 있는 추출물의 건조방법이 제한없이 사용될 수 있으나, 감압건조 또는 동결건조가 바람직하다. As the drying method, natural drying, drying under reduced pressure, and drying methods of the extract that can be used in the art, such as freeze-drying, may be used without limitation, but drying under reduced pressure or freeze-drying is preferable.

본 발명의 다른 일 양태에 따르면, 본 발명은 다음을 포함하는 식물 추출물 및 식물성 생약재료 통분말을 포함하는 식물조성물의 제조방법을 제공한다: According to another aspect of the present invention, the present invention provides a method for producing a plant composition comprising a plant extract and whole powder of a plant herbal material, comprising:

상술한 식물 추출물에, 상기 (c) 단계의 원심분리 또는 여과 후 남은 침전물, 또는 여과물을 건조 및 분쇄하여 제조한 분말을 혼합하는 단계.Mixing the above-mentioned plant extract with a powder prepared by drying and pulverizing the precipitate remaining after centrifugation or filtration in step (c), or the filtrate.

본 발명의 일 구현예에 있어서, 상기 추출물은 상술한 추출물의 제조방법의 (a) 내지 (d) 단계, 또는 (a) 내지 (e) 단계를 포함하는 제조방법에 의하여 제조된다. 상기 식물추출물은 식물원료의 통분말을 추가하여 식품조성물로 제조될 수 있다. 이 경우 식품 조성물의 식감과 기호도가 개선되는 특징이 있다. In one embodiment of the present invention, the extract is prepared by a manufacturing method comprising steps (a) to (d), or (a) to (e) of the above-described method for preparing the extract. The plant extract may be prepared as a food composition by adding whole powder of plant raw materials. In this case, the texture and taste of the food composition are improved.

본 발명은 식물성 콜라겐 및 식물성 뮤신을 포함하는 추출물, 상기 추출물을 포함하는 식품조성물 및 화장료 조성물, 및 상기 추출물의 제조방법을 제공한다. 본 발명의 식물성 콜라겐 및 식물성 뮤신을 포함하는 추출물은 500 Da 이하의 저분자량 콜라겐을 포함하고, 경구 투여와 피부에 적용시 피부보습효과, 피부노화방지 효과, 피부주름 개선효과가 우수한 바, 피부상태 개선용 기능성 식품 및 화장품의 원료로서 유용하게 사용될 수 있다. The present invention provides an extract comprising vegetable collagen and plant mucin, a food composition and a cosmetic composition comprising the extract, and a method for preparing the extract. The extract containing vegetable collagen and vegetable mucin of the present invention contains low molecular weight collagen of 500 Da or less, and has excellent skin moisturizing effect, skin aging prevention effect, and skin wrinkle improvement effect when orally administered and applied to the skin. It can be usefully used as a raw material of functional food and cosmetics for improvement.

도 1은 본 발명의 흰목이버섯 효소처리 추출물의 세포독성시험 결과를 나타낸 도이다.1 is a diagram showing the results of a cytotoxicity test of the enzyme-treated extract of white wood ear mushroom of the present invention.

도 2는 본 발명의 흰목이버섯 효소처리 추출물의 프로콜라겐 합성 촉진효과를 확인한 결과를 나타낸 도이다. Figure 2 is a view showing the results of confirming the procollagen synthesis promoting effect of the enzyme-treated extract of white wood ear mushroom of the present invention.

도 3은 본 발명에 따른 흰목이버섯 발효 조성물의 제조방법의 모식도이다.3 is a schematic diagram of a method for producing a fermented composition for white wood ear mushroom according to the present invention.

도 4는 H&E 염색 결과, 정상 대조군(NOR)에 비해 UVB 조사군(CON)의 표피(epidermis)의 두께가 유의적으로 증가된 것과, 본 발명의 제조예를 투여시 표피 두께가 감소됨을 나타낸 도이다. 4 is a diagram showing that the thickness of the epidermis of the UVB irradiation group (CON) was significantly increased as compared to the normal control group (NOR) as a result of H&E staining, and the epidermis thickness was decreased when the preparation of the present invention was administered to be.

이하, 실시예를 통하여 본 발명을 더욱 상세히 설명하고자 한다. 이들 실시예는 오로지 본 발명을 보다 구체적으로 설명하기 위한 것으로, 본 발명의 요지에 따라 본 발명의 범위가 이들 실시예에 의해 제한되지 않는다는 것은 당업계에서 통상의 지식을 가진 자에 있어서 자명할 것이다.Hereinafter, the present invention will be described in more detail through examples. These examples are only for illustrating the present invention in more detail, and it will be apparent to those of ordinary skill in the art that the scope of the present invention is not limited by these examples according to the gist of the present invention. .

실시예Example

본 명세서 전체에 걸쳐, 특정 물질의 농도를 나타내기 위하여 사용되는 "%"는 별도의 언급이 없는 경우, 고체/고체는 (중량/중량) %, 고체/액체는 (중량/부피) %, 그리고 액체/액체는 (부피/부피) %이다.Throughout this specification, "%" used to indicate the concentration of a specific substance is (weight/weight) % for solid/solid, (weight/volume) % for solid/liquid, and Liquid/liquid is (volume/volume) %.

실시예 1: 복합 효소처리Example 1: Complex Enzyme Treatment

실시예 1-1: 흰목이버섯 효소처리 다당체 추출물의 제조Example 1-1: Preparation of Enzyme-treated Polysaccharide Extract from White Wood Ear Mushroom

건조 흰목이버섯 자실체를 200g씩 정량하여, 2 kg의 정제수에 투입한 후 121℃에서 2시간 동안 환류추출하고, 여액을 분리하였다. 여과된 잔여 흰목이 버섯은 건조 및 잘게 분쇄하여 제조예 2에 사용하였다. 상기 여액을 상온에서 식힌 후, 1% (w/v)의 농도로 복합 효소(SUMIZYME, Ultimase, Viscozyme, 또는 Lyvarome A5)를 첨가하고 50-65℃의 온도에서 48시간 처리한 후 효소를 실활시키기 위하여 100℃에서 5분간 가열하였다. 상기 용액을 여과한 후 여액을 감압건조하여 분말상태의 흰목이버섯 효소처리 다당체 추출물을 수득하였다. After quantifying 200 g of dried white oyster mushroom fruiting body, it was added to 2 kg of purified water, extracted under reflux at 121° C. for 2 hours, and the filtrate was separated. The filtered residual white oyster mushroom was dried and finely pulverized and used in Preparation Example 2. After cooling the filtrate at room temperature, a complex enzyme (SUMIZYME, Ultimase, Viscozyme, or Lyvarome A5) was added at a concentration of 1% (w/v) and treated at a temperature of 50-65° C. for 48 hours to inactivate the enzyme It was heated at 100° C. for 5 minutes. After filtration of the solution, the filtrate was dried under reduced pressure to obtain an enzyme-treated polysaccharide extract of white wood ear mushroom in powder form.

구분division SUMIZYMESUMIZYME UltimaseUltimases ViscozymeViscozyme Lyvarome A5Lyvarome A5 비교예comparative example -- -- -- -- 제조예 1-1Preparation 1-1 1%(w/v)1% (w/v) -- -- -- 제조예 1-2Preparation 1-2 -- 1%(w/v)1% (w/v) -- -- 제조예 1-3Preparation 1-3 -- -- 1%(w/v)1% (w/v) -- 제조예 1-4Preparation Example 1-4 -- -- -- 1%(w/v)1% (w/v)

상기 SUMIZYME AC (Shin Nihon Chemical, Japan)은 아스퍼질러스 니제르(A. niger)에서 생산된 효소복합체로서, 셀룰라아제, 헤미셀룰라아제 및 베타-글루코시다제를 포함하는 복합효소이다.The SUMIZYME AC (Shin Nihon Chemical, Japan) is an enzyme complex produced by Aspergillus niger (A. niger), and is a complex enzyme including cellulase, hemicellulase and beta-glucosidase.

상기 Ultimase는 베타글루카나제, 자일라나제를 포함하는 복합효소이다.The Ultimase is a complex enzyme including beta-glucanase and xylanase.

상기 Viscozyme은 아라바나제, 셀룰라아제, 베타글루카나제, 헤미셀룰라아제, 및 자일라나제를 포함하는 복합효소이다.The Viscozyme is a complex enzyme comprising arabanase, cellulase, beta-glucanase, hemicellulase, and xylanase.

상기 Lyvarome A5는 아스퍼질러스 니제르에서 추출한 펙티나아제이다. The Lyvarome A5 is a pectinase extracted from Aspergillus niger.

실시예 1-2: 흰목이버섯 효소처리 다당체 추출물의 세포독성 평가Example 1-2: Cytotoxicity evaluation of polysaccharide extracts treated with Enzyme-treated White wood ear mushroom

96 well plate에 5× 104 cells/mL로 HDFn 세포를 각각 분주하였고 Media-FBS 10% 조건에서 상기 실시예 1-1에서 제조한 각 시료 추출물(제조예 1-1 내지 1-4)을 농도별로 72시간 처리하였다. 그 후의 각각 세포 배양액 용량의 1/10 배의 MTS 용해액을 첨가한 후 37℃에서 2시간 배양한 후 ELISA reader (Spectrostar-nano, BMG Labtech, Offenburg, Germany)를 이용하여 490 ㎚에서 흡광도를 측정하였다. 이를 통하여 각 시료가 세포 생존율에 영향을 주는지 검사하였다. Each of the HDFn cells was dispensed in a 96 well plate at 5×10 4 cells/mL, and the concentration of each sample extract (Preparation Examples 1-1 to 1-4) prepared in Example 1-1 under Media-FBS 10% conditions. Each was treated for 72 hours. After that, after adding 1/10 times the volume of each cell culture solution, MTS lysate was added, followed by incubation at 37°C for 2 hours, and then absorbance was measured at 490 nm using an ELISA reader (Spectrostar-nano, BMG Labtech, Offenburg, Germany). did. Through this, it was tested whether each sample affects the cell viability.

상기 HDFn 세포는 한국세포주은행 (KCLB, Seoul, Korea)으로부터 분양 받았으며, penicillin/streptomycin 100 unit/mL (10378, Invitrogen, Grand Island, NY, USA)과 10% FBS (16000, Invitrogen, Grand Island, NY, USA) 가 함유된 DMEM 배지 (11995, Invitrogen, Grand Island, NY, USA)를 사용하여 37℃, 5% CO2 인큐베이터 (MCO-17A1, Sanyo, Osaka, Japan)에서 배양하였다.The HDFn cells were purchased from Korea Cell Line Bank (KCLB, Seoul, Korea), and penicillin/streptomycin 100 unit/mL (10378, Invitrogen, Grand Island, NY, USA) and 10% FBS (16000, Invitrogen, Grand Island, NY) , USA) containing DMEM medium (11995, Invitrogen, Grand Island, NY, USA) at 37° C., 5% CO 2 Incubated in an incubator (MCO-17A1, Sanyo, Osaka, Japan).

결과는 도 1에 나타내었다. The results are shown in FIG. 1 .

도 1에 나타낸 바와 같이, 각 흰목이버섯 효소처리 다당체 추출물의 농도는 31.2 - 1,000 μg/mL 범위에서 처리하였다. 제조예 1-1 내지 1-4, 모든 시료에서 500 μg/mL 농도부터 세포 생존율에 영향이 있었으므로, 이하의 실험은 높은 생존율을 보이는 500 μg/mL 이하의 농도에서 진행하였다.As shown in FIG. 1 , the concentration of each polysaccharide extract treated with the enzymatic process of the white wood ear mushroom was treated in the range of 31.2 - 1,000 μg/mL. In Preparation Examples 1-1 to 1-4, all samples had an effect on cell viability from a concentration of 500 μg/mL, so the following experiments were performed at a concentration of 500 μg/mL or less showing a high viability.

실시예 1-3: 흰목이버섯 효소처리 다당체 추출물의 콜라겐 합성 촉진효과 측정Example 1-3: Measurement of Collagen Synthesis Promotion Effect of Enzyme-treated Polysaccharide Extract from White Wood Ear Mushroom

피부의 주름개선 효과를 검정하는 collagen 합성효과를 보기 위해 HDFn 세포를 96 well plate에 1 × 105 cells/well씩 24시간 배양시킨 다음 새로운 무혈청 배지로 단계적으로 희석한 시료를 분주하여 가하고 다시 24시간 동안 CO2 incubator에서 배양하였다. 배양액을 얻은 후 procollagen type I Cpepited EIA kit (MK101, Takara Bio inc, Shiga, Japan)을 이용하여 매뉴얼에 따라 진행하였다. 1차 collagen 항체가 있는 96 well plate에 세포 배양액 20㎕와 2차 항체 100 μL를 혼합하여 넣은 후 37℃에서 3시간 반응시킨 후 PBS로 4회 세척한 다음 ELISA reader (BMG Labtech)를 이용하여 450㎚에서 흡광도를 측정하였다.In order to see the collagen synthesis effect to test the skin wrinkle improvement effect, HDFn cells were cultured in a 96 well plate at 1 × 10 5 cells/well for 24 hours, and then a sample diluted stepwise with a new serum-free medium was dispensed and added again. Incubated in a CO2 incubator for hours. After obtaining the culture medium, the procedure was performed according to the manual using the procollagen type I Cpepited EIA kit (MK101, Takara Bio inc, Shiga, Japan). After mixing 20 μl of cell culture solution and 100 μL of secondary antibody in a 96 well plate with primary collagen antibody, incubate at 37° C. for 3 hours, wash 4 times with PBS, and then 450 using an ELISA reader (BMG Labtech). Absorbance was measured in nm.

결과는 도 2에 나타내었다.The results are shown in FIG. 2 .

도 2에 나타낸 바와 같이, 흰목이버섯 효소처리 다당체를 이용하여 procollagen 합성 실험을 진행하였고, Viscozyme, SUMIZYME, 및 Ultimase을 처리한 시료에서는 62.5 μg/mL 농도에서부터 프로콜라겐 합성이 증가하였고, Lyvarome을 처리한 추출물 및 효소를 처리하지 않은 시료에서는 125 μg/mL 농도에서부터 유의적으로 procollagen 합성이 증가하였다. 상기 결과로부터 본 발명의 흰목이버섯의 효소처리 추출물이 procollagen 합성을 촉진하여 탄력 있는 피부를 만들어주는 주름개선 효능을 나타냄을 알 수 있다.As shown in FIG. 2, procollagen synthesis experiment was performed using polysaccharides treated with enzyme-treated white wood ear mushroom, and in the samples treated with Viscozyme, SUMIZYME, and Ultimase, procollagen synthesis was increased from 62.5 μg/mL concentration, and Lyvarome was treated. In one extract and in the sample not treated with the enzyme, procollagen synthesis was significantly increased from the concentration of 125 μg/mL. From the above results, it can be seen that the enzyme-treated extract of white wood ear mushroom of the present invention exhibits wrinkle improvement effect by promoting procollagen synthesis to make elastic skin.

실시예 1-4: 흰목이버섯 효소처리 다당체 추출물 및 흰목이버섯 통분말을 포함하는 식품조성물의 제조Example 1-4: Preparation of a food composition comprising a white wood ear mushroom enzyme-treated polysaccharide extract and white wood ear mushroom whole powder

상기 실시예 1-1에서 제조한 효소처리 다당체 추출물 중 효과가 가장 우수했던 Viscozyme 처리 추출물(제조예 1-3)과 흰목이버섯을 열수추출하고 여과한 후 남은 흰목이 버섯을 건조 및 잘게 분쇄하여 만든 분말을 1:10의 중량비로 혼합하여 흰목이버섯 추출물 및 흰목이버섯 통분말을 포함하는 식품조성물(제조예 1-5)을 제조하였다. 흰목이버섯 통분말을 포함하지 않은 추출물은 효소를 처리하지 않은 추출물은 비교예 1-1로, 효소를 처리한 추출물은 비교예 1-2로 명명하였다. Among the enzyme-treated polysaccharide extracts prepared in Example 1-1, the Viscozyme-treated extract (Preparation Example 1-3), which had the best effect, and the white wood ear mushroom were hot water extracted and filtered, and the remaining white wood ear mushroom was dried and finely pulverized. The prepared powder was mixed in a weight ratio of 1:10 to prepare a food composition (Preparation Example 1-5) containing the white wood ear mushroom extract and the white wood ear mushroom whole powder. The extract that did not contain the white oyster mushroom powder was named Comparative Example 1-1 for the extract not treated with the enzyme, and Comparative Example 1-2 for the extract treated with the enzyme.

구분division SUMIZYMESUMIZYME UltimaseUltimases ViscozymeViscozyme Lyvarome A5Lyvarome A5 흰목이버섯 통분말Whole White Wood Ear Mushroom Powder 비교예 1-1Comparative Example 1-1 -- -- -- -- 미첨가unadded 비교예 1-2Comparative Example 1-2 -- -- 1%(w/v)1% (w/v) -- 미첨가unadded 제조예 1-5Preparation 1-5 -- -- 1%(w/v)1% (w/v) -- 첨가adding

실시예 1-5: 흰목이버섯 효소처리 다당체 추출물 및 흰목이버섯 통분말을 포함하는 식품조성물의 관능검사Example 1-5: Sensory test of a food composition comprising an enzyme-treated polysaccharide extract of a white wood ear mushroom and whole powder of a white wood ear mushroom

제조예 1-5와 비교예 1-1, 비교예 1-2의 시료 각각을 일정량 취하여 음료를 제조하고, 제조된 음료의 냄새, 맛, 그리고 전체적인 기호도를 평가하였다. 관능검사원은 사전에 식별 훈련을 받은 사람 중에서 예비실험을 거쳐 10명을 최종 선정하였고, 관능평가 항목은 단맛, 향, 식감 및 전체 기호도로써 조사방법은 척도법으로 등급화하여 1등급에서 5등급으로 각각 구분하여 그 도가 약함은 1등급으로, 그 정도가 강함은 5등급으로 표시하도록 하였다. A beverage was prepared by taking a predetermined amount of each of the samples of Preparation Example 1-5, Comparative Example 1-1, and Comparative Example 1-2, and the odor, taste, and overall preference of the prepared beverage were evaluated. The sensory inspector finally selected 10 people through a preliminary experiment from among those who received identification training in advance, and the sensory evaluation items were sweetness, flavor, texture and overall preference. The degree of weakness was graded 1, and the degree of strength was graded 5.

결과는 표 3에 나타내었다.The results are shown in Table 3.

구분division 단맛sweetness incense 식감texture 전체 기호도full symbol 비교예 1-1Comparative Example 1-1 2.82.8 3.13.1 2.882.88 2.932.93 비교예 1-2Comparative Example 1-2 3.253.25 3.43.4 2.502.50 3.053.05 제조예 1-5Preparation 1-5 3.193.19 3.53.5 4.134.13 3.613.61

단맛의 경우는 효소를 처리한 비교예 1-2와 제조예 1-5에서 단맛이 강해진 것을 확인하였고, 향의 경우도 효소를 처리한 비교예 1-2와 제조예 1-5에서 개선이 된 것을 확인하였다. 다만, 식감의 경우는 비교예 1-1과 효소를 처리한 비교예 1-2를 비교한 결과, 효소를 처리한 비교예 1-2에서 식감이 저감되는 것을 확인할 수 있었다. 그러나, 흰목이버섯 통분말을 첨가한 제조예 1-5에서는 식감이 크게 개선되는 것을 확인할 수 있었다. 따라서 전체적인 기호도는 비교예 1-1보다는 효소를 처리한 비교예 1-2가 좋게 평가되었으며, 효소처리 및 흰목이버섯 통분말을 첨가한 제조예 1-5의 전체적인 기호도가 가장 우수한 것으로 나타났다. In the case of sweetness, it was confirmed that the sweetness was strengthened in Comparative Examples 1-2 and Preparation Examples 1-5 treated with enzymes, and the flavor was improved in Comparative Examples 1-2 and Preparation Examples 1-5 treated with enzymes. confirmed that. However, in the case of texture, as a result of comparing Comparative Example 1-1 and Comparative Example 1-2 in which the enzyme was treated, it was confirmed that the texture was reduced in Comparative Example 1-2 in which the enzyme was treated. However, it was confirmed that the texture was greatly improved in Preparation Examples 1-5 in which the whole white wood ear mushroom powder was added. Therefore, as for the overall acceptability, Comparative Example 1-2 treated with the enzyme was evaluated better than Comparative Example 1-1, and it was found that the overall acceptability of Preparation Example 1-5 in which the enzyme treatment and whole white wood ear mushroom powder was added was the best.

이상에서 살펴본 바와 같이 효소를 처리함으로써 효소가 버섯이 포함하는 셀룰로오스, 헤미셀룰로오스 등의 구성성분을 가수분해 시키면서 맛, 향이 개선되는 효과를 얻을 수 있으며, 특히 추출물을 추출하고 남은 흰목이버섯의 통분말을 재활용하여 첨가하는 경우 식감의 면에서 크게 개선되어 전체적인 기호도가 개선되는 효과를 얻을 수 있었다.As described above, by treating the enzyme, the enzyme hydrolyzes the components such as cellulose and hemicellulose contained in the mushroom, and the effect of improving the taste and flavor can be obtained. When added by recycling, it was possible to obtain the effect of improving the overall taste by greatly improving the texture.

실시예 2: 유산균 및 복합효소 처리Example 2: Lactic acid bacteria and complex enzyme treatment

실시예 2-1: 흰목이버섯 발효 콜라겐 펩타이드 조성물의 제조Example 2-1: Preparation of Fermented Collagen Peptide Composition for White Wood Ear Mushroom

덕유산에서 재배된 흰목이버섯 자실체를 수득하고, 이를 곱게 갈아 10-100 메쉬(mesh) 이하의 입자크기로 분쇄하였다. 상기 분쇄된 건조 흰목이버섯 자실체 분말 50 g에 정제수 600g을 붓고 잘 혼합하였다. 완전히 혼합된 혼합액에 건조 흰목이버섯 분말의 2% 분량(1g)으로 복합 효소(SUMIZYME, Ultimase, Viscozyme, 또는 Lyvarome A5)을 첨가하였다. 또한, 유산균주로 락토바실러스 앨리멘터리우스 로이터 균주(Lactobacillus alimentarius Reuter, ATCC 29643)를 첨가하였다. 상기 효소와 유산균주를 투입하고 45℃에서 20 일동안 배양하였다. 상기 배양시 배양액의 pH가 6 내지 8이 되도록 pH를 조절하였다. 배양이 종료된 후 배양액을 여과하여 슬러지를 제거하였다. 여과가 완료된 여액을 모아 95℃에서 1시간 동안 가열하여 여액을 살균하였다. 살균이 완료된 여액을 50-65℃에서 감압농축한 뒤 동결건조하여 분말상의 흰목이버섯 발효 콜라겐 펩타이드 조성물 8 g을 수득하였다. To obtain a fruiting body of the white wood ear mushroom grown in Deogyusan, it was ground finely and pulverized to a particle size of 10-100 mesh or less. 600 g of purified water was poured into 50 g of the pulverized dried oyster mushroom fruiting body powder, and the mixture was well mixed. A complex enzyme (SUMIZYME, Ultimase, Viscozyme, or Lyvarome A5) was added in a 2% portion (1 g) of dry oyster mushroom powder to the thoroughly mixed solution. In addition, Lactobacillus alimentarius Reuter (Lactobacillus alimentarius Reuter, ATCC 29643) was added as a lactic acid strain. The enzyme and lactic acid strain were added and cultured at 45° C. for 20 days. During the culture, the pH was adjusted so that the pH of the culture solution was 6 to 8. After the culture was completed, the culture solution was filtered to remove sludge. The filtered filtrate was collected and heated at 95° C. for 1 hour to sterilize the filtrate. After the sterilization was completed, the filtrate was concentrated under reduced pressure at 50-65° C. and then freeze-dried to obtain 8 g of a powdery white wood ear mushroom fermented collagen peptide composition.

실시예 2-2: 흰목이버섯 발효 콜라겐 펩타이드 조성물의 펩타이드 아미노산 함량 및 성분 분석Example 2-2: Peptide Amino Acid Content and Component Analysis of Fermented Collagen Peptide Composition of White Wood Ear Mushroom

상기 실시예 2-1에서 제조한 본 발명의 흰목이버섯 발효 콜라겐 펩타이드 조성물을 1wt% 농도로 희석하고 이를 구성하는 펩타이드 아미노산의 함량 및 성분을 분석하였다. 결과는 하기 표 4에 나타내었다. The white wood ear mushroom fermented collagen peptide composition of the present invention prepared in Example 2-1 was diluted to a concentration of 1 wt%, and the content and components of peptide amino acids constituting it were analyzed. The results are shown in Table 4 below.

아미노산amino acid 분자량Molecular Weight 농도(ppm)Concentration (ppm) Aspartic acidAspartic acid 133.1133.1 305.2305.2 Glutamic acidGlutamic acid 147.1147.1 315.5315.5 SerineSerine 105.1105.1 183.4183.4 HistidineHistidine 155.2155.2 00 GlycineGlycine 75.175.1 114.5114.5 ThreonineThreonine 119.1119.1 182.1182.1 ArginineArginine 174.2174.2 1372.01372.0 AlanineAlanine 89.189.1 205.4205.4 TyrosineTyrosine 181.2181.2 82.382.3 CystineCystine 121.0121.0 00 ValineValine 117.1117.1 137.5137.5 MethionineMethionine 149.2149.2 00 TryptophanTryptophan 204.2204.2 00 PhenylalaninePhenylalanine 165.2165.2 100.7100.7 IsoleucineIsoleucine 130.0130.0 113.8113.8 LeucineLeucine 131.2131.2 160.8160.8 LysineLysine 145.2145.2 177.7177.7 ProlineProline 115.0115.0 336.7336.7 Total amino acidTotal amino acids -- 3787.53787.5

상기 표 4에 나타낸 바와 같이, 본 발명의 흰목이버섯 발효 콜라겐 펩타이드 조성물은 아미노산 함량이 1wt% 농도를 기준으로 3,787.5 mg/kg인 것으로 분석되어 매우 높은 함량의 아미노산을 포함하는 것을 확인하였다. 특히 혈관을 확장시켜 혈류는 개선하는데 도움을 주는 것으로 알려진 Arginine을 1372 mg/kg을 포함하여 혈액순환 개선용 기능성 식품으로 유용하게 사용할 수 있으며, 콜라겐 생성에 필요한 필수 아미노산 생성을 촉진하여 피부 보습과 주름개선에 기여하는 바, 피부보습용 조성물, 주름개선용 조성물로서의 활용가능성도 높음을 알 수 있었다. As shown in Table 4, it was confirmed that the amino acid content of the fermented white wood ear mushroom collagen peptide composition of the present invention was 3,787.5 mg/kg based on 1wt% concentration, and it was confirmed that it contained a very high content of amino acids. In particular, it contains 1372 mg/kg of Arginine, which is known to help improve blood flow by expanding blood vessels, and can be usefully used as a functional food for improving blood circulation. As a result, it was found that the potential for use as a composition for skin moisturizing and wrinkle improvement was high.

실시예 2-3: 흰목이버섯 발효 콜라겐 음료의 제조Example 2-3: Preparation of fermented Collagen Beverage with White Wood Ear Mushroom

상기 실시예 2-1에서 제조한 흰목이버섯 발효 콜라겐 펩타이드 조성물 분말 3g과 증류수 200 ml에 혼합하여 잘 교반하였다. 교반 후 가열하지 않아도 즉시 점조한 성상의 콜라겐 음료가 제조되었으며, 시럽을 첨가하여 당도를 약 9 brix로 맞추어 발효음료를 제조하였다. 3 g of the white wood ear mushroom fermented collagen peptide composition powder prepared in Example 2-1 and 200 ml of distilled water were mixed and stirred well. Even without heating after stirring, a viscous collagen beverage was prepared immediately, and a fermented beverage was prepared by adding syrup to adjust the sugar content to about 9 brix.

실시예 2-4: 관능평가Example 2-4: sensory evaluation

실시예 2-3에서 제조한 발효 콜라겐 음료에 대해서 관능평가를 실시하였다. 관능평가는 20명의 숙련된 요원(25~40세, 여자)을 선정한 후 실험목적과 평가항목을 설명하고 10회 이상 훈련 과정을 거쳐 실시하였다. 색, 맛, 향 등의 기호도를 1(아주 나쁨)에서 5(아주 좋음)까지의 점수로 표기하는 5점 척도법으로 평가하였다. 비교예로는 건조된 흰목이버섯 자실체를 10-100 메쉬 입자로 분쇄한 분말 3g을 물에 넣고 4시간 동안 끓인 후 시럽을 첨가하여 당도를 약 9 brix로 맞춘 음료를 사용하였다.Sensory evaluation was performed on the fermented collagen beverage prepared in Example 2-3. For sensory evaluation, 20 skilled agents (25-40 years old, female) were selected, the purpose of the experiment and evaluation items were explained, and the training process was conducted more than 10 times. The degree of preference for color, taste, and fragrance was evaluated using a five-point scale in which scores ranged from 1 (very bad) to 5 (very good). As a comparative example, 3 g of powder obtained by pulverizing the dried fruiting body of white wood ear mushroom into 10-100 mesh particles was put in water, boiled for 4 hours, and then syrup was added to adjust the sugar content to about 9 brix was used.

그 결과, 하기 표 5와 같이 본 발명의 효소와 유산균주를 배양한 흰목이버섯 발효음료가 단맛과 향 등 전방적인 기호도가 가장 양호하였다. 특히, 본 발명의 발효음료는 유산균과 효소를 처리하지 않은 비교예와 비교하여 같은 당도임에도 단맛이 더 많이 느껴졌고, 색감과 향이 우수하였다. As a result, as shown in Table 5 below, the fermented white wood ear mushroom fermented beverage in which the enzyme and lactic acid strain of the present invention were cultured had the best overall preferences, such as sweetness and flavor. In particular, the fermented beverage of the present invention had more sweetness and superior color and flavor compared to the comparative example in which lactic acid bacteria and enzymes were not treated, despite the same sugar content.

사용균주strain used 사용효소Enzyme used color 단맛sweetness 신맛Sour taste incense 전반적 기호도overall sign Lactobacillus alimentarius ReuterLactobacillus alimentarius Reuter SUMIZYMESUMIZYME 3.33.3 3.63.6 3.03.0 3.73.7 3.73.7 UltimaseUltimases 3.23.2 3.53.5 3.23.2 3.53.5 3.53.5 ViscozymeViscozyme 3.33.3 3.33.3 3.23.2 3.63.6 3.43.4 Lyvarome A5Lyvarome A5 3.13.1 3.53.5 3.13.1 3.43.4 3.43.4 비교예 2(-)Comparative Example 2 (-) -- 2.92.9 3.03.0 3.23.2 2.22.2 2.62.6

실시예 2-5: 흰목이버섯 발효 콜라겐 화장료 조성물의 제조Example 2-5: Preparation of fermented collagen cosmetic composition for white oyster mushroom

상기 실시예 2-1에서 제조한 흰목이버섯 발효 콜라겐 펩타이드 조성물을 전체 중량대비 0.5% 함유한 영양 화장수를 하기 표 6의 성분비로 제조하였다.A nutrient lotion containing 0.5% of the white wood ear mushroom fermented collagen peptide composition prepared in Example 2-1 based on the total weight was prepared at the component ratios shown in Table 6 below.

성분ingredient 함량(g)content (g) 흰목이버섯 발효 콜라겐 펩타이드White Wood Ear Mushroom Fermented Collagen Peptide 0.50.5 글리세린glycerin 4.84.8 1,3-부틸렌글리콜1,3-butylene glycol 3.03.0 PEG 1500PEG 1500 1.01.0 알란토인allantoin 0.10.1 DL-판테놀DL-Panthenol 0.30.3 EDTA-2NaEDTA-2Na 0.020.02 벤조페논-9Benzophenone-9 0.040.04 소듐 히알루로네이트Sodium Hyaluronate 5.05.0 에탄올ethanol 10.010.0 옥틸도데세스-16Octyldodeces-16 0.20.2 폴리솔베이트 20Polysorbate 20 0.20.2 유니사이드-유 13Uniside-You 13 0.010.01 증류수Distilled water 잔량remaining amount 합계Sum 100100

실시예 2-6: 경피수분손실량, 피부 수분량, 피부탄력도, 미세주름 개선 효과의 비교Example 2-6: Comparison of transdermal moisture loss, skin moisture content, skin elasticity, fine wrinkles improvement effect

상기 실시예 2-5에서 제조한 본 발명의 흰목이버섯 발효 콜라겐을 포함하는 화장료 조성물에 대하여 경피수분손실량, 피부 수분량, 피부탄력도, 미세주름 개선 효과를 측정하였다.The amount of transdermal moisture loss, the amount of skin moisture, the elasticity of the skin, and the effect of improving fine wrinkles were measured for the cosmetic composition containing the fermented collagen of the white wood ear mushroom of the present invention prepared in Examples 2-5.

구체적으로 만 19세 이상의 여성 50명을 시험 대상자로 선정하여, 상기 화장료 조성물 중 대표적으로 실시예 2-5를 시험 대상자의 얼굴 및 전완부 등의 피부에 4주, 8주 및 12주 동안 각각 실험 대상자들에게 적용 한 다음, 적용된 피부 상태를 전안촬영, Antera 3D 촬영, Corneometer, Spectrophotometer CM2500d 및 Skin-Visiometer 등을 이용하여 측정하였다. 그 결과를 평균하여 하기 표 7에 나타내었다.Specifically, 50 women 19 years of age or older were selected as test subjects, and Examples 2-5 were typically applied to the skin of the test subject's face and forearm for 4 weeks, 8 weeks, and 12 weeks respectively. After application to the subjects, the applied skin condition was measured using anterior ocular imaging, Antera 3D imaging, Corneometer, Spectrophotometer CM2500d, and Skin-Visiometer. The results were averaged and shown in Table 7 below.

실험항목Experimental items 치료 전before treatment 4주 후after 4 weeks 8주 후after 8 weeks 12주 후after 12 weeks 경피수분손실량transdermal water loss 33.1±10.333.1±10.3 31.6±7.1431.6±7.14 29.6±7.629.6±7.6 26.6±6.626.6±6.6 피부 수분량skin moisture content 64.1±4.964.1±4.9 65.1±5.165.1±5.1 67.2±5.167.2±5.1 68.5±4.668.5±4.6 피부 탄력도skin elasticity 0.82±0.090.82±0.09 0.62±0.050.62±0.05 0.53±0.030.53±0.03 0.06±0.10.06±0.1 미세 주름fine wrinkles 66.3±1.566.3±1.5 -- -- 65.9±1.265.9±1.2 피부결skin texture 7.2±1.67.2±1.6 6.3±1.16.3±1.1

상기 표 7을 참조하면, 본 발명에 따른 실시예 2-5에서 제조한 본 발명의 흰목이버섯 발효 콜라겐을 포함하는 화장료를 사용한 경우 경피수분손실량의 감소, 피부 수분량의 증가, 피부탄력 증가 및 미세주름과 피부결 개선 효과가 우수함을 알 수 있다. Referring to Table 7 above, when the cosmetic containing the fermented collagen of the white wood ear mushroom of the present invention prepared in Examples 2-5 according to the present invention is used, the amount of transdermal water loss is reduced, the amount of skin moisture is increased, the skin elasticity is increased, and the fine It can be seen that the effect of improving wrinkles and skin texture is excellent.

실시예 2-7: 패널 평가Example 2-7: Panel evaluation

30~40대 여성 30명을 패널로 하여 사용감을 평가하였다. 상기 실시예 2-5에서 제조된 화장료 조성물을 시험군으로 사용하였고, 건조된 흰목이버섯 자실체를 10-100 메쉬 입자로 분쇄한 분말을 물에 넣고 4시간 동안 끓인 후 농축 건조하여 분말화한 후, 실시예 5와 같은 농도로 제조한 화장료 조성물을 비교예로 사용하였다. 각 샘플을 주 3회씩 2주 동안 안면에 도포시켜 피부 미용 효과를 하기 표 8에 제시된 항목에 따라 각 항목당 5점 만점으로 측정하여 그 결과를 대표적으로 나타내었다.The feeling of use was evaluated by using 30 women in their 30s and 40s as a panel. The cosmetic composition prepared in Example 2-5 was used as a test group, and a powder obtained by pulverizing the dried white wood ear mushroom fruiting body into 10-100 mesh particles was put in water, boiled for 4 hours, concentrated to dryness, and then powdered. , a cosmetic composition prepared at the same concentration as in Example 5 was used as a comparative example. Each sample was applied to the face 3 times a week for 2 weeks, and the skin cosmetic effect was measured on a 5-point scale for each item according to the items shown in Table 8 below, and the results are representatively shown.

평가 항목evaluation item 실시예 5Example 5 비교예comparative example 전체적인 기호도overall sign 4.34.3 3.73.7 사용 후 피부 감촉Skin feel after use 4.34.3 3.63.6 피부 도포시 발림성Spreadability when applied to the skin 4.24.2 3.63.6 사용 후 피부 자극정도Degree of skin irritation after use 0.50.5 1.11.1

상기 표 8에 나타낸 바와 같이, 본 발명에 따른 실시예 2-5에서 제조한 본 발명의 흰목이버섯 발효 콜라겐을 포함하는 화장료를 사용한 경우 피부 자극성이 낮고 전체적인 기호도와 사용후 피부 감촉이 우수하였으나, 본 발명의 비교예 2의 경우 실시예 2-5에 비해 피부 자극이 크고 사용감 또한 불량한 것을 확인하였다.As shown in Table 8 above, when the cosmetic containing the fermented collagen of the white wood ear mushroom of the present invention prepared in Examples 2-5 according to the present invention was used, skin irritation was low, overall preference and skin feel were excellent after use, In the case of Comparative Example 2 of the present invention, compared to Examples 2-5, it was confirmed that the skin irritation was large and the feeling of use was also poor.

실시예 3 Example 3

실시예 3-1: 식물성 생약재료를 이용한 식물성 콜라겐 및 식물성 뮤신을 함유하는 추출물(제조예 3-1 내지 3-16)의 제조Example 3-1: Preparation of extracts (Preparation Examples 3-1 to 3-16) containing vegetable collagen and vegetable mucin using plant herbal materials

시금치, 스위스차드, 당근, 토마토, 황기, 천궁, 목이버섯, 흰목이버섯, 둥근마, 연근, 유채꽃, 유채씨, 석류, 타트체리, 블루베리, 마늘, 망고, 오렌지, 아보카도, 화이트리, 케슈넛, 히비스커스, 딸기, 금화규, 키위, 구아바, 파인애플, 콩, 피망, 라즈베리, 블랙베리, 구기자, 복령, 및 숙지황의 분말을 5-10%의 구연산, 아세트산 또는 묽은 염산에 2시간 동안 침지한 후에 중화시킨 후, 하기 표 9의 조건과 같은 용매 (정제수 또는 20% 에탄올 수용액) 50g을 첨가하고 잘 혼합하였다. 상기 생약 분말에 포함된 식물성 콜라겐과 식물성 뮤신이 잘 추출될 수 있도록 상기 혼합물을 70℃에서 1시간 동안 교반하였다. 상기 혼합 후의 교반 공정은 3기압의 고압 조건 하에서 이루어졌다. Spinach, Swiss chard, carrot, tomato, astragalus, chrysanthemum, wood ear mushroom, white wood ear mushroom, round hemp, lotus root, rape flower, rapeseed, pomegranate, tart cherry, blueberry, garlic, mango, orange, avocado, white lily, Powder of cashew nut, hibiscus, strawberry, goldfish, kiwi, guava, pineapple, soybean, green pepper, raspberry, blackberry, goji berry, bokryeong, and succulent yellow is immersed in 5-10% citric acid, acetic acid or dilute hydrochloric acid for 2 hours. After neutralization, 50 g of a solvent (purified water or 20% ethanol aqueous solution) as shown in Table 9 below was added and mixed well. The mixture was stirred at 70° C. for 1 hour so that the vegetable collagen and vegetable mucin contained in the herbal powder could be well extracted. The stirring process after the mixing was performed under high pressure conditions of 3 atmospheres.

완전히 혼합된 혼합액에 0.1g의 복합효소 (SUMIZYME, Ultimase, Viscozyme, 또는 Lyvarome A5; 각각 S, U, V, L로 표시), 유산균(Lactobacillus alimentarius Reuter ATCC 29643, 1x103 cfu/ml), 또는 이들의 조합을 첨가하고 37℃에서 48시간 동안 배양하였다. 배양 12시간마다 한 번씩 혼합물을 교반해주었다. 상기 배양시 배양액의 pH가 6 내지 8이 되도록 pH를 조절하였다. 배양이 종료된 후 배양액을 원심분리하여 침전된 슬러지 및 전분를 제거하고, 점성을 가진 상층액을 분리하였다. 분리된 점성 상층액을 가열하여 130℃ 에서 2초간 가열하여 효소를 실활시키고 유산균을 살균하였다. 상기 실활 및 살균이 완료된 점성 상층액을 여과하여 액상의 추출물 또는 이를 감압농축 및 동결건조하여 분말상의 추출물을 수득하였다. 0.1 g of a complex enzyme (SUMIZYME, Ultimase, Viscozyme, or Lyvarome A5; denoted as S, U, V, and L, respectively), lactic acid bacteria ( Lactobacillus alimentarius Reuter ATCC 29643, 1x10 3 cfu/ml), or these was added and incubated at 37°C for 48 hours. The mixture was stirred once every 12 hours of incubation. During the culture, the pH was adjusted so that the pH of the culture solution was 6 to 8. After the culture was completed, the culture solution was centrifuged to remove the precipitated sludge and starch, and the viscous supernatant was separated. The separated viscous supernatant was heated at 130° C. for 2 seconds to inactivate the enzyme and sterilize the lactic acid bacteria. The viscous supernatant, which has been deactivated and sterilized, was filtered to obtain a liquid extract or a powdery extract by concentrating and freeze-drying it under reduced pressure.

제조예production example 생약 분말(g)Herbal medicine powder (g) 용매(50g)Solvent (50 g) 효소(0.1 g)Enzyme (0.1 g) 유산균주(103 cfu/ml)Lactobacillus strain (10 3 cfu/ml) 3-13-1 5g5g 정제수Purified water SUMIZYMESUMIZYME -- 3-23-2 5g5g 정제수Purified water UltimaseUltimases -- 3-33-3 5g5g 정제수Purified water ViscozymeViscozyme -- 3-43-4 5g5g 정제수Purified water Lyvarome A5Lyvarome A5 -- 3-53-5 5g5g 정제수Purified water -- OO 3-63-6 5g5g 정제수Purified water -- OO 3-73-7 5g5g 정제수Purified water -- OO 3-83-8 5g5g 정제수Purified water -- OO 3-93-9 5g5g 정제수Purified water SUMIZYMESUMIZYME OO 3-103-10 5g5g 정제수Purified water UltimaseUltimases OO 3-113-11 5g5g 정제수Purified water ViscozymeViscozyme OO 3-123-12 5g5g 정제수Purified water Lyvarome A5Lyvarome A5 OO 3-133-13 5g5g 20% 에탄올수용액20% ethanol aqueous solution SUMIZYMESUMIZYME -- 3-143-14 5g5g 20% 에탄올수용액20% ethanol aqueous solution UltimaseUltimases -- 3-153-15 5g5g 20% 에탄올수용액20% ethanol aqueous solution ViscozymeViscozyme -- 3-163-16 5g5g 20% 에탄올수용액20% ethanol aqueous solution Lyvarome A5Lyvarome A5 --

이중 제조예 3-1, 3-5, 3-9, 및 3-13의 추출물을 건조한 분말상의 추출물을 이하의 실시예에 사용하였다. Of these, the extracts of Preparation Examples 3-1, 3-5, 3-9, and 3-13 were dried and powdery extracts were used in the following examples.

실시예 3-2 내지 3-5는 식품 조성물로서의 효능을 평가하였고, 실험예 3-6 및 3-7은 화장료 조성물로서의 효능을 평가하였다.Examples 3-2 to 3-5 evaluated the efficacy as a food composition, and Experimental Examples 3-6 and 3-7 evaluated the efficacy as a cosmetic composition.

실시예 3-2: 피부수분 보유량, 경표피 수분 손실량(TEWL) 및 홍반 평가 Example 3-2: Skin water retention, transepidermal water loss (TEWL) and erythema evaluation

실험동물의 처치Treatment of laboratory animals

실험군은 총 6군(군당 6마리)으로 정상대조군(normal, not UVB-induced), 음성대조군(control, UVB-irradiated), 제조예 3-1, 3-5, 3-9, 및 3-13의 처리군으로 분류하였다.The experimental group was a total of 6 groups (6 mice per group), a normal control group (normal, not UVB-induced), a negative control group (control, UVB-irradiated), Preparation Examples 3-1, 3-5, 3-9, and 3-13 of the treatment group.

실험동물은 SKH-1 Hairless mice(SkH: HR-1) 수컷을 오리엔트바이오에서 구입하여 사육하였다. 동물 사육실 환경 온도는 22±2°C, 상대습도는 50±10%, 명암은 12시간 주기로 조절하였고 음수와 사료는 자유급식으로 하였다. As experimental animals, SKH-1 hairless mice (SkH: HR-1) were purchased from Orient Bio and were bred. The environment temperature of the animal breeding room was 22±2°C, the relative humidity was 50±10%, and the light and dark were adjusted in a 12-hour cycle. Drinking water and feed were ad libitum.

본 실험은 고려대학교 동물실험윤리위원회 승인을 받은 후 '실험동물 관리 및 이용에 관한 지침(Guide for the Care and Use of Laboratory Animals, NRC)'에 맞추어 관리하며 실시하였다. This experiment was conducted under the 'Guide for the Care and Use of Laboratory Animals (NRC)' after receiving approval from the Animal Experimental Ethics Committee of Korea University.

일주일 동안의 적응기가 지난 후 정상대조군(NOR)을 제외한 6군에 8주간 주 3회 UVB-자외선램프(T-8M; Vilber Lourmat, France)가 부착된 자외선 조사기(BLX-254; Vilber Lourmat, France)를 이용하여 등 피부에 자외선을 쬐어 광노화를 유발하였다(Hong et al., 2015). 자외선 조사량은 UV Light meter (UV-340; Lutron, Taiwan)로 자외선 조사기 내부의 조사량을 측정하여 조정한 뒤 아래의 표 10과 같이 UVB 조사량을 조절하였다.After the adaptation period for one week, UVB-ultraviolet lamp (T-8M; Vilber Lourmat, France) was attached to group 6 except for the normal control group (NOR) 3 times a week for 8 weeks (BLX-254; Vilber Lourmat, France) ) was used to induce photoaging by exposing the back skin to ultraviolet rays (Hong et al., 2015). The amount of UV irradiation was adjusted by measuring the dose inside the UV irradiator with a UV light meter (UV-340; Lutron, Taiwan), and then the UVB dose was adjusted as shown in Table 10 below.

WeekWeek 1One 22 33 4-84-8 UVB dosageUVB dosage 1 MED1 MED 2 MED2 MED 3 MED3 MED 4 MED4 MED

1 MED=75 mJ/cm2자외선 조사 시작일로부터 8주간 정상대조군(NOR)과 음성대조군(CON)은 음용수만 경구투여 하였으며, 시료 처리군은 체중 측정 후 농도에 맞추어 시료를 음용수와 혼합하여 경구투여하였다. 각 마우스들은 8주간의 자외선 조사 및 제조예 투여 기간이 종료된 후 희생하였다.1 MED=75 mJ/cm 2 For 8 weeks from the start date of UV irradiation, only drinking water was orally administered to the normal control group (NOR) and negative control group (CON). did Each mouse was sacrificed after 8 weeks of UV irradiation and the administration period of Preparation Example was completed.

<음수 섭취량 및 사료 섭취량> <Drinking water intake and feed intake>

본 발명자들은 본 발명의 조성물이 마우스의 음수 및 사료 섭취량에 미치는 영향을 확인하고자, 마우스를 자외선 조사하고 시료를 투여하는 기간 동안 일주일에 1회씩 음수 및 사료의 섭취량을 측정하였다. 식이 섭취량은 그룹 간의 유의적인 차이는 나타나지 않았다(표 11 및 12).The present inventors measured the intake of water and feed once a week during the period of irradiating the mouse with UV light and administering the sample in order to confirm the effect of the composition of the present invention on the intake of water and feed of the mouse. There was no significant difference in dietary intake between groups (Tables 11 and 12).

구분division 사료 섭취량 (g/day)Feed intake (g/day) 정상대조군normal control group 14.614.6 음성대조군negative control 17.217.2 제조예 3-1Preparation Example 3-1 17.017.0 제조예 3-5Preparation 3-5 16.516.5 제조예 3-9Preparation 3-9 16.116.1 제조예 3-13Preparation 3-13 18.318.3

구분division 물 섭취량 (mL/day)Water intake (mL/day) 정상대조군normal control group 14.514.5 음성대조군negative control 16.316.3 제조예 3-1Preparation Example 3-1 15.115.1 제조예 3-5Preparation 3-5 12.812.8 제조예 3-9Preparation 3-9 13.513.5 제조예 3-13Preparation 3-13 17.617.6

<피부 수분 보유량, 경표피 수분 손실량(TEWL) 및 홍반 평가> <Evaluation of skin water retention, transepidermal water loss (TEWL) and erythema>

본 발명자들은 본 발명의 조성물이 피부 상태에 미치는 영향을 확인하고자, 자외선을 조사한 쥐의 등 쪽 피부를 Multi Probe Adapter® MPA 6(Courage und Khazaka, Germany)로 피부의 수분보유량, 경표피수분손실량(TEWL)과 홍반을 측정하였다. 자외선 조사 시작 전 모든 그룹에서 피부 측정이 진행되었으며, NOR 그룹과 CON 그룹 사이의 피부 측정 결과에서 유의적인 차이가 나타나는 것을 확인하고자 자외선 조사 4주 이후부터 일주일 간격으로 피부측정을 진행하였다. 피부 측정 결과는 희생 전날 마지막으로 측정한 결과를 표 13 내지 표 15로 나타내었다.The present inventors used Multi Probe Adapter® MPA 6 (Courage und Khazaka, Germany) on the dorsal skin of rats irradiated with ultraviolet rays to confirm the effect of the composition of the present invention on the skin condition, the amount of moisture retention in the skin and the amount of transepidermal water loss ( TEWL) and erythema were measured. Skin measurements were carried out in all groups before the start of UV irradiation, and skin measurements were performed every week from 4 weeks after UV irradiation to confirm that there was a significant difference in skin measurement results between the NOR and CON groups. The skin measurement results are shown in Tables 13 to 15, showing the results of the last measurement on the day before sacrifice.

피부 수분 보유량skin moisture retention

구분division 피부 수분 보유량skin moisture retention 정상대조군normal control group 43.143.1 음성대조군negative control 27.527.5 제조예 3-1Preparation Example 3-1 40.140.1 제조예 3-5Preparation 3-5 39.839.8 제조예 3-9Preparation 3-9 41.341.3 제조예 3-13Preparation 3-13 38.638.6

표 13는 본 발명의 실험군별 피부 수분 보유량을 나타낸 것이다. Table 13 shows the amount of skin moisture retention for each experimental group of the present invention.

표 13에 나타낸 바와 같이, 수분 보유량은 음성 대조군(CON)에서 정상 대조군(NOR) 대비 약 36.2%의 유의적 감소를 나타냈으며, 모든 시료 투여군에서 음성대조군 대비 수분 보유량이 증가하였다. As shown in Table 13, water retention was significantly reduced in the negative control group (CON) compared to the normal control group (NOR) by about 36.2%, and water retention was increased in all sample administration groups compared to the negative control group.

경표피 수분 손실량Transepidermal water loss

구분division 경표피 수분 손실량 (g/h/m2)Transepidermal water loss (g/h/m 2 ) 정상대조군normal control group 12.012.0 음성대조군negative control 53.653.6 제조예 3-1Preparation Example 3-1 23.323.3 제조예 3-5Preparation 3-5 25.125.1 제조예 3-9Preparation 3-9 19.819.8 제조예 3-13Preparation 3-13 21.521.5

표 14는 본 발명의 실험군별 경피 수분 손실량을 나타낸다. Table 14 shows the amount of transdermal water loss for each experimental group of the present invention.

표 14에 나타낸 바와 같이, 경표피 수분 손실량은 음성 대조군(CON)이 정상 대조군(NOR) 대비 약 4.47배 유의적으로 증가하였다(p<0.05). 모든 시료 투여군은 음성대조군(CON) 대비 경표피 수분 손실량이 유의적으로 감소하였으며, 특히 효소와 유산균을 동시에 처리하여 배양한 제조예 3-9 처리군에서 가장 큰 폭으로 경표피 수분 손실량이 감소하였다(p<0.05).As shown in Table 14, the amount of transepidermal water loss was significantly increased by about 4.47 times in the negative control group (CON) compared to the normal control group (NOR) (p<0.05). All sample administration groups significantly decreased transepithelial water loss compared to the negative control group (CON), and in particular, the greatest decrease in transepithelial water loss was achieved in Preparation Example 3-9 treated group, which was cultured by simultaneously treating enzymes and lactic acid bacteria. (p<0.05).

홍반 수치erythema level

구분division 홍반 수치erythema level 정상대조군normal control group 142.1142.1 음성대조군negative control 224.5224.5 제조예 3-1Preparation Example 3-1 198.4198.4 제조예 3-5Preparation 3-5 192.7192.7 제조예 3-9Preparation 3-9 201.2201.2 제조예 3-13Preparation 3-13 195.2195.2

표 15에 나타낸 바와 같이, 홍반 수치는 정상대조군(NOR) 대비 음성대조군(CON)이 약 1.58배 유의적인 증가를 나타냈으며(p<0.05), 시료 투여 군에서의 홍반 수치는 음성대조군 대비 유의적으로 감소하였다.As shown in Table 15, the erythema level in the negative control group (CON) showed a significant increase of about 1.58 times compared to the normal control group (NOR) (p<0.05), and the erythema level in the sample administration group was significant compared to the negative control group. decreased to

상기 결과를 종합하여 볼 때, 본 발명의 식물성 콜라겐 및 식물성 뮤신을 포함하는 추출물은 수분 보유량, 경표피 수분 손실량 및 홍반 수치 모두에서 긍정적인 활성을 나타냄을 확인하였다. 따라서 본 발명의 식물 혼합 추출물은 자외선에 의해 유발되는 피부 수분 손실 및 피부 장벽의 손상을 방지하고 피부 장벽기능이 정상적으로 작용할 수 있도록 도움을 준다는 것을 알 수 있었다.When the above results are taken together, it was confirmed that the extract containing vegetable collagen and vegetable mucin of the present invention exhibited positive activity in both water retention, transepidermal water loss, and erythema level. Therefore, it was found that the plant mixed extract of the present invention helps prevent skin moisture loss and damage to the skin barrier caused by UV rays, and helps the skin barrier function to function normally.

실시예 3-3: 피부 주름의 분석Example 3-3: Analysis of skin wrinkles

본 발명자들은 본 발명의 식품조성물의 노화방지 및 주름 개선효과를 확인하고자, 쥐의 등쪽 피부를 촬영하고, 주름 양상의 분석을 위해 Visioline(VL650; CK electronic GmbH, Germany)를 사용하여 얻은 replica를 이용하여 주름의 면적, 수, 길이, 깊이 등을 분석하였다. 결과는 표 16에 나타내었다.In order to confirm the anti-aging and anti-wrinkle effect of the food composition of the present invention, the present inventors photographed the dorsal skin of a rat and used a replica obtained using Visioline (VL650; CK electronic GmbH, Germany) to analyze the wrinkle pattern Thus, the area, number, length, and depth of wrinkles were analyzed. The results are shown in Table 16.

구분division 전체 주름 면적 (mm2)Total crease area (mm 2 ) 최대 주름 깊이 (μm)Maximum wrinkle depth (μm) 정상대조군normal control group 4.74.7 221221 음성대조군negative control 23.823.8 728728 제조예 3-1Preparation Example 3-1 15.415.4 575575 제조예 3-5Preparation 3-5 13.713.7 560560 제조예 3-9Preparation 3-9 11.311.3 411411 제조예 3-13Preparation 3-13 12.412.4 432432

표 16을 통해 주름 양상의 지표를 분석한 결과, 음성 대조군(CON)은 주름 면적과 깊이가 정상대조군(NOR) 대비 유의적으로 증가하였다(p<0.05). 또한, 본 발명의 식물성 콜라겐 및 식물성 뮤신을 함유하는 추출물을 투여시 주름 양상의 지표가 음성대조군(CON) 대비 유의적으로 감소되는 경향을 확인하였으며, 특히 조성물 중 효소와 유산균을 동시에 처리하여 배양한 군(제조예 3-9)에서 주름의 면적과 최대 깊이가 가장 유의적으로 감소한 것을 확인하였다(p<0.05). As a result of analyzing the wrinkle pattern index through Table 16, the wrinkle area and depth of the negative control group (CON) were significantly increased compared to the normal control group (NOR) (p<0.05). In addition, when the extract containing vegetable collagen and vegetable mucin of the present invention was administered, it was confirmed that the index of the wrinkle pattern was significantly reduced compared to the negative control group (CON). In the group (Preparation Example 3-9), it was confirmed that the area and maximum depth of wrinkles were most significantly decreased (p<0.05).

이를 통하여 본 발명의 식물성 콜라겐 및 식물성 뮤신을 함유하는 추출물을 섭취 시 UVB에 의한 광노화 방지 및 주름 생성에 대한 억제 효과가 있다는 것을 확인하였다.Through this, it was confirmed that when the extract containing vegetable collagen and vegetable mucin of the present invention was ingested, there was an inhibitory effect on UVB-induced photoaging and wrinkle formation.

실시예 3-4: 표피의 두께 및 콜라겐 측정Example 3-4: Epidermal thickness and collagen measurement

본 발명자들은 본 발명의 조성물이 표피의 콜라겐 발현에 미치는 영향을 확인하기 위하여, 자외선 조사 및 조성물 투여 실험 종료 후 모든 쥐의 등 쪽 피부를 채취하여 10% formalin에 넣은 후, 조직병리학적인 변화를 확인할 수 있는 hematoxylin and eosin(H&E) 염색, 및 진피(Dermis)에 존재하는 콜라겐을 확인할 수 있는 immunohistochemistry(IHC)염색을 수행하였다. 염색이 완료된 조직을 광학현미경을 이용하여 사진을 찍어 이미지화 한 후, 분석하였다. In order to confirm the effect of the composition of the present invention on the collagen expression of the epidermis, the present inventors collected the dorsal skin of all mice after UV irradiation and the composition administration experiment was completed, put it in 10% formalin, and confirmed histopathological changes Hematoxylin and eosin (H&E) staining was performed, and immunohistochemistry (IHC) staining was performed to confirm collagen present in the dermis. After the stained tissue was imaged by taking a picture using an optical microscope, it was analyzed.

도 4에 나타낸 바와 같이, H&E 염색 결과, 정상 대조군(NOR)에 비해 UVB 조사 군의 표피(epidermis)의 두께가 유의적으로 증가된 것을 확인하였다(p<0.05). 또한, 전체 시료 투여군에서 음성대조군(CON) 대비 표피 두께가 유의적으로 감소했으며, 특히 효소와 유산균을 통시에 처리하여 배양한 군(제조예 3-9)에서 표피의 두께가 음성대조군 보다 유의적으로 감소한 경향을 나타냄을 확인하였다(p<0.05). As shown in FIG. 4 , as a result of H&E staining, it was confirmed that the thickness of the epidermis of the UVB irradiation group was significantly increased (p<0.05) compared to the normal control group (NOR). In addition, in the total sample administration group, the epidermal thickness was significantly reduced compared to the negative control group (CON), and in particular, in the group cultured by treating enzymes and lactic acid bacteria at the same time (Preparation Example 3-9), the epidermal thickness was significantly higher than that of the negative control group was confirmed to show a decreasing trend (p<0.05).

구분division 표피의 두께 (μm)Epidermis thickness (μm) 콜라겐 (%)Collagen (%) 정상대조군normal control group 9292 4.74.7 음성대조군negative control 438438 23.823.8 제조예 3-1Preparation Example 3-1 210210 15.415.4 제조예 3-5Preparation 3-5 187187 13.713.7 제조예 3-9Preparation 3-9 143143 11.311.3 제조예 3-13Preparation 3-13 161161 12.412.4

콜라겐에 대한 IHC 염색 결과, 정상 대조군(NOR)에 비해 음성 대조군(CON)의 진피(dermis) 내 콜라겐 비율이 유의적으로 감소한 것을 확인하였다(p<0.05). 또한 전체 시료 투여군에서 음성대조군(CON) 대비 진피 내 콜라겐 비율이 유의적으로 증가하였다(p<0.05).As a result of IHC staining for collagen, it was confirmed that the collagen ratio in the dermis of the negative control group (CON) was significantly decreased compared to the normal control group (NOR) (p<0.05). In addition, the collagen ratio in the dermis was significantly increased in the total sample administration group compared to the negative control group (CON) (p<0.05).

실험예 3-5: 진피의 엘라스틴(Elastin) 측정Experimental Example 3-5: Elastin measurement of the dermis

피부 진피의 구성물질인 엘라스틴은 피부조직의 탄력에 영향을 미치는 탄력질로, 피부가 광노화 되었을 때 그 수와 직경이 감소하며 피부탄력을 감소시키게 된다. 본 발명자들은 본 발명의 조성물이 피부 탄력에 미치는 영향을 확인하고자, 각 실험군별로 10 mg 가량의 피부조직을 추출한 뒤 Fastin Elastin assay(F2000; Biocolor, UK)에서 제공한 방법을 이용하여 피부조직 내의 엘라스틴 양을 측정하였다.Elastin, a component of the skin dermis, is an elastic substance that affects the elasticity of the skin tissue. In order to confirm the effect of the composition of the present invention on skin elasticity, the present inventors extracted about 10 mg of skin tissue from each experimental group, and then used the method provided by Fastin Elastin assay (F2000; Biocolor, UK) to elastin in the skin tissue. The amount was measured.

구분division 엘라스틴 함량 (μg/mg)Elastin content (μg/mg) 정상대조군normal control group 1.41.4 음성대조군negative control 0.90.9 제조예 3-1Preparation Example 3-1 1.31.3 제조예 3-5Preparation 3-5 1.51.5 제조예 3-9Preparation 3-9 1.61.6 제조예 3-13Preparation 3-13 1.31.3

표 18에 나타낸 바와 같이, 본 발명의 조성물 투여군은 음성대조군(CON)과 비교하였을 때 모두 엘라스틴 함량이 증가하는 경향을 나타냈으며, 특히 본 발명의 효소와 유산균을 동시에 처리하여 배양한 군(제조예 3-9)에서 음성대조군(CON) 대비 가장 유의적으로 증가하였다(p<0.05).As shown in Table 18, the composition administration group of the present invention showed a tendency to increase the elastin content in all compared to the negative control group (CON), in particular, the group cultured by treating the enzyme and lactic acid bacteria of the present invention at the same time (Preparation Example) 3-9) showed the most significant increase compared to the negative control group (CON) (p<0.05).

상기 결과로부터 본 발명의 식물성 콜라겐 및 식물성 뮤신을 함유하는 식물 추출물을 경구 섭취할 경우 UV에 의해 감소된 엘라스틴의 함량을 증강시켜 피부의 진피층 그물망 구조를 개선을 통해 탄력 증진 효과를 기대할 수 있는 것을 확인하였다.From the above results, when the plant extract containing vegetable collagen and vegetable mucin of the present invention is orally ingested, it is confirmed that the elasticity enhancing effect can be expected by enhancing the elastin content reduced by UV and improving the dermal layer network structure of the skin. did

실험예 3-6: 인간섬유아세포에서 콜라겐 총량 증가 효과Experimental Example 3-6: Effect of increasing total amount of collagen in human fibroblasts

본 발명의 제조예 3-1, 3-5, 3-9, 3-13의 추출물을 인간 유래 섬유아세포의 배양액에 첨가하여 세포 수준에서 콜라겐 총량을 측정하였다. 콜라겐 총량은 PICP EIA kit(Procollagen Type I C-Peptide Enzyme ImmunoAssay KIT)를 이용하여 정량하였다. 실험 전 인간 유래 섬유아세포를 대상으로 실험물질의 농도 10 ppm, 1 ppm, 0.1 ppm, 0.01 ppm, 0.001 ppm에서 세포 독성을 평가하였으며, 세포독성이 없는 농도를 선정하여 콜라겐 총량을 측정하였다. 실험에서 본 발명의 제조예의 농도는 각각 1 ppm, 10 ppm으로 하였으며, 각각의 시료는 인간 섬유아세포의 배양 배지에 첨가하여 2일간 배양한 후, 배양액을 취하여 PICP EIA 키트로 각 농도에서의 콜라겐 총량을 분광 광도계를 이용하여 450 nm에서 측정하였다. 효과의 비교를 위하여 아무것도 첨가하지 않은 섬유아세포의 배양 배지(대조군)와 비타민 C를 최종 농도 52.8 ppm이 되도록 첨가한 시료에 대하여 동일한 방법으로 콜라겐 총량을 측정하였다. 콜라겐 총량은 UV 흡광도로서 측정하였으며, 콜라겐 총량의 증가율은 대조군에 대한 상대적인 콜라겐 총량 비율로 계산하고, 그 결과를 하기 표 19에 정리하였다.The extracts of Preparation Examples 3-1, 3-5, 3-9, and 3-13 of the present invention were added to the culture solution of human-derived fibroblasts to measure the total amount of collagen at the cellular level. The total amount of collagen was quantified using the PICP EIA kit (Procollagen Type I C-Peptide Enzyme ImmunoAssay KIT). Before the experiment, human-derived fibroblasts were evaluated for cytotoxicity at concentrations of 10 ppm, 1 ppm, 0.1 ppm, 0.01 ppm, and 0.001 ppm of the test substance, and the total amount of collagen was measured by selecting a concentration without cytotoxicity. In the experiment, the concentrations of the preparation examples of the present invention were 1 ppm and 10 ppm, respectively, and each sample was added to the culture medium of human fibroblasts and cultured for 2 days, then the culture solution was taken and the total amount of collagen at each concentration with the PICP EIA kit. was measured at 450 nm using a spectrophotometer. For comparison of the effect, the total amount of collagen was measured in the same manner for the fibroblast culture medium (control group) to which nothing was added and the sample to which vitamin C was added to a final concentration of 52.8 ppm. The total amount of collagen was measured as UV absorbance, and the increase rate of the total amount of collagen was calculated as the ratio of the total amount of collagen relative to the control group, and the results are summarized in Table 19 below.

구분division 흡광도 평균Absorbance Average 콜라겐 증가율 (%)Collagen increase rate (%) 정상대조군normal control group 612612 145.3145.3 음성대조군negative control 421421 -- 제조예 3-1Preparation Example 3-1 527527 125.2125.2 제조예 3-5Preparation 3-5 510510 121.1121.1 제조예 3-9Preparation 3-9 572572 135.9135.9 제조예 3-13Preparation 3-13 533533 126.6126.6 비타민 Cvitamin C 586586 139.2139.2

상기 표 19에 나타난 바와 같이, 본 발명의 제조예의 추출물은 일반적으로 콜라겐 합성 능력이 있는 것으로 알려진 비타민 C를 적용한 경우 보다 적은 농도로 더 우수한 콜라겐 증가율을 나타내었다. 따라서, 본 발명의 제조예의 추출물은 피부재생, 주름개선을 위한 용도로 사용할 수 있음을 알 수 있었다.As shown in Table 19, the extract of Preparation Example of the present invention generally exhibited an excellent collagen increase rate at a lower concentration than when vitamin C, which is known to have a collagen synthesis ability, was applied. Therefore, it was found that the extract of Preparation Example of the present invention can be used for skin regeneration and wrinkle improvement.

실험예 3-7: 콜라게나아제 활성 억제 효과 Experimental Example 3-7: Collagenase activity inhibitory effect

본 발명의 제조예 3-1, 3-5, 3-9, 3-13의 추출물에 의한 인간 유래 섬유아세포에서의 콜라게나아제 활성 억제 효과를 다음과 같이 확인하였다. The effect of inhibiting collagenase activity in human-derived fibroblasts by the extracts of Preparation Examples 3-1, 3-5, 3-9, and 3-13 of the present invention was confirmed as follows.

실험 전 인간 유래 섬유아세포를 대상으로 실험물질의 농도 10 ppm, 1 ppm, 0.1 ppm, 0.01 ppm, 0.001 ppm에서 세포독성을 평가하였으며, 세포독성이 없는 농도를 선정하여 콜라게나제 평가법을 수행하였다. 인간 정상 피부 세포인 섬유아세포를 24-웰 마이크로 플레이트에 각 웰당 2.5x104 세포가 되도록 접종하고, 10% 혈청 DMEM 배지 및 37℃의 조건에서 24시간 동안 배양한 후 10% 혈청 DMEM 배지를 제거하고 인산완충용액으로 1회 세척한 후 본 발명의 제조예의 추출물을 첨가한 무혈청 DMEM 배지 및 정상대조군 및 음성대조군으로 무혈청 DMEM 배지에서 30분 동안 추가로 배양하였다. 시료 처리 30분 후 콜라겐 분해효소인 MMP-1을 생성시키는 것으로 알려진 물질인 TNF-α(tumor necrosis factor-α) 50 ng/mL로 자극 후 24시간 배양하였다. 이때, 본 발명의 추출물이 포함되지 않은 대조군중 TNF-α를 처리한 군을 음성대조군으로, TNF-α를 처리하지 않은 군을 정상대조군으로 정하였다. 각 웰의 상층액을 모아 MMP-1 분석 키트(Amersham, 미국)를 이용하여 새로 합성된 MMP-1의 양(ng/mL)을 측정하고, 콜라게나제 활성 저해율은 하기 수학식 1에 따라 MMP-1 생성 억제율(%)을 계산하였으며, 그 결과는 하기 표 20에 나타낸 바와 같다. Before the experiment, human-derived fibroblasts were evaluated for cytotoxicity at concentrations of 10 ppm, 1 ppm, 0.1 ppm, 0.01 ppm, and 0.001 ppm of the test substance, and a collagenase evaluation method was performed by selecting a concentration without cytotoxicity. Fibroblasts, which are normal human skin cells, were inoculated in a 24-well microplate so as to become 2.5x10 4 cells per well, and cultured for 24 hours in 10% serum DMEM medium and 37° C., and then 10% serum DMEM medium was removed. After washing once with a phosphate buffer solution, it was further cultured for 30 minutes in serum-free DMEM medium to which the extract of Preparation Example of the present invention was added, and in serum-free DMEM medium as a normal control group and a negative control group. After 30 minutes of sample treatment, the cells were stimulated with 50 ng/mL of TNF-α (tumor necrosis factor-α), a substance known to produce MMP-1, a collagen degrading enzyme, and cultured for 24 hours. At this time, among the controls not containing the extract of the present invention, the group treated with TNF-α was defined as a negative control group, and the group not treated with TNF-α was defined as a normal control group. The supernatant of each well was collected and the amount of newly synthesized MMP-1 (ng/mL) was measured using an MMP-1 assay kit (Amersham, USA), and the collagenase activity inhibition rate was determined according to Equation 1 below. -1 production inhibition rate (%) was calculated, and the results are shown in Table 20 below.

[수학식 1][Equation 1]

MMP-1 생성 억제율(%) = [1 - (실험군의 MMP-1 생성량 - 음성대조군의 MMP-1 생성량)/(정상대조군의 MMP-1 생성량 - 음성대조군의 MMP-1 생성량)]x100MMP-1 production inhibition rate (%) = [1 - (Experimental group MMP-1 production amount - Negative control group MMP-1 production amount) / (Normal control group MMP-1 production amount - Negative control group MMP-1 production amount)]x100

구분division MMP-1의 생성량MMP-1 production 억제율(%)Inhibition rate (%) 정상대조군 (TNF-alpha 무처리)Normal control group (no TNF-alpha treatment) 5.65.6 -- 음성대조군 (TNF-alpha 처리)Negative control group (TNF-alpha treatment) 20.420.4 -- 제조예 3-1Preparation Example 3-1 15.815.8 125.2125.2 제조예 3-5Preparation 3-5 16.716.7 121.1121.1 제조예 3-9Preparation 3-9 8.58.5 135.9135.9 제조예 3-13Preparation 3-13 11.311.3 126.6126.6

제제예Formulation example

한편, 본 발명의 제조예의 추출물을 포함하는 조성물의 제제예를 하기에 기술하였다. 다만, 하기의 제제예는 본 발명의 사용예를 구체적으로 설명하고자 하는 것일 뿐, 본 발명의 권리범위를 하기의 제제예로 한정하고자 하는 것은 아님은 당업자에게 자명하다.On the other hand, the formulation examples of the composition comprising the extract of Preparation Example of the present invention are described below. However, it is apparent to those skilled in the art that the following formulation examples are only intended to specifically describe examples of use of the present invention, and are not intended to limit the scope of the present invention to the following formulation examples.

제제예 1: 영양 화장수 (로션)의 제조Formulation Example 1: Preparation of nutritional lotion (lotion)

하기 표 21에 기재된 바와 같이, 제조예 3-1 내지 3-16에서 수득한 추출물을 함유하는 영양화장수 (로션)를 통상의 방법에 따라 제조하였다.As shown in Table 21 below, a nutrient lotion (lotion) containing the extract obtained in Preparation Examples 3-1 to 3-16 was prepared according to a conventional method.

번호number 원료Raw material 함량 (중량%)content (wt%) 1One 제조예 3-1 내지 3-16Preparation Examples 3-1 to 3-16 10.010.0 22 시토스테롤sitosterol 1.71.7 33 폴리길리세릴 2-올레이트Polyglyceryl 2-oleate 1.51.5 44 세테아레스-4Ceteares-4 1.21.2 55 콜레스테롤cholesterol 1.51.5 66 디세틸포스페이트dicetyl phosphate 0.40.4 77 글리세롤glycerol 5.05.0 88 카르복시비닐폴리머Carboxyvinyl Polymer 10.010.0 99 선플라워 오일sunflower oil 0.20.2 1010 산탄검Xanthan Gum 0.30.3 1111 방부제antiseptic 미량a very small amount 1212 향료Spices 미량a very small amount 1313 정제수Purified water 잔량remaining amount

제제예 2: 유연 화장수 (스킨)의 제조Formulation Example 2: Preparation of softening lotion (skin)

하기 표 22에 기재된 바와 같이, 제조예 3-1 내지 3-16에서 수득한 추출물을 함유하는 유연화장수 (스킨)를 통상의 방법에 따라 제조하였다.As shown in Table 22 below, a softening lotion (skin) containing the extract obtained in Preparation Examples 3-1 to 3-16 was prepared according to a conventional method.

번호number 원료Raw material 함량 (중량%)content (wt%) 1One 제조예 3-1 내지 3-16Preparation Examples 3-1 to 3-16 5.05.0 22 글리세린glycerin 3.03.0 33 부틸렌글리콜butylene glycol 2.02.0 44 프로필렌글리콜propylene glycol 2.02.0 55 폴리옥시에칠렌(60)경화 피마자유Polyoxyethylene (60) hydrogenated castor oil 1.01.0 66 에탄올ethanol 10.010.0 77 프리에탄올아민preethanolamine 0.10.1 88 방부제antiseptic 미량a very small amount 99 색소pigment 미량a very small amount 1010 향료Spices 미량a very small amount 1111 정제수Purified water 잔량remaining amount

제제예 3: 영양크림 제조Formulation Example 3: Preparation of nourishing cream

하기 표 23에 기재된 바와 같이, 제조예 3-1 내지 3-16에서 수득한 추출물을 함유하는 영양크림을 통상의 방법에 따라 제조하였다.As shown in Table 23 below, a nutritional cream containing the extract obtained in Preparation Examples 3-1 to 3-16 was prepared according to a conventional method.

번호number 원료Raw material 함량 (중량%)content (wt%) 1One 제조예 3-1 내지 3-16Preparation Examples 3-1 to 3-16 10.010.0 22 시토스테롤sitosterol 4.04.0 33 폴리길리세릴 2-올레이트Polyglyceryl 2-oleate 3.03.0 44 세테아레스-4Ceteares-4 2.02.0 55 콜레스테롤cholesterol 3.03.0 66 디세틸포스페이트dicetyl phosphate 0.40.4 77 농글리세롤concentrated glycerol 5.05.0 88 선플라워 오일sunflower oil 22.022.0 99 카르복시비닐폴리머Carboxyvinyl Polymer 0.50.5 1010 트리에탄올아민triethanolamine 0.50.5 1111 방부제antiseptic 미량a very small amount 1212 향료Spices 미량a very small amount 1313 정제수Purified water 잔량remaining amount

제제예 4: 에센스의 제조Formulation Example 4: Preparation of Essence

하기 표 24에 기재된 바와 같이 제조예 3-1 내지 3-16에서 수득한 추출물을 함유하는 에센스를 통상의 방법에 따라 제조하였다.As described in Table 24 below, an essence containing the extract obtained in Preparation Examples 3-1 to 3-16 was prepared according to a conventional method.

번호number 원료Raw material 함량 (중량%)content (wt%) 1One 제조예 3-1 내지 3-16Preparation Examples 3-1 to 3-16 5.05.0 22 시토스테롤sitosterol 1.71.7 33 폴리길리세릴 2-올레이트Polyglyceryl 2-oleate 1.51.5 44 세테아레스-4Ceteares-4 2.02.0 55 콜레스테롤cholesterol 3.03.0 66 디세틸포스페이트dicetyl phosphate 0.40.4 77 농글리세롤concentrated glycerol 5.05.0 88 선플라워 오일sunflower oil 22.022.0 99 카르복시비닐폴리머Carboxyvinyl Polymer 0.50.5 1010 트리에탄올아민triethanolamine 0.50.5 1111 방부제antiseptic 미량a very small amount 1212 향료Spices 미량a very small amount 1313 정제수Purified water 잔량remaining amount

제제예 5: 파운데이션의 제조Formulation Example 5: Preparation of foundation

하기 표 25에 기재된 바와 같이, 제조예 3-1 내지 3-16에서 수득한 추출물을 함유하는 파운데이션을 통상의 방법에 따라 제조하였다.As shown in Table 25 below, a foundation containing the extract obtained in Preparation Examples 3-1 to 3-16 was prepared according to a conventional method.

번호number 원료Raw material 함량 (중량%)content (wt%) 1One 제조예 3-1 내지 3-16Preparation Examples 3-1 to 3-16 1.01.0 22 밀납beeswax 2.02.0 33 사이크로메치콘cyclomethicone 2.02.0 44 유동파라핀liquid paraffin 5.05.0 55 스쿠알란squalane 5.05.0 66 스테아린산stearic acid 2.02.0 77 친유성 모노스테이린산 글리세린lipophilic monostearate glycerin 3.03.0 88 카프릴릭/카프릭트리글리세라이드Caprylic/Capric Triglycerides 4.04.0 99 글리세린glycerin 4.04.0 1010 프로필렌글리콜propylene glycol 3.03.0 1111 부틸렌글리콜butylene glycol 3.03.0 1212 트리에탄올아민triethanolamine 1.01.0 1313 알루미늄마그네슘실리케이트Aluminum Magnesium Silicate 0.50.5 1414 안료pigment 1212 1515 방부제antiseptic 미량a very small amount 1616 향료Spices 미량a very small amount 1717 정제수Purified water 잔량remaining amount

제제예 6: 헤어컨디셔너의 제조Formulation Example 6: Preparation of hair conditioner

하기 표 26에 기재된 바에 같이, 제조예 3-1 내지 3-16에서 수득한 추출물을 함유하는 헤어컨디셔너를 통상의 방법에 따라 제조하였다.As shown in Table 26 below, hair conditioners containing the extracts obtained in Preparation Examples 3-1 to 3-16 were prepared according to a conventional method.

번호number 원료Raw material 함량 (중량%)content (wt%) 1One 제조예 3-1 내지 3-16Preparation Examples 3-1 to 3-16 5.05.0 22 에탄올ethanol 3.53.5 33 글리세린glycerin 1.51.5 44 프로필렌글리콜propylene glycol 2.52.5 55 염화스테아릴트리에틴암모늄Stearyl Triethine Ammonium Chloride 2.02.0 66 색소pigment 미량a very small amount 77 향료Spices 미량a very small amount 88 정제수Purified water 잔량remaining amount

Claims (20)

식물성 콜라겐 및 식물성 뮤신을 포함하는 식물 추출물을 유효성분으로 포함하는 피부노화방지, 주름개선, 피부장벽 강화 또는 피부보습용 식품조성물.A food composition for skin aging prevention, wrinkle improvement, skin barrier strengthening, or skin moisturizing comprising a plant extract containing vegetable collagen and plant mucin as an active ingredient. 제1항에 있어서, 상기 식물은 시금치, 스위스차드, 당근, 토마토, 황기, 천궁, 버섯류, 둥근마, 연근, 유채꽃 및 유채씨로 이루어진 군으로부터 선택된 1종 이상의 생약 재료를 혼합한 혼합물을 추출하여 얻은 것인, 식품조성물.According to claim 1, wherein the plant is spinach, Swiss chard, carrot, tomato, astragalus, chrysanthemum, mushrooms, round hemp, lotus root, rape flower and rapeseed extract a mixture of one or more kinds of herbal ingredients selected from the group consisting of extract A food composition obtained by 제2항에 있어서, 상기 식품조성물은 석류, 타트체리, 블루베리, 마늘, 망고, 오렌지, 아보카도, 화이트리, 케슈넛, 히비스커스, 딸기, 금화규, 키위, 구아바, 파인애플, 콩, 피망, 라즈베리, 블랙베리, 구기자, 복령, 및 숙지황으로 이루어진 군으로부터 선택된 1종 이상의 생약 재료를 혼합한 혼합물을 추출하여 얻은 추출물을 추가적으로 포함하는 것인, 식품조성물. According to claim 2, wherein the food composition is pomegranate, tart cherry, blueberry, garlic, mango, orange, avocado, white lily, cashew nut, hibiscus, strawberry, goldfish, kiwi, guava, pineapple, soybean, green pepper, raspberry , blackberry, goji berry, bokryeong, and to further include an extract obtained by extracting a mixture of one or more herbal ingredients selected from the group consisting of sukjihwang, a food composition. 제2항에 있어서, 상기 버섯류는 흰목이버섯, 목이버섯, 영지버섯, 치마버섯, 송이버섯, 표고버섯, 송로버섯, 상황버섯, 말굽버섯, 송화버섯, 차가버섯, 능이버섯, 노루궁뎅이버섯, 느타리버섯, 및 까치버섯으로 이루어진 군으로부터 선택된 1종 이상의 버섯인, 식품조성물. According to claim 2, wherein the mushrooms are white wood ear mushroom, wood ear mushroom, reishi mushroom, chima mushroom, matsutake mushroom, shiitake mushroom, truffle, situation mushroom, horseshoe mushroom, pineal mushroom, chaga mushroom, neungi mushroom, enoki mushroom, Oyster mushroom, and at least one mushroom selected from the group consisting of blackcurrant, a food composition. 제1항에 있어서, 상기 조성물은 피부내 콜라겐 및 엘라스틴의 발현을 증가시키는 것인, 식품조성물.The food composition according to claim 1, wherein the composition increases the expression of collagen and elastin in the skin. 식물성 콜라겐 및 식물성 뮤신을 포함하는 식물 추출물을 유효성분으로 포함하는 피부노화방지, 주름개선, 피부장벽 강화 또는 피부보습용 화장료 조성물.A cosmetic composition for skin anti-aging, wrinkle improvement, skin barrier strengthening, or skin moisturizing comprising a plant extract containing vegetable collagen and plant mucin as an active ingredient. 다음 단계를 포함하는 식물성 콜라겐 및 식물성 뮤신을 포함하는 식물 추출물의 제조방법:A method for producing a plant extract comprising plant collagen and plant mucin comprising the steps of: (a) 식물성 생약재료 분말에 용매를 혼합하는 단계;(a) mixing a solvent in the herbal herbal material powder; (b) 상기 혼합액에 효소, 유산균, 또는 이들의 조합을 첨가하고 배양하는 단계;(b) adding an enzyme, lactic acid bacteria, or a combination thereof to the mixed solution and culturing; (c) 상기 배양액을 원심분리 또는 여과하여 슬러지 및 전분을 제거하고 점성 상층액을 분리하거나, 여과액을 제조하는 단계; 및(c) centrifuging or filtering the culture solution to remove sludge and starch and separating the viscous supernatant, or preparing a filtrate; and (d) 상기 점성 상층액 또는 여과액을 가열하여 효소, 유산균 또는 이들의 조합을 실활 및 살균시키는 단계.(d) heating the viscous supernatant or the filtrate to inactivate and sterilize the enzyme, lactic acid bacteria, or a combination thereof. 제7항에 있어서, 상기 추출물의 제조방법은 (e) 액상의 추출물 또는 이를 건조하여 분말상의 추출물을 수득하는 단계를 추가적으로 포함하는 것인, 추출물의 제조방법.The method according to claim 7, wherein the method for preparing the extract further comprises the step of (e) obtaining a powdery extract by drying the liquid extract or the same. 제7항에 있어서, 상기 생약 재료는 시금치, 스위스차드, 당근, 토마토, 황기, 천궁, 버섯류, 둥근마, 연근, 유채꽃 및 유채씨로 이루어진 군으로부터 선택된 1종 이상인, 추출물의 제조방법.The method according to claim 7, wherein the herbal material is at least one selected from the group consisting of spinach, Swiss chard, carrot, tomato, astragalus, chrysanthemum, mushrooms, round hemp, lotus root, rape flower and rapeseed. 제9항에 있어서, 상기 생약 재료는 석류, 타트체리, 블루베리, 마늘, 망고, 오렌지, 아보카도, 화이트리, 케슈넛, 히비스커스, 딸기, 금화규, 키위, 구아바, 파인애플, 콩, 피망, 라즈베리, 블랙베리, 구기자, 복령, 및 숙지황으로 이루어진 군으로부터 선택된 1종 이상을 추가적으로 포함하는 것인, 추출물의 제조방법.10. The method of claim 9, wherein the herbal material is pomegranate, tart cherry, blueberry, garlic, mango, orange, avocado, white lily, cashew nut, hibiscus, strawberry, goldfish, kiwi, guava, pineapple, soybean, green pepper, raspberry , blackberry, goji berry, bokryeong, and the method for producing an extract further comprising at least one selected from the group consisting of sukhwanghwang. 제7항에 있어서, 상기 (a) 단계에서 상기 용매는 식물성 생약재료 분말 1 중량부에 대하여, 1 내지 100 중량부로 첨가되는 것인, 추출물의 제조방법.The method according to claim 7, wherein in step (a), the solvent is added in an amount of 1 to 100 parts by weight based on 1 part by weight of the plant herbal material powder. 제7항에 있어서, 상기 (a) 단계에서는 식물성 생약재료 분말에 용매를 첨가하고, 0.2 내지 5기압 조건에서 가압처리하는 것인, 추출물의 제조방법.The method of claim 7, wherein in step (a), a solvent is added to the plant herbal material powder, and the process is pressurized at 0.2 to 5 atmospheres. 제7항에 있어서, 상기 (b) 단계의 효소는 셀룰라아제, 헤미셀룰라아제, 베타-글루코시다제, 베타글루카나제, 자일라나제, 아라비나제, 프로테아제, 및 아밀라아제로 이루어진 군으로부터 선택되는 1종 이상의 효소인, 제조방법.The method of claim 7, wherein the enzyme in step (b) is cellulase, hemicellulase, beta-glucosidase, beta-glucanase, xylanase, arabinase, protease, and one selected from the group consisting of amylase The above enzyme, the manufacturing method. 제7항에 있어서, 상기 (b) 단계의 유산균은 류코노스톡 속, 락토바실러스 속, 비피도박테리움 속, 엔테로코커스 속 균주, 락토코커스 속 균, 또는 이들의 조합인, 제조방법. The method according to claim 7, wherein the lactic acid bacteria of step (b) are Leukonostok genus, Lactobacillus genus, Bifidobacterium genus, Enterococcus spp. strain, Lactococcus genus, or a combination thereof. 제7항에 있어서, 상기 (b) 단계의 배양은 1일 내지 50일간 이루어지는 것인, 제조방법.The method according to claim 7, wherein the culturing in step (b) is made for 1 to 50 days. 제7항에 있어서, 상기 (d) 단계의 가열은 60-150℃에서 0.5초 내지 3시간 동안 이루어지는 것인, 제조방법.The method according to claim 7, wherein the heating in step (d) is performed at 60-150° C. for 0.5 seconds to 3 hours. 제16항에 있어서, 상기 (d) 단계의 가열은 61-65℃에서 30분 내지 1시간, 또는 95~150℃에서 0.5초 내지 30초 동안 이루어지는 것인, 제조방법. The method according to claim 16, wherein the heating in step (d) is performed at 61-65°C for 30 minutes to 1 hour, or at 95-150°C for 0.5 seconds to 30 seconds. 제7항에 있어서, 상기 (a) 단계의 식물성 생약재료 분말은 1 내지 80%(w/w) 농도의 구연산, 아세트산, 또는 묽은 염산으로부터 선택된 산으로 1 내지 5시간 동안 처리한 것인, 제조방법.The method according to claim 7, wherein the plant herbal material powder of step (a) is treated with an acid selected from citric acid, acetic acid, or dilute hydrochloric acid at a concentration of 1 to 80% (w/w) for 1 to 5 hours, manufacturing Way. 제18항에 있어서, 상기 산처리 후 중화시키는 단계를 포함하는, 제조방법.The method according to claim 18, comprising neutralizing after the acid treatment. 제7항의 (a) 내지 (d) 단계, 또는 제8항의 (a) 내지 (e) 단계를 포함하는 제조방법에 의하여 제조된 추출물에, 상기 (c) 단계의 원심분리 또는 여과 후 남은 침전물, 또는 여과물을 건조 및 분쇄하여 제조한 분말을 혼합하는 단계를 포함하는, 식물성 콜라겐 및 식물성 뮤신을 포함하는 추출물 및 식물성 생약재료 통분말을 포함하는 식물조성물의 제조방법.(a) to (d) of claim 7, or to the extract prepared by the manufacturing method comprising the step (a) to (e) of claim 8, the precipitate remaining after centrifugation or filtration of step (c), Or drying and pulverizing the filtrate, comprising the step of mixing the powder prepared, a method for producing a plant composition comprising an extract comprising vegetable collagen and plant mucin and whole powder of plant herbal material.
PCT/KR2021/008104 2020-06-26 2021-06-28 Vegetable extract comprising vegetable collagen and vegetable mucin, and method for preparing same Ceased WO2021261975A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022580932A JP2023532093A (en) 2020-06-26 2021-06-28 Plant extract containing plant collagen and plant mucin, and method for producing the same

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
KR10-2020-0078772 2020-06-26
KR1020200078772A KR102535894B1 (en) 2020-06-26 2020-06-26 Method for preparing enzyme-treated polysaccharide extract derived from Korean Tremella fuciformis comprising plant collagen
KR10-2020-0182639 2020-12-23
KR1020200182639A KR102351730B1 (en) 2020-12-23 2020-12-23 Food comprising fermented Tremella fuciformis and Method for preparing the same
KR1020210043663A KR102432924B1 (en) 2021-04-02 2021-04-02 Extract and composition comprising plant-derived collagen and mucin
KR10-2021-0043663 2021-04-02

Publications (1)

Publication Number Publication Date
WO2021261975A1 true WO2021261975A1 (en) 2021-12-30

Family

ID=79281524

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2021/008104 Ceased WO2021261975A1 (en) 2020-06-26 2021-06-28 Vegetable extract comprising vegetable collagen and vegetable mucin, and method for preparing same

Country Status (2)

Country Link
JP (1) JP2023532093A (en)
WO (1) WO2021261975A1 (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116920002A (en) * 2023-05-30 2023-10-24 广州家化化学有限公司 Mi Luo Mu extract with efficacy of removing erythema, and preparation method and application thereof
KR102604036B1 (en) * 2023-09-15 2023-11-20 주식회사 토리든 Cosmetic Composition for Improving Skin Wrinkle and Moisturizing Skin Comprising Plant-derived 5D Complex Collagen
KR20230161560A (en) * 2022-05-18 2023-11-28 정도원농업회사법인 (주) Manufacturing method of onion juice with improved nutritional content and preference
CN117187307A (en) * 2023-10-25 2023-12-08 广州奥蓓斯化妆品有限公司 Tremella fermentation extract and preparation method thereof
CN117694549A (en) * 2024-02-05 2024-03-15 北京衡美金叶营养健康科技有限公司 Moisturizing, freckle-removing and whitening composition, preparation method and application
KR20240064975A (en) * 2022-11-04 2024-05-14 삼성웰스토리 주식회사 Clean Label Plant-Meat
CN118743460A (en) * 2024-07-15 2024-10-08 广东同德药业有限公司 Anti-glycation beverage containing white kidney bean and cherry blossom compound extract and preparation method thereof
CN119506098A (en) * 2024-10-25 2025-02-25 青岛黛优佳生物科技有限公司 A kind of red ganoderma fermentation lysate and its preparation method and application

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080036315A (en) * 2006-10-23 2008-04-28 주식회사 두산 Situation mushroom lactic acid bacteria fermented product and preparation method thereof
KR20080114069A (en) * 2007-06-26 2008-12-31 전북대학교산학협력단 Functional Soy Sausage Using Protein and Anthocyanin Extract Extracted from Black Soybean and Its Manufacturing Method
KR20110050138A (en) * 2009-11-06 2011-05-13 (주)청산녹수 Homogenized aging rice wine manufacturing method
KR20150024628A (en) * 2013-08-27 2015-03-09 주식회사 더말코리아 Method for preparing fermented vegitable mucin from yam and cosmetic compositions with it having superior collagen synthetic abilities, moisturizing effect, skin protection and wound healing
CN105524964A (en) * 2016-02-17 2016-04-27 常州市庆发工业气体有限公司 Extraction method of collagen peptide from tremella

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101405827B1 (en) * 2013-01-22 2014-06-11 주식회사 바이온셀 Fermented Extract for Preventing Apotic Dermatitis and Cosmatic Composition Using Same
JP6670166B2 (en) * 2016-05-10 2020-03-18 丸善製薬株式会社 Cosmetics

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080036315A (en) * 2006-10-23 2008-04-28 주식회사 두산 Situation mushroom lactic acid bacteria fermented product and preparation method thereof
KR20080114069A (en) * 2007-06-26 2008-12-31 전북대학교산학협력단 Functional Soy Sausage Using Protein and Anthocyanin Extract Extracted from Black Soybean and Its Manufacturing Method
KR20110050138A (en) * 2009-11-06 2011-05-13 (주)청산녹수 Homogenized aging rice wine manufacturing method
KR20150024628A (en) * 2013-08-27 2015-03-09 주식회사 더말코리아 Method for preparing fermented vegitable mucin from yam and cosmetic compositions with it having superior collagen synthetic abilities, moisturizing effect, skin protection and wound healing
CN105524964A (en) * 2016-02-17 2016-04-27 常州市庆发工业气体有限公司 Extraction method of collagen peptide from tremella

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230161560A (en) * 2022-05-18 2023-11-28 정도원농업회사법인 (주) Manufacturing method of onion juice with improved nutritional content and preference
KR102784276B1 (en) * 2022-05-18 2025-03-24 정도원농업회사법인 (주) Manufacturing method of onion juice with improved nutritional content and preference
KR20240064975A (en) * 2022-11-04 2024-05-14 삼성웰스토리 주식회사 Clean Label Plant-Meat
KR102851144B1 (en) * 2022-11-04 2025-08-27 삼성웰스토리 주식회사 Clean Label Plant-Meat
CN116920002A (en) * 2023-05-30 2023-10-24 广州家化化学有限公司 Mi Luo Mu extract with efficacy of removing erythema, and preparation method and application thereof
CN116920002B (en) * 2023-05-30 2024-01-30 广州家化化学有限公司 Mi Luo Mu extract with efficacy of removing erythema, and preparation method and application thereof
KR102604036B1 (en) * 2023-09-15 2023-11-20 주식회사 토리든 Cosmetic Composition for Improving Skin Wrinkle and Moisturizing Skin Comprising Plant-derived 5D Complex Collagen
WO2025058455A1 (en) * 2023-09-15 2025-03-20 주식회사 토리든 Cosmetic composition for reducing skin wrinkles and moisturizing skin containing plant-derived 5d composite collagen
CN117187307A (en) * 2023-10-25 2023-12-08 广州奥蓓斯化妆品有限公司 Tremella fermentation extract and preparation method thereof
CN117694549A (en) * 2024-02-05 2024-03-15 北京衡美金叶营养健康科技有限公司 Moisturizing, freckle-removing and whitening composition, preparation method and application
CN118743460A (en) * 2024-07-15 2024-10-08 广东同德药业有限公司 Anti-glycation beverage containing white kidney bean and cherry blossom compound extract and preparation method thereof
CN119506098A (en) * 2024-10-25 2025-02-25 青岛黛优佳生物科技有限公司 A kind of red ganoderma fermentation lysate and its preparation method and application

Also Published As

Publication number Publication date
JP2023532093A (en) 2023-07-26

Similar Documents

Publication Publication Date Title
WO2021261975A1 (en) Vegetable extract comprising vegetable collagen and vegetable mucin, and method for preparing same
WO2021137677A1 (en) Composition containing plant extract
KR102432924B1 (en) Extract and composition comprising plant-derived collagen and mucin
WO2020122360A1 (en) Method for preparing enzyme-treated zizania latifolia turcz. extract having increased tricin content, and composition for whitening, wrinkle reduction, anti-inflammation, anti-allergy and moisturization, prepared thereby
KR101914858B1 (en) Protein Hydrolysate of larva of Protaetia brevitarsis, Method for Preparing the Same and Composition Comprising the Same
WO2017146414A1 (en) Composition for skin moisturization and skin wrinkle alleviation, containing α-terpineol as active ingredient
WO2018004141A1 (en) Composition having effect of skin moisturization improvement, skin exfoliation, skin elasticity enhancement, erythema inhibition, skin wrinkle alleviation or skin photoaging alleviation, containing, as active ingredient, any one or more selected from group consisting of cymene, behenic acid, 2-methoxynaphthalene, thymol, and salts thereof
WO2016013709A9 (en) Composition for improving skin, containing pomegranate concentrate as active ingredient
WO2017222317A1 (en) Composition having effect of improving skin moisturization, removing skin keratin, improving skin elasticity, inhibiting erythema, improving skin wrinkles or improving skin photoaging, containing ionone or salt thereof as active ingredient
WO2020235941A1 (en) Spray composition for improving scalp health containing eoseongcho component
WO2018062777A1 (en) Muscular strength and muscle mass improving composition comprising soybean juice peptide derived from germinated soybean treated with unripened tangerine water
WO2018186640A1 (en) Composition for reducing skin wrinkles, moisturizing skin, improving skin elasticity, exfoliating skin, inhibiting erythema or reducing skin photoaging, containing ocimene or salt thereof as active ingredient
WO2022092735A1 (en) Composition containing 5-aminolevulinic acid hydrochloride
KR101935153B1 (en) Protein Hydrolysate of larva of Allomyrina dichotoma, Method for Preparing the Same and Composition Comprising the Same
WO2020218890A1 (en) Composition comprising actinidia polygama extract for alleviating skin damage or moisturizing skin
WO2018186641A1 (en) Composition for reducing skin wrinkles, moisturizing skin, improving skin elasticity, exfoliating skin, inhibiting erythema or reducing skin photoaging, containing piperonal or salt thereof as active ingredient
WO2018186644A1 (en) Composition for reducing skin wrinkles, moisturizing skin, improving skin elasticity, exfoliating skin, inhibiting erythema or reducing skin photoaging, containing jasmone or salt thereof as active ingredient
WO2018186643A1 (en) Composition for reducing skin wrinkles, moisturizing skin, improving skin elasticity, exfoliating skin, inhibiting erythema or reducing skin photoaging, containing cinchonine or salt thereof as active ingredient
WO2019059668A2 (en) Composition for skin, containing, as active ingredient, milk cream liquid fermented by lactic acid bacteria
WO2017142265A1 (en) Composition containing adipic acid as active ingredient for skin wrinkle alleviation and skin elasticity enhancement
KR20230108164A (en) Method for preparing plant-derived collagen
WO2019017677A2 (en) Composition comprising citral as effective ingredient for exhibiting effect of muscle strengthening, muscle enhancement, muscle differentiation, muscle regeneration, or sarcopenia suppression
WO2023113431A1 (en) Novel strain and use thereof
WO2024181725A1 (en) Red centella asiatica fermented with monascus and use thereof
WO2018186639A1 (en) Composition for reducing skin wrinkles, moisturizing skin, improving skin elasticity, exfoliating skin, inhibiting erythema or reducing skin photoaging, containing ionol or salt thereof as active ingredient

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21828670

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2022580932

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 21828670

Country of ref document: EP

Kind code of ref document: A1